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Abstract 
Current notions of genome organisation hold that chromatin is structurally and functionally 
partitioned into domains delimited by specialised chromatin elements. In transgenic studies a 
variety of chromatin domains and functional elements isolated from them have been shown to 
direct physiological levels of gene expression independent of the integration position of the 
transgene within the genome. This would make them useful components of transgene constructs 
which are intended to give reliably high levels of tissue-specific gene expression. Since most 
chromatin domains are larger than can be accommodated by conventional cloning vectors, the 
advent of systems for handling very large DNA molecules in vitro has greatly facilitated this 
work. In particular, yeast artificial chromosomes (YACs) have proved useful in the discovery 
and study of chromatin domain elements such as insulators, locus control regions and nuclear 
scaffold attachment regions. 
The principal aim of this project was to assay for position independent, copy number dependent 
and tissue- and developmental stage-specific gene expression from the human and murine casein 
gene loci in transgenic mice. Two overlapping YACs covering the murine casein gene locus 
were restriction mapped, generating the first reported physical map of this locus. The order of 
the five casein genes is a—f—y--€—ic; as in other mammals the ic casein gene, though 
evolutionarily unrelated to the other members of the locus, is closely linked, which may imply 
that casein gene expression is under locus control. The YACs are collinear within the region of 
overlap, suggesting that neither is rearranged. One of these YACs was manipulated with the 
intention of inserting a reporter gene under the control of an ovine -1actoglobulin promoter 
downstream of the murine 0 casein polyadenylation site, so that gene expression from the YAC 
could be detected against a murine background in cell culture or transgenic mice. In parallel, a 
YAC bearing the human casein locus was used to establish transgenic mice. Unexpectedly, none 
expressed detectable levels of human casein RNA when analysed by northern blot, although four 
produced human K casein RNA that was detectable by reverse transcriptase polymerase chain 
reaction, indicating basal levels of transcription of the gene. The reasons for this are unknown, 
though initial characterisation of genomic DNA from the transgenic animals suggests that the 
YAC is not intact in any of the eight lines. The human casein YAC was also transfected into 
HC 11 murine mammary epithelial cells with a view to assessing the level of human casein gene 
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expression from the YAC in vitro, but unfortunately no stably transfected cell lines were 
established. These results and their implications for the use of large DNA constructs in 
transgenic mammals are discussed. 
iv 
Acknowledgements 
Firstly I must thank my supervisors Mike Dalrymple, Angelika Schnieke, Ian Garner and David 
Melton for their support and patience throughout this project. Ian Garner in particular offered 
constructive criticism, support, encouragement and the occasional tab at all the right moments. I 
am also very grateful to the staff and management of PPL Therapeutics Ltd. for the opportunity 
to pursue this PhD, and to my labmates past and present for putting up with me, especially when 
I was writing up. You can have your computers back now. There is a list of very important 
people that all deserve a mention here, though more because they're my friends than for any 
trivial reasons such as material contributions to this work. In no order at all they are Geoff, Al, 
Ste, Paul, John, Miriam, Peet, Gordon('s), Celia, Simon, Jose, Sarah, Tim, Jenny, Sebastienne, 
Tim, Brian, Byro and Julian. Cheers. Special mention must go to my ex-flatmates Miriam, 
Julian and Celia for that fantastic year when I sorted myself out and learned advanced dinner 
party etiquette at Miriam's knee. We were cool. 
Serious bits: thanks to Sarah for helping me with the thesis and lots of other things, and for being 
so diverting. Thanks too to the Lads for crisis care and toxicity management when I needed it 
(not to mention outrageously salubrious dosshouse facilities), and for continuity of care despite 
my fickle dalliances with wives, careers and the like. Not so serious bits: no navel-gazing 
episode would be complete without mention of the monster, the black bomb, the tractor, the 
binned-it and Cliffhanger - all had their day, and all made a lasting impression on me (some 
more literally than others). 
Among the many great folk at PPL there are some that stand out. Andy Carver and Mike 
Dalrymple have sadly left along with Jayne Wu (née Keenan) and Anona Cranston (née 
Turnbull), but in times gone by they showed me the nobility of labour in quite unexpected ways. 
Still hanging on are other stalwarts like Ann Scott, Liz Emslie and Simon Temperley, who can 
still recall the great days when the mood is on them. Special thanks to Sebastienne, Chris and 
Jenny for valued friendship. Thanks also to those without whom this thesis would have been 
much worse. Katrina Gordon tried valiantly to teach me cell culture, Yvonne Gibson kept track 
of all of my mice far better than I did, and Chris Coles kept me well supplied with reading 
material, snide humour and Square Crisps. Ian Garner gave staunch unwavering support while I 
v 
was writing up, without which I would have been sunk, and the staff and students of the 
Wellcome Trust 19th Summer School convinced me that there was still some merit in molecular 
biology after all. 
I also want to thank my parents. Mum taught me that I was clever and Dad taught me that I 
wasn't stupid (and to weld, of course). Thank you both. You were right though - I'd probably 
have been happier in the Saracen's. 
Finally, thank you Karla. Rah rah PhD, yahda yahda, an' all that jazz ........ 
vi 
Abbreviations 




bp base pairs 
cDNA complementary DNA 
d days 
DNA deoxyribonucleic acid 
DNaseI deoxyribonuclease I 
dNTP 2'-deoxy (N) 5'-triphosphate; N can be 
adenosine (A), cytidine (C), guanosine (G) or 
thymidine (T) 




kb kilobase pairs 
1 litre 
LCR locus control region 
M molar 




MOPS 3-(N-morpholino)-propanesulphonic acid 
MW molecular weight 
Vii 
N 	 normal (molar equivalent) 
NaOAc 	 sodium acetate 
ng nanogramme 
NH4OAc ammonium acetate 
ni nanolitre 
nt nucleotides 
OD optical densitywaveleflgth in mzmometms 
pg picogramme 
PI picolitre 
RNA ribonucleic acid 
RNase A ribonuclease A 
rpm revolutions per minute 
rRNA ribosomal RNA 
SAR scaffold attachment region 
SDS sodium dodecyl sulphate 
sec seconds 
TEMED N, N, N', N' tetramethylethylenediamine 
tris tris (hydroxymethyl) aminoethane 
tRNA transfer RNA 
UHP ultra high purity (water) 
wlv weight per unit volume 
WAP whey acidic protein 
xg, g times the force of gravity 
viii 
Figures 
Figure Note Page 
Figure 1.1 The human -globin locus 13 
Figure 3.1 Murine 3 casein genomic probes 66 
Figure 3.2 Screening YAC clones by colony hybridisation 68 
Figure 3.3 Screening of YAC clones by PFGE and Southern blotting 69 
Figure 4.1 Genomic YAC mapping probes 75 
Figure 4.2 Restriction mapping of MP14 and MPI2 77 
Figure 4.3 Aligning restriction maps of MPI4 and MP12 78 
Figure 4.4 Mapping the murine a and 0 casein genes 80 
Figure 4.5 Resolving the munne a and 3 casein genes 81 
Figure 4.6 Mapping the murine y casein gene 83 
Figure 4.7 Mapping the murine ycasein gene 	 84 
Figure 4.8 Mapping the murine E casein gene 85 
Figure 4.9 Complete digests probed for E casein 	 86 
Figure 4.10 Partial restriction digests probed for ic casein 	 87 
Figure 4.11 Complete restriction digests probed for ic casein 88 
Figure 4.12 Comparison of reported casein locus maps 90 
Figure 5.1 Constructs used in MP14 manipulation 99 
Figure 5.2 Construction of pAR1 retrofitting construct 101/102 
Figure 5.3 Construction of the retrofitting vector pURACorp3 107 
Figure 5.4 Clones produced by transforming MP14 with pURACorp3 110 
Figure 5.5 Structure of yE43, yEll and yATS1 114 
Figure 5.6 Structure of yE92 115 
Figure 5.7 Fine structure of right arm of yE92 116 
Figure 5.8 Insertion of URA3 into the 3 casein locus of yE92 118 
Figure 6.1 HP8 YAC DNA purification 126 
Figure 6.2 Structure of probes for screening HP8 mice 127/128 
Figure 6.3 Initial screen for HP8 transgenic mice 130 
Figure 6.4 Secondary screening of HP8 GO animals 131 
Figure 6.5 HP8 YAC transgenic mice 133 
Figure 6.6 Northern blot analysis of human casein transgene expression 140 
Figure 6.7 RTPCR on HP8 mammary gland RNA 143 
Figure 6.8 RTPCR product sequences 144 
Figure 6.9 Scoring HP8 GI mice for the human P casein gene 147 
Figure 6.10 Scoring HP8 GI mice for the human a casein gene 148 
Figure 6.11 Scoring HP8 GI mice for the human ic casein gene 149 
ix 
Tables 
Table 	 Note 	 Page 
Table 2.1 Buffers and solutions 41/42 
Table 2.2 Bacterial and yeast media 42 
Table 2.3 Yeast medium supplements 43 
Table 2.4 Bacterial and yeast host strains 44 
Table 3.1 Murine casein screening probes 69 
Table 3.2 Murine casein YAC clones 70 
Table 4.1 Restriction fragments detected in Figure 4.2 78 
Table 5.1 pCorp3 expression data from previous work 96 
Table 5.2 Oligonucleotides used in YAC manipulations 102 
Table 6.1 Probes for screening HP8 mice 124 
Table 6.2 Summary of HP8 transgenic mouse studies 137 
Table 6.3 HP8 transgenic mice 138 
Table 6.4 RTPCR primers 143 
X 
Contents 
1. CHAPTER 1-INTRODUCTION 	 .1 
1.1 TRANSGENIC ANIMALS AS TOOLS FOR RESEARCH AND PROTEIN PRODUCTION ................................1 
1.1.1 Generation of transgenic mice by pronuclear microinjection................................................ 2 
1.1.2 Transgenic livestock................................................................................................................. 3 
1.1.3 Gene targeting in mice .............................................................................................................. 3 
1.1.4 Cloning by nuclear transfer.....................................................................................................4 
1.2 TRANSGENE EXPRESSION ................................................................................................................... 6 
1.2.1 Position effects .......................................................................................................................... 6 
1.2.2 Introns and transgene expression............................................................................................ 9 
1.3 1'HE ROLE OF CHROMATIN STRUCTURE IN GENE EXPRESSION .........................................................10 
1.4 THE 	 GLOBINLCR .......................................................................................................................... 	11 
1.4.1 Chromatin opening by the f3 globin LCR............................................................................... 13 
1.4.2 Transcriptional activation by the 6 globin LCR.................................................................... 14 
1.4.3 Developmental regulation of the 13 globin locus................................................................... 16 
1.4.4 Models 0fLCR function.......................................................................................................... 19 
1.5 OTHER LONG RANGE CONTROL ELEMENTS...................................................................................... 22 
1.5.1 Structural chromatin elements and insulators....................................................................... 26 
1.6 YEAST ARTIFICIAL CHROMOSOMES.................................................................................................. 28 
1.6.1 Transgenic animals and YACs............................................................................................... 30 
1.7 THE MILK PROTEIN GENES ................................................................................................................. 31 
1.7.1 13 lactoglobulin........................................................................................................................ 31 
1.7.2 a lactalbumin.......................................................................................................................... 34 
1.73 Whey acidic protein................................................................................................................ 34 
1.7.4 The caseins .............................................................................................................................. 36 
1.8 SUMMARY OF PROJECT AIMS ............................................................................................................ 38 
2. 	CHAPTER 2- MATERIALS AND METHODS ................................................................................ 40 
	
2.1 	SUPPLIERS OF MATERIALS................................................................................................................40 
2.1.1 	Bacterial and yeast media.....................................................................................................40 
2.1.2 PFGE reagents.......................................................................................................................40 
2.1.3 	Enzymes ................................................................................. . ................................................. 40 
2.1.4 Southern blotting materials....................................................................................................40 
2.1.5 	Radiolabelled reagents...........................................................................................................41 
2.1.6 Mice.........................................................................................................................................41 
2.2 	BUFFERS AND SOLUTIONS - TABLE 2.1 ............................................................................................42 
2.3 MEDIA FOR YEAST AND BACTERIAL CULTURE.................................................................................43 
2.3.1 	Yeast "dropout" powders.......................................................................................................43 
2.4 	PLASMID DNA STOCKS ....................................................................................................................44 
X1 
2.5 	GENOMIC DNA STOCKS 	 .44 
2.6 BACTERIAL AND YEAST HOST STRAINS............................................................................................ 45 
2.7 	PLASMID DNA PREPARATION .......................................................................................................... 45 
2.71 Alkaline Lysis miniprep.......................................................................................................... 45 
2.72 Large scale "midi" plasmid DNA prep................................................................................. 46 
2.8 	GENOMIC DNA PREPARATION......................................................................................................... 48 
2.8.1 From mouse tail biopsy.......................................................................................................... 48 
2.8.2 From yeast - DNA in agarose plugs...................................................................................... 49 
2.9 	ETHANOL PRECIPITATION OF DNA.................................................................................................. 49 
2.10 QUANTIFICATION OF DNA.......................................................................................................... 49 
2.11 ENZYMATIC MODIFICATIONS OF DNA - RESTRICTION DIGESTS, LIGATIONS ETC ..................... 50 
2.12 GEL-PURIFICATION OF SMALL DNA FRAGMENTS....................................................................... 51 
2.13 DNA SEQUENCING ...................................................................................................................... 51 
2.14 RADIOLABELLING OF DOUBLE-STRANDED DNA ......................................................................... 52 
2.15 RADIOLABELLING OF OLIGONUCLEOTIDES ................................................................................. 53 
2.16 POLYMERASE CHAIN REACTIONS (PCR) ..................................................................................... 53 
2.16.1 Amplification of murine /3 casein probes /33 and /35........................................................ 53 
2.162 Amplification of human /3 casein probe from human genomic DNA ............................... 53 
2.163 Amplification ofTRP1 for construction ofpURACorp3.................................................. 53 
2.164 Amplification of HIS3 for retrofitting ofyATSi ............................................................... 54 
2.17 REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTIONS (RTPCR)...................................... 54 
2.17.1 Amplification of murine casein cDNA probes................................................................... 54 
2.17.2 RTPCR to detect human casein gene expression in HP8 mice........................................ 55 
2.18 ELECTROPHORESIS OF DNA........................................................................................................ 55 
2.19 SOUTHERN TRANSFER OF DNA ................................................................................................... 55 
2.20 HYBRIDISATION OF SOUTHERN BLOTS AND COLONY LIFT FILTERS............................................ 56 
	
2.21 	AUTORADIoGRAPHY .................................................................................................................... 56 
2.22 RNA PREPARATION ..................................................................................................................... 56 
2.23 	NORTHERN BLOTS........................................................................................................................ 56 
2.24 PULSED FIELD GEL ELECTROPHORESIS ...................................................................................... 57 
2.25 	PREPARATION OF CHEMICALLY COMPETENT E. COLI FOR TRANSFORMATION..........................58 
2.26 TRANSFORMATION OF CHEMICALLY COMPETENT E. COLI ........................................................58 
2.27 	YEAST COLONY LIFT PROTOCOL.................................................................................................. 59 
2.28 YEAST STRAIN MATING .............................................................................................................. 59 
2.28.1 	Mating on solid medium ....................................................................................................59 
2.28.2 Random sporulation...........................................................................................................60 
2.29 	YEAST TRANSFORMATION ...........................................................................................................60 
2.29.1 	Lithium acetate transformation.........................................................................................60 
2.29.2 Yeast spheroplast transformation......................................................................................61 
3. CHAPTER 3- SCREENING AND CLONE CHARACTERISATION .......................................... 63 
3.1 	SUMMARY.........................................................................................................................................63 
3.2 	PROBES .............................................................................................................................................64 
xii 
	
3.2.1 	Genomic probes 	 . 64 
3.3 	PRIMARY LIBRARY SCREENING ........................................................................................................67 
3.4 	SECONDARY SCREENING ..................................................................................................................67 
4. 	CHAPTER 4- MAPPING THE MOUSE CASEIN GENE LOCUS...............................................73 
4.1 	INTRODUCTION .................................................................................................................................73 
4.2 PROBES .............................................................................................................................................74 
4.3 	CALCULATION OF RESTRICTION FRAGMENT SIZES ..........................................................................76 
4.4 A RESTRICTION MAP OF THE MOUSE CASEIN GENE LOCUS ..............................................................76 
4.4.1 	Organisation of the murine casein genes..............................................................................79 
4.5 	DISCUSSION ......................................................................................................................................91 
5. 	CHAPTER 5- MOUSE YAC MANIPULATIONS............................................................................ 96 
5.1 INTRODUCTION................................................................................................................................. 96 
5.2 RETROFITTING MP14 FOR COPY NUMBER AMPLIFICATION........................................................... 100 
5.2.1 Construction ofpARl retrofitting construct........................................................................100 
5.2.2 Change of MP14 yeast host strain.......................................................................................104 
5.2.3 Use of pAR1 .......................................................................................................................... 105 
5.3 INSERTION OF PCORP3 INTO MP14 VECTOR ARM ......................................................................... 106 
5.3.1 Construction ofpURACorp3 ..................... ........................................................................... 106 
5.3.2 Transformation ofp URA Corp3 into MPJ4 ......................................................................... 108 
5.4 TWO-STEP GENE TARGETING OF PCORP3 TO THE MP14 0 CASEIN LOCUS ...................................111 
5.4.1 New his3 MPI4 derivative strain ......................................................................................... 111 
5.4.2 Replacement of URA3 with HIS3 on yATSJ ........................................................................ III 
5.4.3 Two-step gene targeting....................................................................................................... 113 
6. 	CHAPTER 6- HUMAN YAC TRANSGENIC MICE .................................................................... 121 
6 .1 INTRODUCTION............................................................................................................................... 121 
6 .2 YAC DNA PREPARATION.............................................................................................................. 123 
6.3 	CONSTRUCTS AND PROBES ...............................................................................  .............................. 124 
6.4 HP8 MICROINJECION STUDY I......................................................................................................129 
6.5 	HP8 MICROINJECTION STUDY II.....................................................................................................132 
6.6 	SUMMARY OF HP8 TRANSGENIC FOUNDERS .................................................................................138 
6.7 ANALYSIS OF HUMAN CASEIN GENE EXPRESSION IN 1HP8 TRANSGENIC MICE ..............................139 
67.1 	Analysis by northern blot.....................................................................................................139 
6.7.2 Analysis by RTPCR...............................................................................................................143 
67.3 	Southern analysis of Gi mice...............................................................................................147 
6.8 	DISCUSSION ....................................................................................................................................151 
7. 	CHAPTER 7 — DISCUSSION ............................................................................................................. 158 
7.1 	CASEIN GENE EXPRESSION .............................................................................................................158 
7.2 MAPPING AND MANIPULATION OF THE MURINE CASEIN YACS ....................................................161 
7.3 	HUMAN CASEIN YAC TRANSGENIC MICE......................................................................................163 
7.4 FURTHER WORK..............................................................................................................................165 
xlii 
7.5 	SUMMARY 	 . 169 
xiv 
to whom I owe the leaping delight 
xv 
1. Chapter 1 - Introduction 
1.1 Transgenic animals as tools for research and protein production 
The use of transgenic animals in research and biotechnology is now well established (reviewed 
by Clark et al. 1992). The core technology consists of the introduction of a cloned DNA 
construct into the germ line of the animal, either by gene targeting in embryonic stem cells, 
transfer of transfected cells into enucleated oocytes (nuclear transfer) or, more commonly, by 
pronuclear injection of a fertilised egg (reviews: Palmiter and Brinster, 1986; Moreadith and 
Radford, 1997; Wolf et al. 1998). Transgenic animals of a number of species have now been 
described including mice, rats, rabbits, sheep, goats, cattle and pigs. Transgenic mice have 
generally been the research tool of choice while transgenic livestock have been used for 
agricultural strain improvement and the large-scale production of therapeutic proteins, notably in 
the milk (reviewed by Clark, 1992). The potential of this system is widely recognised, and 
therapeutic proteins have already been expressed at economically-viable levels in the milk of 
transgenic sheep (reviewed by Clark et at. 1992a). Compared to in vitro cell-based sources 
transgenic animals produce protein which is relatively pure, appropriately modified and 
efficiently secreted. Therapeutic proteins are also purified from natural human sources but in 
many cases the protein is present at low concentration in the source material and purification is 
therefore prohibitively expensive or impossible. In addition the risk of disease transmission, 
especially from human blood products, is significant. Transgenic animals might circumvent all 
of these problems by producing large quantities of easily purified human protein in a disease-
free environment at a very low cost. 
The use of transgenic animals has greatly advanced our understanding of gene expression, and in 
particular the role of chromatin structure in controlling transcription. Only in whole animals can 
the full complexity of gene control by developmental stage, tissue type and hormonal action be 
studied. Only whole animals undergo embryogenesis, which has important implications for the 
expression of a number of genes. The remodelling of chromatin during development of a 
differentiated cell type is not replicated in tissue culture, where introduced DNA encounters a 
fully differentiated chromatin structure immediately. This may be important in such phenomena 
as position effect variegation (reviewed by Karpen, 1994), the role of introns in transgene 
expression (Brinster et al. 1988) and the opening of chromatin by locus control regions (LCRs; 
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reviewed by Kiousiss and Festenstein, 1997). In addition, cell culture does not necessarily 
replicate the full range of gene expression seen in the tissue, especially when cell-cell 
interactions are important controls, as is the case in the mammary gland, for example. 
1.1.1 Generation of transgenic mice by pronuclear microinfection 
Since the pioneering work of Palmiter and Brinster (reviewed by Palmiter and Brinster, 1986) 
this technology has become widespread. It is by far the most common means of generating 
transgenic mice and other animals, and technical manuals are available (e.g. Hogan et al. 1986). 
DNA is usually injected into the pronuclei of fertilised mouse eggs as pure linear molecules in a 
low salt buffer. The eggs are then transferred into the oviduct of day 1 pseudopregnant foster 
mice and carried to term. The pups are screened for the presence of the transgene, usually by 
PCR and/or Southern blot of tail biopsy DNA. Typically, 10 % of live births are transgenic 
(reviews: Palmiter and Brinster, 1986; Pinkert, 1994), although much higher and lower 
frequencies may be observed. 
Among the poorly understood phenomena associated with transgenesis the most striking is the 
mechanism of integration of the transgene into the host genome as tandem arrays of between 1 
and over 200 copies. Integration rarely occurs at more than a single site which suggests that the 
introduction of a break in the genome may be the rate limiting step. The process by which the 
injected DNA forms tandem arrays is not understood. A model has been proposed by Bishop. 
and Smith (1989) in which injected DNA fragments are circularised in the egg and homologous 
recombination with other linear molecules extends the circle to a large circular head-tail 
concatemer. The circular array may then be broken randomly and incorporated opportunistically 
into the genome at a chromosomal break. This model accounts for tandem arrays and for the 
rarity of integration, because chromosomal breaks are rare. However; it does not explain why 
linear molecules are integrated preferentially over circular molecules (reviewed by Palmiter and 
Brinster, 1986). In addition the prediction of the model that the end copies of a transgene array 
will be incomplete is not borne out by direct cloning of transgene-transgene and transgene-
genome junctions (A. Turnbull, personal communication; McFarlane and Wilson 1996; A. 
Tomlinson and M. Dalrymple, unpublished results). 
2 
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1.1.2 Transgenic livestock 
There are several technical and logistical problems associated with extending the pronuclear 
microinjection technology from mice to livestock. Typically, low numbers of ova are obtained 
from superovulated livestock and so high numbers of animals must be superovulated and 
subjected to rapid surgery to obtain sufficient numbers of eggs. Bovine ova have been obtained 
from slaughterhouses and matured and fertilised in vitro, but the viability of embryos produced 
in this way is low (Krimpenfort etal. 1991; summarised by Clark et al. 1992a). Large animals 
rarely carry more than twins, although pigs are a notable exception, and pregnancy rates are 
generally poor, so large numbers of recipients are usually needed. Lastly, the generation time of 
large animals is very long in research terms, often involving a wait of many months between 
microinjection and phenotypic analysis. These factors and the extremely high cost of farm 
animal husbandry on this scale compared to mouse husbandry mean that transgenic farm animals 
represent a major undertaking in time and resources (reviews: Clark et al. 1992; Wall and Seidel, 
1992; Pursel and Rexroad, 1993). However, the potential benefits to medicine and agriculture 
are sufficient to warrant continued research in this area. To date, transgenic goats, sheep, pigs 
and cows have been generated (e.g. Clark et al. 1989; Wall et al. 1991; Ebert etal. 1991; 
Krimpenfort et al. 1991), and three therapeutic proteins produced in transgenic animals are 
currently undergoing clinical trials. Human a—i antitrypsin (AAT) has been expressed in 
transgenic sheep (Wright et al. 1991) and is currently in Phase llb clinical trials as a treatment 
for lung damage in victims of cystic fibrosis. Human antithrombin HI has been produced in 
transgenic goats (Edmunds et al. 1998) and is currently in clinical trials as an adjunct to 
anticoagulant treatment during coronary artery bypass grafting (Scrip 2192, 1996). Human 
cx—glucosidase, produced in transgenic rabbits (Bijvoet et al. 1998), is currently in clinical trials 
as a treatment for Pompe's disease (Scrip 2328, 1998). All of these proteins are secreted into the 
milk of the transgenic animal. 
1.1.3 Gene targeting in mice 
The generation of mouse clones from cultured embryonic stem (ES) cells is an established 
technology (Thompson et al. 1989; reviewed by Moreadith and Radford, 1997). ES cells lines 
are pluripotent, may be stably propagated in culture and when microinjected into an early 
embryo can contribute to all tissues of the resultant chimera. DNA may .be introduced and 
3 
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randomly integrated into ES cells as an alternative to the microinjection of DNA into zygotes. 
This has been used to introduce YACs into the mouse germline (Jakobovits et al. 1993). 
However, the greatest potential of ES cells lies in their amenability to modification by 
homologous recombination (HR; Capecchi, 1989), which has facilitated the generation of 
genetically modified mice by gene targeting (reviewed by Brandon et al. 1995). The targeting 
construct is transfected into ES cells and transfected cells are screened for the HR event. 
Positive cells are microinjected into recipient blastocysts which are then transferred into foster 
animals and carried to term. The resultant chimeras are bred to establish germline transmission 
of the desired genotype. This technology has mostly been used to generate loss of function or 
"knockout" mutations, but has also been used to introduce genes into specific loci, make defined 
changes in genes or control sequences and to replace one gene with another. This latter 
procedure involves two targeting events, inserting the hypoxanthine phosphoribosyltransferase 
(HPRT) counterselectable marker as an intermediate which is removed in the second targeting 
event, leaving only the intended alteration to the mouse genome (Reid etal. 1990). 
Thus, gene targeting in murine ES cells is a powerful technique in that it allows predetermined 
changes to be made to the mouse genome which may not readily be achieved by any other 
means. However, gene targeting is time-consuming compared with pronuclear microinjection. 
In addition, expression of a transgene may be improved as a result of the multimerisation that 
often accompanies random transgene integration. Nevertheless, for investigation of the 
subtleties of gene expression at natural loci and for definitive loss of function studies, gene 
targeting in mice remains the paradigm. There are efforts to develop ES cells for other species 
which have been partially successful; rat (lannaccone, 1994) and pig (Wheeler, 1994) chimeras 
have been reported. However, germline transmission has not been demonstrated in either case. 
Thus, to date this technology is confined to mice. 
1.1.4 Cloning by nuclear transfer 
Another method for the introduction of exogenous DNA into the germline of mammals has 
recently emerged with the generation of viable sheep (Campbell et al. 1996; Wells et al. 1997; 
Schnieke etal. 1997; Wilmut et al. 1997), cattle (Cibelli etal. 1998), and mice (Wakayama et al. 
1998) by nuclear transfer from cultured primary cells. Cloning was first achieved in mammals 
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by embryo splitting (Willadsen, 1979) but separation of an embryo into more than two parts 
gives drastically reduced viability (reviewed by Wolf et al. 1998). Nuclear transfer advanced 
this technology because single embryonic cells could be transferred into enucleated oocytes to 
give viable offspring, thus generating numbers of cloned animals from a single early embryo. 
Eventually these cells were successfully cultured for increasing periods of time prior to nuclear 
transfer, and ultimately animals were derived from cells taken from proliferating culture, thus 
giving access to potentially unlimited numbers of cloned animals as well as the possibility of 
cell-mediated transgenesis in non-murine species (reviewed by Wolf et al. 1998). 
The advantages of this technique over earlier cloning experiments using ex vivo embryonic cells 
are that it allows much larger clones of animals to be generated and that the cells may be 
modified in culture, generating cloned transgenic animals which would greatly reduce the 
wastage inherent in traditional microinjection-based transgenesis. 
There are a number of further advantages that nuclear transfer might have over microinjection 
for the generation of transgenic animals. All of the animals derived from the same cell 
population would be of the same sex which would be useful for production of proteins in the 
mammary gland, for example. Mosaicism would be avoided and thus founder (G 0) animals 
could be used for production, which would save a great deal of time when dealing with large 
animals. Generation of large numbers of animals for production purposes would be simpler and 
faster than by normal means, and the genetic stability of the transgene would not be a factor if 
the production animals were all founders. Screening of transfected cell lines might reduce the 
number of animal lines which have to be produced to obtain high expression and maximise the 
potential of a given construct. Ultimately, gene targeting followed by nuclear transfer could 
allow work in other species to parallel the ES cell-based work in mice. The first transgenic 
cloned mammals have already been produced (Schnieke et al. 1997; Cibelli et al. 1998), proving 
that at least in principle this technology is viable. 
However, there are many technical problems associated with nuclear transfer at present. 
Transfer of cells from adult somatic tissue is possible (Wilmut et al. 1997) but in practice there 
should be no need to use adult tissue to establish suitable cell lines. Nuclear transfer from foetal 
cells is more straightforward but still relatively inefficient compared to embryo transfer 
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following microinjection. The value of screening for transgene expression in cultured cells 
would far outweigh this problem but to date this is not feasible for genes which are not normally 
expressed in those cells. Work is underway to establish cell lines which may mimic terminally 
differentiated tissue such as the mammary epithelium, whilst remaining amenable to nuclear 
transfer (Gordon et al. in press). The combination of HR and nuclear transfer which would 
allow gene targeting experiments to be carried out in non-murine mammals is a distant goal at 
present, but would be of considerable use in both research and medicine. For example, deletion 
of porcine cell-surface markers might overcome hyperacute rejection of porcine-human 
xenografts. 
1.2 Transgene expression 
1.2.1 Position effects 
Expression levels of most transgenes are low with respect to the endogenous gene, vary over 
several orders of magnitude between transgenic lines, are unrelated to copy number and may be 
spatiotemporally inappropriate (reviewed by Brinster et al. 1986). These results have been 
ascribed to influences of the chromatin surrounding the site of integration, which had been 
named the position effect in earlier studies of natural translocations and integrations, particularly 
in Drosophila (reviewed by Udvardy, 1999). The subsequent discovery of sequences which 
could overcome these effects has greatly advanced the study of genome structure, particularly 
the involvement of chromatin in the control of gene expression. 
The lack of correlation between transgene expression and copy number is most often cited as the 
definitive evidence for a position effect. A position effect may be more accurately defined as a 
change from the expected transgene expression level due to its position in the genome. This 
could include an increase in transcription as well as a decrease, and also a change in the pattern 
of expression. In most cases in fact, the exact expression level and pattern of a transgene cannot 
be precisely predicted, because position effects can never be ruled out. However, by generating 
many lines of transgenic animals, the general expression pattern of a transgene can be estimated. 
Position effects are classically due to translocations of endogenous genes and here it is 
straightforward to describe the change in expression. In this context, a position effect is 
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diagnosed when a chromosomal rearrangement causes a change in the expression pattern of a 
gene without perturbation of the transcription unit or proximal promoter, although this may be 
difficult to demonstrate definitively if the gene has not been fully characterised. For example, 
Nishio et al (1994) discovered an additional exon of the dystrophin gene some 500 kb 5' to the 
previously described promoter. 
Position effects have been studied extensively in Drosophila. The P transposon system allows 
single copy transgenics to be made and for the transgene to transpose inducibly. This facilitates 
the study of single copies of the transgene in multiple integration sites. Multiple copy genes are 
frequently silenced in Drosophila, and indeed a similar system has been proposed to explain the 
generally lower levels of gene expression per copy that are seen in multiple copy transgenic 
vertebrates (Dorer, 1997). As yet there is little concrete evidence to support this hypothesis. 
Stable position effects are thought to occur when by translocation or transgenesis a gene is 
separated from some of its cognate control elements, or brought under the influence of newly-
juxtaposed elements, and thus fails to express efficiently. The loss of elements which protect the 
gene from neighbouring chromatin effects might result in silencing or inappropriate activation. 
Alternatively the effect of a gene's cognate enhancer might be diluted by competition from a 
newly juxtaposed promoter for the enhancer activity. Finally, if a gene is normally activated by 
an LCR (see below), removal of the LCR might result in a combination of inappropriate 
activation and general silencing due to the loss of a chromatin-opening function (reviewed by 
Higgs, 1998). Stable position effects lead to reproducible expression between animals of the 
same transgenic line. 
Position effect variegation (PEV) has been extensively studied in yeast and Drosophila. It is 
characterised by a variation in expression of the transgene, or translocated gene, between 
animals of the same line, and also between cells within the same tissue. PEV is thought to occur 
when a gene is introduced near to heterochromatin such that the heterochromatin may engulf and 
silence the gene in some cells but not others. At some point in development the 
heterochromatinisation of a cell lineage appears to be fixed, because in variegated tissue clonal 
inheritance of expression characteristics is observed. Interestingly, two Drosophila genes have 
been moved from heterochromatin to euchromatin, and display PEV in their new locations 
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(reviewed by Kleinjan and van Heyningen, 1998). This suggests that heterochromatin may not 
simply be a stochastically silent transcriptional region but may in fact be a fundamentally 
different transcriptional area of the genome, possibly mediated by the physical separation of 
heterochromatin and euchromatin within the interphase nucleus (reviewed by Karpen, 1994). 
PEV has not been definitively demonstrated in vertebrates,. There are several reports which 
describe mosaicism in the expression of transgenes and invoke PEV as a probable cause 
(Pretcheva etal. 1994; Dobie et al. 1996; Robertson et al. 1995) but not all of these transgenes 
are inserted into obvious heterochromatin. In Drosophila tandem gene arrays tend to become 
heterochromatinised (Dorer and Henikoff, 1994) and this has been suggested to occur in 
vertebrates (Dobie et al. 1996, Dorer, 1998). However, there are few supporting data at present 
and the occasionally described reduction. in expression per copy could in most cases be due to 
titration of trans-acting factors. Davis and McDonald (1988) used double transgenics and 
nuclear run-on analyses to show that the average rate of transcription per gene decreased with 
increased copy number of an elastase I (El) transgene, while 250 copies of this gene had no 
deleterious effect on the expression of a growth hormone transgene driven by the same El 
promoter at a different integration site. However, although this study demonstrated a lack of 
competition for the enhancer; there may be other essential factors that bind elsewhere in the El 
transgene which are titrated in multiple copy lines. 
Dobie et a! (1996) described PEV in transgenic mice carrying an ovine Vlactoglobulin (BLG) 
transgene. Here there was a clear correlation between apparent PEV and pericentromeric 
integration, as shown by fluorescent in situ hybridisation (FISH). In this paper it was reasoned 
that the transgene repeats themselves might attract heterochromatinisation similarly to repeated 
sequences in Drosophila (Dorer and Henikoff, 1994). Elliot et al (1995) described an apparent 
PEV when transgenic mice were generated carrying a human CD2 transgene including the LCR 
(Greaves et al. 1989) linked to the immunoglobulin heavy chain enhancer Eji. Normally the 
CD2 transgene would be expressed position independently and copy number dependently, but in 
the presence of Ep some lines displayed PEV. In the silenced loci the chromatin was found to 
be resistant to nuclease digestion, specifically lacking the hypersensitive sites characteristic of 
the CD2 LCR. In addition to demonstrating that the effects of the LCR may be overcome by the 
presence of other elements in cis and therefore that the LCR may not give truly position- 
8 
Chapter 1 - Introduction 
independent expression, these results have also been interpreted to support the hypothesis that 
heterochromatinisation may be potentiated by transgene repeats in vertebrates (Dorer, 1998). 
However, two of the five PEV lines are described as low copy number and one is said to be two 
copy. At least one of the non-PEV lines is also two copy. Thus, transgene copy number alone 
has no proven correlation with PEV in this experiment. It is possible that additional factors such 
as the position of integration have an effect on the probability of gene silencing in the 
variegating mice. 
Whatever its aetiology, and whether or not it is analogous to PEV in Drosophila, variegated 
transgene expression in vertebrates has been unequivocally demonstrated and could pose major 
practical difficulties in the application of transgenesis for medicine. For example, in a mouse 
model of Duchenne muscular dystrophy (DMD), gene therapy by transgenesis was impaired by 
mosaic expression of the transgene (reviewed by Dorer, 1998). In the remodelling of porcine 
cell surface markers to render pig organs suitable for transplantation into humans, mosaicism 
- could mean that a proportion of the cells of the organ remain antigenic and result in rejection. In 
addition, the recent reports connecting vertebrate PEV with LCR function and chromatin 
dynamics (reviewed by Kioussis and Festenstein, 1997) suggest that this phenomenon might 
soon be incorporated into the overall picture of gene expression in vertebrates, and prove to be 
more than a curiosity of transgene expression. 
1.2.2 Introns and transgene expression 
Owing to the relative ease with which they can be cloned and the occasionally prohibitive size of 
genomic constructs, cDNAs have often been introduced into transgenic animals. Although 
cDNAs are expressed efficiently in cell culture, in transgenic animals efficient cDNA expression 
is rare (reviewed by Palmiter and Brinster, 1986), though with some exceptions (Ebert et al. 
1991; Velander et at. 1992). This has resulted in the interesting finding that introns, particularly 
intron 1 of several genes (Brinster et at. 1988; Whitelaw et at. 1991; Aronow et at. 1992; 
Hurwitz et at. 1994), can enhance the transcription of many cDNA and minigene constructs. 
Heterologous introns seem to function as well as homologous introns (Palmiter et at. 1991). The 
mechanism of this phenomenon is unknown, but may provide insights into chromatin 
remodelling at transcription as well as a practical means of enhancing transgene expression from 
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cDNAs. A construct based on a published ovine —lactogIobulin (BLG) expression vector but 
with the first intron and non-coding exon from the bovine —casein gene has resulted in 
expression of transgenic cDNAs which is comparable to that of the equivalent genomic construct 
(I. Garner, unpublished results). 
1.3 The role of chromatin structure in gene expression 
The current view of the genome is that it consists of essentially discrete transcriptional domains 
which are somehow prevented from interaction with neighbouring domains by specialised 
chromatin elements. Constructs which show position independent expression in transgenic 
animals are thought to be able to create discrete chromatin domains autonomously and therefore 
to contain all of the necessary components of such. domains. Prevailing ideas on how these 
domains may be maintained and some of the elements which may be involved are discussed 
below (reviews: Sippel et al. 1992; Kollias .and Grosveld, 1992; Sippel et al. 1993; Geyer, 1997; 
Kioussis and Festenstein, 1997; Hart and Laemmli, 1998; Udvardy, 1999). Broadly, these 
elements may be delineated into LCRs, insulators and structural chromatin elements. 
Actively transcribed genes are invariably found to reside within a region of chromatin with 
increased sensitivity to DNase I digestion, which may extend far to either side of the gene. 
"Open" or "decondensed" chromatin is also referred to as euchromatin, contrasting with 
"closed", "condensed", heterochromatin. In general, euchromatin is replicated early in the cell 
cycle, is physically decondensed, concentrates in the interior of the nucleus, is CpG-
hypomethylated and contains hyperacetylated histones, while heterochromatin generally has the 
opposite properties (reviewed by Higgs, 1998). In addition to the mild hypersensitivity of open 
chromatin to DNaseI. digestion, there are smaller discrete DNase I hypersensitive sites (HSs), 
which are some 100 fold more sensitive to DNaseI than bulk chromatin. These are sites of 
protein-DNA interaction as determined directly and by the presence of consensus binding sites 
for DNA-binding proteins (reviews: Sippel et al. 1993; Higgs, 1998). 
Thus, active transcription of a gene is associated with a decondensed, open chromatin 
configuration and the presence of DNase I hypersensitive protein binding sites. However, the 
causal relationship between the chromatin opening, binding of protein factors and active 
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transcription is open to question. In particular, whether open chromatin is a requirement for 
transcriptional activation or a direct topological result of active transcription has not been 
unequivocally resolved. 
The description of the position effect led to a functional assay for complete transcription loci, 
because only a construct containing all of the regulatory elements associated with a gene will be 
expressed in a correct, position-independent, copy number dependent pattern. A number of loci 
have now been used to successfully reproduce this pattern of expression in transgenic animals 
(Grosveld et al. 1987; Chamberlain et al. 1988; Lang et al. 1988; Greaves et al. 1989; Bonifer et 
al. 1990; Aronow et al. 1992; Carson and Wiles, 1993; Neznanov et al. 1993; Schedl et al. 
1993a; Palmiter et al. 1993; Diaz et al. 1994; Talbot et al. 1994; Jones et al. 1995; May and 
Enver, 1995; reviews: Higgs, 1998; Udvardy, 1999) of which the most intensively studied is the 
human f3-globin locus (Grosveld et al. 1987; Blom van Assendelft et al. 1989). A new 
regulatory element, the locus control region (LCR), was described in these studies. The LCR 
was defined functionally as able to confer high (i.e. physiological), tissue specific, position 
independent and copy number dependent levels of expression upon a Pglobin transgene. A 
number of discrete functions have since been ascribed to LCRs (reviewed by Higgs, 1998) but 
broadly these may be divided into chromatin remodelling and transcriptional control. The globin 
LCR, for example, seems to mediate the formation of an erythroid-specific open chromatin 
domain and to strongly enhance the transcription of the globin genes at appropriate 
developmental stages. Since the P globin locus contains the archetypal LCR a summary of the 
key findings in this area is presented below, followed by a brief consideration of some of the 
chromatin remodelling functions associated with other gene loci reported in recent years. 
1.4 The 3 globin LCR 
The human 3—globin locus comprises 5 closely related genes, E which is expressed in the yolk 
sac, y° and yA which are expressed in the foetal liver, and ö and 0 which are expressed in the 
adult bone marrow and peripheral reticulocytes; there is also a nonexpressed pseudogene (Figure 
1.1; reviews: Maniatis etal. 1981; Kollias and Grosveld, 1992; Martin et al. 1996). The genes 
are located at the locus in order of their expression during development (Figure 1. 1), and are all 
transcribed from the same strand. Many natural mutations in the 0 globin locus have been 
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described which perturb the normal patterns of expression and lead to clinical disorders 
including sickle-cell anaemia and various 13thalassaemias. Analysis of one such lesion 
(Hispanic thalassaemia) which deleted 35 kb of DNA approximately 15 kb upstream of the locus 
led to the description of the LCR. The LCR consists of 4 sites, HS  to HS4, which are 
extremely hypersensitive to DNase I and are located approximately 12 to 20 kb upstream of E 
globin (Figure 1.1). These sites are developmentally stable but are only present in erythroid cell 
lineages. In addition, there is a constitutive hypersensitive site, 5' HS5, located further 
upstream, which has been reported to have an insulator function (Li and Stamatoyannopoulis, 
1994; Chung et al. 1993; reviewed by Geyer, 1997). Recently the existence of a sixth DNaseI 
hypersensitive site (HS6) has been reported in mice (Bender et al. 1998) but this does not appear 
to be conserved in humans. In erythroid cells the globin locus resides in a region of open 
chromatin which extends 3' from HS5 for approximately 200 kb and appears to be dependent 
upon the LCR, as suggested by transgenic studies and naturally occurring mutations (Kioussis et 
al. 1983; Grosveld et al. 1987; Forrester etal. 1990). 
Following the report by Grosveld et a! (1987) that a construct based on the human 13 globin locus 
including the LCR was expressed in a correct, position independent pattern in transgenic mice, 
several groups began dissecting the structure and function of HS 1 to HS4 (reviews: Kollias and 
Grosveld, 1992; Grosveld et al. 1993; Engel, 1993; Wood, 1996; Martin et al. 1996; Kioussis 
and Festenstein, 1997; Higgs, 1998; Udvardy, 1999). In general, studies have involved 
constructs containing subsets of the LCR in attempts to dissect the chromatin opening function 
from the transcriptional activator function, and to define minimal sequences required for each. 
Broadly, these attempts were unsuccessful until very recently, although some useful insights 
were gained into the LCR function. There are numerous conflicts in the data, which mainly 
seem to depend on the exact constructs and criteria employed. For example, Ellis • et a! (1993) 
suggest that deletion of the GATA-1 or USF transcription factor binding sites in a 215 bp 
synthetic HS2 construct has no significant effect on the expression of a linked 13 globin gene, but 
using a 1.9 kb HS2 fragment Caterina et a! (1994) demonstrate that deletion of these sites leads 
to a 75 % diminution in 13 globin mRNA levels. It seems that in isolation a given LCR element 
may exhibit different effects from those observed in a more natural context. In addition, the 
spatial organisation of the control elements may be of functional significance. Finally, although 
the correlation of DNaseI hypersensitivity with LCR function cannot be denied, there is no 
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reason to suppose that all of the functionality of the LCR is confined to the hypersensitive sites, 
since no report has demonstrated full LCR activity from a miniconstruct containing only HSs 1-4 
without any intervening DNA. In this light, it would seem prudent to view with caution all 
results obtained by deletion and mutation of small portions of the P globin LCR, since the 
interactions between 'core' sequences and globin promoters, especially at multiple copy (Ellis et 
al. 1993, 1996), cannot be assumed to accurately represent the function of the locus as a whole. 
In support of this, several groups have more recently begun studying the globin LCR in a more 
natural chromosomal context, using low copy number transgenics, YACs and somatic cell 
hybrids carrying human chromosome 11 (Ellis et al. 1996; Gribnau et al. 1998; Reik et al. 1998; 
Epner et al. 1998) and these studies seem to be yielding less ambiguous data than the earlier 
work with small constructs. - 
Figure 1.1: The human f3—globin locus 
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Erythroid-specific DNAase I hypersensitive sites are shown by arrows. 
1li 1 is a non-exvressed pseudogene. 
HS2 of the Oglobin LCR has classical enhancer activity in that it functions as an enhancer of 
heterologous genes in transient assays, while the other three HSs do not. HS 1 appears to have 
little independent function, and natural mutations deleting HS I have no apparent phenotype. 
Similarly, HS4 has little or no function in isolation. HS3 appears to direct position-independent 
expression to an extent, and also to enhance expression when stably integrated. However, these 
properties are merely generalisations and the complexities of the reported data over the last 
decade could allow almost any interpretation to be made if viewed injudiciously. Recently a 
clearer view has emerged of the regulation of the 3 globin locus but there are still some 
outstanding controversies. These are discussed below. 
1.4.1 Chromatin opening by the J3 globin LCR 
The human P globin locus is characterised by a region of general erythroid-specific, 
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developmentally stable DNaseI I hypersensitivity relative to the surrounding chromatin. This 
open chromatin conformation is dependent upon the presence of the LCR. There is evidence 
that the opening of chromatin is independent of gene expression in as much as it precedes globin 
transcription (Forrester et al. 1986; Groudine et al. 1983; Forrester et al. 1987; reviewed by 
Grosveld et al. 1993). Also, in experiments where low levels of overall expression are seen, 
expression is still position independent (Fraser et al. 1993). It may be that the LCR 
autonomously opens the chromatin in erythroid cells, and that this open conformation facilitates 
the binding of transcription factors to both the LCR and the proximal promoters of the globins 
(Grosveld et al. 1987; Shesely et al. 1991; Kim et al. 1992). Reitman et a! (1993) report that 
when linked to a truncated chicken Oglobin gene missing its promoter, the 3' enhancer 
(corresponding to LCR HS2 in humans) is not DNaseI I hypersensitive. However, only six such 
lines were generated and the HS was created in three of these. In addition, it should be noted 
that while the chicken and human 3 globin loci are often considered together, the rearrangement 
within the chicken relative to the human locus complicates the picture, and the functions of the 
HSs may not be strictly identical in both species. Finally, HS2 is generally accepted to have no 
chromatin-opening function in isolation (Ellis et al. 1993) and therefore a construct containing 
only HS2 would be susceptible to chromatin condensation which would presumably preclude 
formation of the HS. 
Ellis et a! (1996) recently conducted a careful analysis of the functions of the four HSs in single 
copy transgenic mice. HS3 was found to be necessary and sufficient to direct position 
independent expression and therefore is probably responsible for chromatin opening-by the LCR. 
In the same paper they confirm the inability of HS2 to direct position-independent expression at 
single copy. 
1.4.2 Transcriptional activation by the /3 globin LCR 
HS2 is the only HS of the LCR capable of enhancing expression in transient assays (reviewed by 
Grosveld et al. 1993) and for this reason has received a great deal of attention in loss of function 
studies (Ryan etal. 1989; Caterina etal. 1991; Ellis etal. 1993; Caterina etal. 1994). However 
HS2 is only capable of expressing Pglobin at 40 % of wild type levels, and although it does 
seem to be able to direct position independent expression in transgenic animals (Fraser et al. 
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1993), this is only at high copy number (Ellis et al. 1993, 1996). The core of HS2 consists of 
binding sites for the haematopoietic transcription factor NF-E2, flanked by binding sites for the 
transcription factors GATA-1, USF and SP1 (Ellis et al. 1993; Caterina et at. 1994). Deletion of 
any of these sites reduces expression levels of a linked 0 globin gene, but no significant effect on 
position independence is observed unless the entire HS2 is deleted (Caterina et al. 1994). Ellis 
et at (1993) showed that the dimer of NF-E2 binding sites is sufficient to direct modest levels of 
position independent I3expression in multiple copy arrays. This result may indicate that 
multiple protein-DNA interactions are responsible for LCR function in vivo. 
Binding sites for the haematopoietic factors NF-E2 and GATA-1 have also been shown to be 
necessary for the formation of HS4 (Stamatoyannopoulis et al. 1995) and are present in a similar 
conformation in HS3 (Pruzina et al. 1994; Stamatoyannopoulis et at. 1995). Thus these factors 
seem to be important in the formation of the LCR, although their functional significance is as yet 
unclear. As discussed below, in isolation individual HSs have differing activating properties 
with different genes of the locus, although no variation of this activation function with 
development has been demonstrated. 
The LCR as a whole must be viewed as a strong activator of transcription within the locus, 
which is associated with several general and erythroid-specific transcription factor binding sites. 
Despite considerable effort by a number of research groups the mechanisms of this activation 
and its variation between genes and developmental stages remain unclear. Martin et a! (1996) 
suggest that enhancers create favourable chromatin conditions for transcription rather than 
increasing the rate of transcription initiation per Se, which would make enhancers and LCRs 
functionally similar. The best evidence to support this position comes from single cell 
expression analysis in variegating cell populations (Walters et al. 1995, 1996) where it has been 
demonstrated that enhancers increase the probability of gene expression without significantly 
altering the expression per cell, a role that has been a major feature in descriptions of LCRs. 
However, in this context the successful dissection of the position-independence function from 
the classical enhancer function within the globin LCR (Ellis et at. 1996) makes no sense - HS2 
and HS3 clearly play different roles, at least in isolation. It may be that the classical enhancer 
activity of HS2 - the ability to enhance transcription of a linked transgene in a transient assay - is 
irrelevant to its function when stably integrated, but this seems unlikely given that strong 
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potentiation of expression coupled to sensitivity to position effects are the undisputed 
characteristics of HS2. Similarly, it now seems very clear that HS3 can suppress position 
effects, but has only a modest ability to increase transcription of linked globin genes. This, 
according to Martin et al (1996), would identify HS3 as an enhancer, yet in transient assays HS3 
has no enhancer activity. Perhaps in time the original definition of an enhancer will be 
abandoned, but until then it must be concluded that the HS2 enhancer does not suppress position 
effects, while the position effect-suppressing HS3 element does not have enhancer activity. 
However, it may be that HS2 increases the probability that transcription factors will interact with 
the promoter, while HS3 increases and ensures the accessibility of HS2 to those factors which 
mediate its activity. Taken together, these two functions would allow HS2 to act as a enhancer 
as postulated by Martin et al (1996) while still depending on H53 for reliable function in 
different chromosomal positions. 
1.4.3 Developmental regulation of the 13 globin locus 
Fraser et al (1993) analysed the developmental pattern of expression of the human globins in 
transgenic mice when linked to each HS of the LCR. The constructs were based upon a 36 kb 
restriction fragment encompassing the y, Sand P globin genes with a single HS cloned in 3.4 kb 
5' to the '/ globin gene. yand P globin steady-state mRNA levels were analysed in whole 
embryo, 16 day foetal liver and adult blood. 
HS 1 gave very low overall levels of 0 and y globin mRNA, 4 % and 2 % respectively of the 
murine f3Hl embryonic) and f3maj globin (foetal and adult) mRNA levels. However, these 
levels were 50 fold higher than those obtained with a control construct with no HS at all. 
Expression was copy number dependent, although only two lines were examined. y globin was 
expressed in the embryo but not in the foetal liver, which is a target of normal y globin 
expression. P globin, which is normally expressed in foetal liver and adult blood, was expressed 
at a low level in all tissues under HS1. HS2 gave similar results to HS1, but the overall level of 
expression was higher. Unlike HS 1, HS2 did not stimulate 0 globin transcription over y globin 
transcription. Again, although only two lines were examined, expression was related to copy. 
number. 
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HS3 was the only HS which drove y  globin transcription in foetal liver. y globin mRNA levels 
in the embryo and foetal liver were comparable to those obtained with the entire locus in 
transgenic mice (Strouboulis et al. 1992). In contrast to the y globin pattern, 0 globin steady-
state mRNA levels were 15 % of endogenous levels in the foetal liver, and at 20 % in the adult 
blood. The entire locus gives 90 - 100 % 0 globin expression (Strouboulis et al. 1992). 
HS4 gave low levels of y globin mRNA (2 % of endogenous levels) in the embryo and no 
detectable mRNA in the foetal liver. P globin mRNA was 8 % of endogenous levels in the 
foetal liver but 25 % in adult blood, the highest levels of 0 globin expression observed in this 
study. 
These results raise a number of interesting points. As has been seen by other groups (Magram et 
al. 1985; Kollias et al. 1986; Shih et al. 1990; Starck et al. 1994), in the absence of any LCR 
elements the globins still exhibit developmental regulation of expression. This, and the 
developmental stability of the LCR, has led to the belief that it is developmentally inactive. 
Fraser et al (1993) hold that their results suggest that the LCR is not developmentally neutral. 
However, results obtained with individual HSs must be viewed with caution, as many results 
point to a concerted action of the LCR as a whole and any HS in isolation may therefore not 
function as if it were part of the LCR. Also, the data obtained without an LCR cannot be 
ignored. y globin expression in the foetal liver requires HS3, but silencing of the 'y globin gene 
in adult tissues is autonomous (no requirement for the LCR). Therefore it may be that yglobin 
expression is regulated developmentally at the promoter, but that HS3 is needed for this 
regulation to result in detectable mRNA levels in the foetal liver. In support of this, hereditary 
persistence of foetal haemoglobin (HPFH), where silencing of yglobin in adult tissues is 
inoperative, can be caused by deletions and point mutations in the region from -117 to -202 bp 
from the y globin cap sites (Berry et al. 1992; reviewed by Engel, 1993). Functional deletion 
studies of the yglobin promoter in transgenic mice confirm the presence of proximal sequences 
required for developmental regulation, especially silencing (Stamatoyannopoulis et al. 1993). 
Finally, no stage-specific proteins have been detected bound to HS3 or the LCR in general 
(Reitman et al. 1993), and the pattern of DNaseI I hypersensitivity within the LCR is 
developmentally invariant. Thus the role of the LCR in developmental regulation of y globin 
transcription is not obvious, while the major role of the promoter seems incontrovertible. 
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The situation for E globin is very similar to that for y globin, in that it is autonomously silenced 
in foetal and adult tissues and requires at least part of the LCR for high levels of transcription in 
the yolk sac (Raich et al. 1990; Shih etal. 1990). 
The results for 3globin are more complex. In the absence of HS3 and HS4, 0 globinis 
transcribed prematurely in the embryo, though at low levels (Fraser et al. 1993). The pattern of 
expression is correct in the presence of either HS3 or HS4. Thus silencing of the 0 globin gene 
is at least partly dependent upon the LCR. However, several reports suggest that competition 
between 0 globin and the other globin genes for the LCR is responsible for the developmental 
regulation of P globin (Choi and Engel, 1988; Shesely etal. 1991; Hanscombe etal. 1991; Berry 
et al. 1992; Kim et al. 1992). In HPFH, the persistence of y  globin transcription is accompanied. 
by a decrease in 13 transcription (reviewed by Engel, 1993). In the absence of the other globins, 
13 globin expression is developmentally inappropriate and elevated in the presence of HS2, HS3 
or HS4 (Fraser et al. 1993), suggesting that the LCR alone is not sufficient for developmental 
regulation of 13 globin. In murine erythroleukaemia (MEL) cells carrying a single human 
chromosome 11, which behave, as adult erythroid cells, human 13globin transcription is 
abolished in the presence of an inducible selectable marker gene within the LCR (Kim et al. 
1992). Hanscombe et a! (1991) generated transgenic mice with constructs in which the LCR 
was linked to the yand 13 globin genes in different orders, and also with a construct containing 
the LCR, the 13 globin gene and the a globin gene, which are normally unlinked. When the 
13 globin gene was 3' to the y globin gene normal expression patterns were seen in embryo and 
foetus (adult animals were non-viable). However, when the 13 globin gene was 5' to the y globin 
gene (i.e. closest to the LCR) 13 was expressed in the yolk sac; y globin expression was unaltered 
in terms of developmental regulation, but was lower overall. Similarly, the presence of a globin 
between the 13 globin gene and the LCR gives rise to the correct pattern of 13 globin expression, 
even though the a globin gene does not normally interact with this LCR. When the 13 globin 
gene is closer than the a globin gene to the LCR the embryonic silencing of 13 globinis 
abolished. Thus the presence of another gene between the 13globin gene and the LCR is 
necessary for correct developmental regulation of 13 globin transcription. 
In summary, the picture of developmental regulation of the 13 globin locus is broadly thus: the 
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E globin gene and the two y globin genes are autonomously regulated by their proximal 
promoters, being expressed in the correct developmental pattern in the absence of the Pglobin 
gene and also in the absence of the LCR, although low overall levels of expression make 
interpretation difficult. In contrast, the P globin gene is silenced in embryonic tissue only in the 
presence of the LCR (specifically HS3 and/or HS4) and the y globin gene, or indeed another 
gene, provided it is proximal to the LCR relative to the P globin gene. Correspondingly, correct 
expression of P globin in adult tissues requires the silencing of upstream embryonic/foetal genes. 
1.4.4 Models 0fLCR function 
In light of the above results, the most convincing model is a development of that first suggested 
by Choi and Engel (1988) for the chicken P globin locus, in which competition for activation by 
the LCR between the globins is responsible for the gene switching in the presence of stage-
specific gene silencers. The notion that competition for the LCR between promoters regulates 
expression within the locus has largely been accepted (reviewed by Dillon and Grosveld, 1993). 
The early proposal that competition was reciprocal (Behringer et al. 1990; Enver et al. 1990) has 
been disproved by work in transgenic systems (Hanscombe et al. 1991; Kim et al. 1992) and 
also by looking at natural genetic lesions (Berry et al. 1992). Instead, a polar competition model 
has emerged, where the order of the genes and their relative distances from the LCR are crucial. 
in determining which is expressed at a given stage. However, the issue is complicated by the 
finding that Eand y  globins are autonomously, developmentally regulated, and do not require 
either the P globins or the LCR for the correct pattern of expression (although in the absence of 
the LCR expression levels are low and subject to position effects). 
The model which best fits the data would hold that in embryonic tissues the LCR opens 
chromatin in the erythroid cells and strongly enhances E and y  globin gene expression. In foetal 
liver cells, stage-specific factors binding to the Eglobin promoter silence E globin expression, 
but y globin is still expressed at high levels and silences the more distal fglobin gene by 
competition for the LCR, which is closer to the yglobin gene than the P globin gene and so 
interacts with the 'y globin promoter preferentially. In adult erythropoietic cells, the y globin 
genes are silenced by factors binding to their promoters and interaction with the LCR is blocked. 
Now the nearest active (non-silenced) gene to the LCR is the 3 globin (and 6) gene, and so the 
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adult globins are transcribed at high levels. In fact, the autonomous silencing of the Eand 
y globin genes is consistent with this model, which would predict that those genes closest to the 
LCR would always be activated by it unless silenced, while distal genes would naturally be 
silenced by competition with the proximal genes and so would not be expected to be silenced 
autonomously (Hanscombe et al. 1991). 
A refinement of the polar competition model asks whether the LCR 'seeks' promoters by 
diffusion through solution, or by tracking along the DNA until a promoter is reached. The main 
results in favour of the diffusion model come from Kim et al (1992) and Hanscombe et al 
(1991), where relative distance from the LCR is seen to be important, which is predicted by the 
diffusion model but not by the tracking model (reviewed by Dillon et al. 1997). 
The above model is general in that it does not attempt to describe the conformation of the LCR 
or the nature of the interaction between it and the globin promoters. In general, most results 
point towards a view of the LCR as a single functional unit, but there are other models in the 
literature. Engel (1993) has proposed that the LCR is an 'amalgam' rather than a 'complex', 
suggesting that the functional linkage of the HSs is not reflected by a physical interaction. The 
stage-specific silencing of an individual globin gene is suggested to occur by a stable interaction 
between the promoter, a HS of the LCR, and a negative protein factor. In this context an LCR 
HS is proposed to act as part of a stage-specific silencing 'complex'. However, the data do not 
support this, and there are several results which suggest that the LCR constitutes a single 
regulatory unit in erythroid cells. Firstly, expression of all globins is higher in the presence of 
the entire LCR than any single HS or combination of HSs, including high copy number arrays 
(Fraser et al. 1993; Reitman et al. 1993). Secondly, DNaseI hypersensitivity pattern of the LCR 
is developmentally stable, even though different HSs seem to be most important at different 
developmental stages (Forrester et al. 1987; Tuan et al. 1989; Fraser et al. 1993). Finally, 
competition for the LCR occurs between the f3 and y globin genes even though different HSs 
maximally stimulate their expression (Choi and Engel, 1988; Dillon and Grosveld, 1993; Fraser 
et al. 1993). If y and 0 interact with different HSs, competition can only occur if these elements 
are stably complexed and acting as a single regulatory unit. 
Also, in the absence of the LCR developmental silencing of the c and 'y globin gene still occurs, 
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so there is no reason to suppose that the LCR would be necessary to silence them. In addition, 
HS3 is invoked as the element responsible for silencing the yglobin genes (Engel, 1993), but 
there are two y globin genes and only one HS3. It might be expected that a y globin gene not 
bound to HS3 would be transcribed in adult cells under this model unless it is autonomously 
silenced, which would obviate the model. 
In the absence of any data suggesting that the LCR performs a silencing function, and in the light 
of data which suggest that e and yare autonomously silenced while 0 is silenced in early stages 
by competition for the LCR, a model based on negative regulation by the LCR seems less 
credible than a model based on positive interaction with the LCR which may be blocked by stage 
specific silencer factors. 
It has also been suggested that the LCR plays no direct role at all in enhancing the expression of 
the globin genes, but merely maintains an open chromatin domain within which the genes are 
activated or silenced according to the suite of transcription factors bound to their proximal 
promoters (Groudine and Weintraub, 1982; Martin et al. 1996). This may seem at odds with the 
current body of data, but Martin et al (1996) point out that there is no definitive evidence for 
globin switching as a dynamic process; the suggestion is rather that it may be a stably 
established chromatin formation in different erythroid cells. Wiejgerde et al (1995) used FISH 
in single foetal erythroid cells to study the transcription of globin genes, and found that 85% of 
cells contained one species of globin transcript only (either yor ) during a switching period, 
while some 15% contained both transcripts. This was interpreted as evidence that only one gene 
was transcribed at a time, the double signals arising from persistence of transcripts in cells where 
a switch had recently taken place to the other gene, which supports the "looping out" model 
where the LCR interacts directly with globin promoters as a single holocomplex. However, 
Martin et al (1996) interpret the double signal as evidence of simultaneous transcription of 
globin genes, which is inconsistent with the "looping out" model, and instead propose that the 
data presented by Wiejgerde et al (1995) are consistent with their hypothesis that the LCR is not 
involved in switching, and that globin gene transcription is in fact a stochastic process. 
To address this ambiguity, Gribnau et al (1998) performed single cell primary transcript FISH 
using a more stringent technique which removes all nascent transcripts (by allowing enough time 
21 
Chapter 1 - Introduction 
for processing and degradation) during a reversible inactivation of transcription elongation, 
before the block is removed allowing transcription to resume. In this manner they removed all 
previously synthesised and nascent primary transcripts from the cells so that any globin primary 
transcripts detected should be nascent at the time of assay. 
The results of this experiment unambiguously demonstrate that only one 0 globin gene is 
transcribed at a time in any one erythroid cell and thus support the hypothesis that a single 
regulatory unit, the LCR, is dynamically alternating between globin promoters in globin gene 
switching. Double transcripts were detected with a lag time (from release of the block to intron 
2 detection) of approximately double that of single transcripts, indicating switching. Although 
there is still no evidence that the LCR physically interacts with globin promoters, the hypothesis 
that globin transcription is a stochastic process operating independently at each promoter can 
now be rejected. 
1.5 Other long range control elements 
Over the last decade, a wealth of elements have been described which are reported to have LCR 
function (reviews: Higgs, 1998; Udvardy, 1999). Some of the more significant examples are 
briefly. described below. 
The structure of the 3 globin locus is conserved in mammals and chickens, although in chickens 
a duplication event has complicated the issue. Due to its similarities to the human 0 globin 
locus, the chicken locus will not be discussed here. 
The chicken lysozyme locus has been extensively studied, its role as a marker of macrophage 
lineages paralleling that of 0 globin as a marker for erythroid lineages (reviewed by Sippel et al. 
1992). Chicken lysozyme constitutes a major component of egg albumen, and is also expressed 
in the myeloid lineage of the haematopoietic cells. The gene lies within a 20 kb region of 
general DNaseI I hypersensitivity (Stratling and Dölle, 1986; Jantzen et al. 1986) at the borders 
of which are found the so-called A elements (Phi-Van and Stratling, 1988; Sippel et al. 1992, 
below) which have matrix attachment activity in vitro as well as a constitutive transcriptional 
activating activity in transgenic studies with homologous and heterologous genes, though not in 
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transient assays. Within this domain reside up to 9 DNase I hypersensitive sites comprising a 
complex system of tissue specific enhancers, promoter elements and a silencer element 
(reviewed by Sippel et at. 1992). The entire domain functions in a developmentally correct, 
position independent pattern in transgenic mice (Bonifer et at. 1990), and thus may be described 
as possessing a locus control function (Bonifer et at. 1990; Sippel et at. 1992; Sippel et al. 
1993). The most elegant dissection of the regulatory elements of this locus has been reported by 
Bonifer et al (1994), in which the entire domain and deletions thereof were analysed in 
transgenic mice. Specifically, the work focused on the -6.1 kb early enhancer, which is DNaseI 
I hypersensitive in all appropriate cell types (oviduct, macrophage precursor cell lines and 
primary macrophages), the -2.7 kb late enhancer, which is only hypersensitive in the late stages 
of macrophage differentiation, (reviewed by Sippel et at. 1992), and the two flanking A 
elements. In contrast to expected results, deletion of the A elements did not abolish copy 
number dependent expression provided all of the cis-regulatory elements were intact, but it did, 
result in an increased frequency of ectopic expression of the transgene, which was aggravated by 
the additional deletion of either enhancer. Deletion of either the -6.1 kb or the -2.7 kb enhancers 
resulted in a loss of position independence. 
These results suggest that all of the cis-regulatory elements within the lysozyme domain are 
necessary for locus control function and that they act cooperatively rather than hierarchically, 
and also that the A elements do not protect from negative position effects in the context of the 
entire locus, but seem to insulate the gene from possible stimulation by elements outside the 
domain (see later discussion). 
The human aglobin locus is evolutionarily related to the 0 locus (although divergent in 
structure), and coordinate expression of both loci results in the various stage-specific 
heterodimenc haemoglobins, each formed by a gene product from each locus (summarised by 
Higgs et al. 1990). Following the description of a natural deletion of 65 kb upstream of the 
a locus, resulting in repression of both a globins (Hatton et at. 1990), Higgs et al (1990) 
analysed the deleted region and fragments thereof linked to an a gene in stably transfected MEL 
cells and transgenic mice. Two erythroid specific HSs some 30 to 40 kb upstream of globin 
were discovered, and a construct containing these directed high levels of developmentally 
correct a globin transcription in transgenic mice, although copy number, which was analysed 
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over a much broader range than for the 0 LCR, was not correlated with expression level in high 
copy individuals. 
The human major histocompatibility complex (AMC) class I antigen HLA-B7 gene is expressed 
on the cell surface of a wide range of cell types at different levels, is induced by viral infection 
and lymphokines, and may be repressed by some oncogenes (summarised by Chamberlain et al. 
1991). Remarkably, a construct containing the HLA-B7 gene and just 0.66 kb of 5' and 2.0 kb 
of 3' flanking DNA in transgenic mice is expressed in a position independent, tissue specific 
pattern at levels approaching endogenous, and is inducible by the lymphokine IFNy 
(Chamberlain et al. 1988). Deletion studies suggest that sequences from -0.66 kb to -0.11 kb are 
necessary and sufficient to direct high, position independent, IFNy inducible expression of HLA-
B7 (Chamberlain etal. 1991). 
Human CD2 is expressed on the surface of differentiating T cells, and is present on most 
thymocytes and essentially all peripheral T cells (summarised by Greaves et al. 1989). A 
construct with the 15 kb CD2 gene, 4.5 kb of 5' and 9 kb of 3' flanking sequences was expressed 
in a copy number dependent pattern on T cells and megakaryocytes of transgenic mice at similar 
levels to the endogenous gene (Lang et al. 1988). Greaves et al (1989) demonstrated that T cell 
specific HSs in the 3' flank were necessary for high level tissue-specific expression, and 
sufficient to direct position independent expression of a thymus specific (Thy-1) and a 
heterologous (P globin) gene in the T cells of transgenic mice. Thus this element comprises a 
functional LCR. Interestingly, 0 globin was not prevented from expressing in the foetal liver, 
nor was Thy-i silenced in the brain, indicating that the CD2 LCR does not possess any 
insulating or tissue-specific silencing function. 
Deletion studies of the 3' flank of human CD2 revealed a 1.5 kb minimal region that conferred 
high level, copy number dependent expression in transgenic mice (Lang et al. 1991), and also 
assigned the enhancer and LCR functiois to CD2 HS 1 and CD2 HS3 respectively. HS 1 had 
previously been shown to function as an enhancer in transient assays (Lake et al. 1990). 
More recently, the expression of various CD2 constructs in the thymus of transgenic mice has 
been studied at the level of single cells (Festenstein et al. 1996), a study which provided the first 
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direct link between LCR function and PEV in vertebrates. Constructs in which HS3 was deleted 
expressed in a copy number dependent manner in most cases, but in some animals this was not 
the case. The transgene in these animals was found to have integrated pericentromerically. 
When thymus cells from these animals were flow-sorted according to CD2 expression, they 
separated into CD2+ and CD2- populations, which displayed open or closed chromatin around 
the transgene respectively. Thus in the absence of HS3 a CD2 transgene is expressed copy-
number dependently in most animals, but when integrated pericentromerically is stochastically 
silenced with accompanying changes in chromatin structure. This study was soon followed by 
similar work with the human f—globin LCR (Milot et al. 1996a). 
There are two reports of Alu sequences which appear to be implicated in LCR-like functions. 
Neznanov et al (1993) conducted deletion analyses of the 5' and 3' flanks of the human keratin 
18 (K18). They found that with both flanks expression of a K18 transgene was indistinguishable 
from the endogenous mouse gene, but in the absence of the 3.5 kb 3' flank position independent 
expression is lost in some tissues but not in others. In addition, a TK reporter construct flanked 
by the 5' and 3' regions in transgenic mice was expressed in a position independent but not 
tissue specific pattern. The flanking regions have no obvious HSs or MARs, but do have A/u 
sequences. In the absence of the 3' flank, Thorey et al (1993) demonstrated that transcription of 
an Alu element in the 5' flank was necessary for copy number dependent expression in the 
kidneys of transgenic mice. Regulation of this locus is extremely complicated, but some locus 
control function is clear within the constructs used, although more work is necessary to obtain a 
clear picture. Aronow et a! (1992) report a major regulatory complex in intron I of the human 
adenosine deaminase (ADA) gene, consisting of six DNaseI I hypersensitive sites, HSI to HSVI, 
and also Alu elements. HSIII has classic tissue specific enhancer activity in transient assays with 
a CAT reporter gene, but is subject to position effects in transgenic mice. Addition of non-HS 
sites flanking HSHI, including an Alu element, removes this position effect. Since CAT is 
activated tissue specifically and position independently, this represents an LCR function, the first 
described within a gene. The roles of the Alu elements in these loci are unclear, but active 
transcription of the element seems to be important for function. 
The metallothionein genes MTI and MTh are expressed in essentially all cell types, and are 
regulated by environmental factors (metal ions) and cell-cell signalling. The MTI promoter 
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directs transgene expression in mice, but at low levels, subject to position effects and not related 
to copy number. The two MT genes are closely linked in mice, flanked by DNaseI I 
hypersensitive sites. When these sites were used in a mini-locus containing MTI, they were able 
to direct position independent copy number dependent expression in transgenic mice (Palmiter et 
al. 1993), which was stimulated correctly by environmental and developmental signals 
(metallothionein transcription is stimulated in the foetal liver). Thus these elements comprise an 
LCR function. However, only two of four heterologous genes showed position independent 
expression when driven by these regions, and MTI is expressed in over 50 % of transgenic lines 
even in the absence of the flanking elements, so the LCR function may be comparatively 
modest. 
The albino phenotype of mice is caused by a point mutation in the tyrosinase gene, which spans 
80 kb of chromatin. Introduction of a tyrosinase minigene including 5.5 kb of promoter 
sequences rescues the albino phenotype, but is subject to position effects (summarised by Ganss 
et al. 1994). Schedl et al (1993a) generated transgenic albino mice with a 250 kb yeast artificial 
chromosome (YAC) harbouring the tyrosinase gene and 155 kb of upstream sequences. All 
transgenic mice were fully pigmented, indicating correct expression of the tyrosinase gene. A 
HS 12 kb upstream of the gene was demonstrated to be melanocyte-specific (Ganss et al. 1994) 
and was used to drive expression of the tyrosinase minigene in transgenic mice. Coat colour and 
eye colour (which tissues derive from the two lineages in which tyrosinase is expressed) were 
found to roughly correlate with copy number, but some ectopic expression was seen which had 
not been detected with the YAC construct. Thus the YAC construct was correctly expressed, but 
the minigene construct has only imperfect LCR function, either because the upstream element is 
incomplete or because the minigene lacked elements necessary for tissue specificity. Work in 
YACs with the entire gene should address this question. 
1.5.1 Structural chromatin elements and insulators 
Along with the idea of a transcription domain within which influence from chromatin outside the 
domain is negligible, comes the idea that the domain has borders. Matrix attachment regions or 
scaffold attachment regions (MARs and SARs) have been proposed as the boundaries of these 
domains. The topological loops of up to 100 kb that chromatin is found in have been proposed 
as physical transcription domains (reviews: Cook, 1989; Eissenberg and Elgin, 1991). However, 
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some MARs reside within genes, which would suggest that a MAR is no barrier to the 
transcription complex, and therefore no barrier to other protein-DNA interactions. It is worth 
noting here that current in vitro assays for MAR function may introduce artefactual DNA-
protein interactions, so that not all MAR elements may be functional in vivo. 
Stief et al (1989) demonstrated that the chicken lysozyme 5' A element is able to protect a -6.1 
kb enhancer/lysozyme promoter/CAT construct from position effects in stably transfected 
promacrophage cell lines, and report an enhancer function of the A element which differs from 
classical enhancers in that it is not apparent in transient transfection assays. Interestingly, the 
expression levels are not strictly copy number dependent, but rather seem to increase by more 
than the increase in copy number. McKnight et al (1992) analysed the effect of the A element in 
transgenic mice, using a construct linking the 5' MAR to the gene for whey acidic protein 
(WAP) under its own promoter. Expression of WAP was developmentally correct (i.e. lactation 
and mammary gland specific), which contrasts with the results from WAP transgenes in the 
absence of the MAR. However, no copy number dependence or elevation of expression levels 
were seen. Clark et al (1994) linked the A element to a chloramphenicol acetyltransferase 
(CAT) transgene driven by the ovine J3—lactoglobulin (BLG) promoter. No significant increase 
in the frequency of CAT expression or in the correlation of CAT protein with transgene copy 
number was observed. Thus the A element is able to buffer a gene from some position effects in 
different tissues, but the protection is imperfect. It must be concluded from the limited data 
available that the A element is not simply an efficient 'insulator'. It has intrinsic enhancer-like 
properties, while its ability to create a topological chromatin loop, or confer copy number 
dependent expression, has not been proven (see also Dillon, 1993). 
The scs elements of Drosophila insulate the white gene from both positive and :negative position 
effects in Drosophila (Kellum and Schedl, 1991) and therefore seem to function as true 
insulators (reviewed by Sippel et al. 1992). 5' HS4 from the chicken globin locus, which is 
constitutive, has been reported to block the function of a linked LCR element and relieve 
position effects in Drosophila (Chung et al. 1993). Similarly, 5' HS5, the constitutive HS from 
the human P globin locus, has been used to insulate a P globin gene from stimulation by a linked 
HS3 element. The general region of DNaseI I sensitivity in the globin locus ends abruptly at this 
element in vivo (reviewed by Kollias and Grosveld, 1992), further suggesting that HS5 has an 
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insulating function. 
1.6 Yeast artificial chromosomes 
Yeast artificial chromosomes comprise an insert of apparently limitless size plus the three main 
specialised elements which direct efficient replication, maintenance and segregation of 
eukaryotic chromosomes, namely an origin of replication (ARS), telomeres (TEL) and a 
centromere (CEN) (reviewed by Hieter et al. 1990). There are also usually auxotrophic marker 
genes which allow selection in yeast for the arms of the YAC and bacterial sequences allowing 
propagation in E. coli. 
ARS (autonomously replicating) sequences, first identified by the ability to confer high 
frequency, transformation and extrachromosomal maintenance upon plasmids, consist of a core 
of at least, one copy of the domain A consensus sequence (ATF)TTTAT(AIG)TFT(A/T), two or 
three 5' flanking nucleotides and a varying number of 3' flanking nucleotides (reviewed by 
Newlon, 1988). ARS1, used in pYAC vectors (Burke et al. 1987) conforms to this model. 
Plasmids and YACs bearing ARS elements are subject to the same replication as normal 
chromosomes in that they are replicated once in S phase of the cell cycle. It may be that large 
.eukaryotic DNA fragments (such as YAC inserts) contain additional ARS regions, and a number 
of eukaryotic DNA fragments have been shown to contain functional ARSs in yeast (reviewed 
by Newlon, 1988). 
Plasmids bearing ARSs are characterised by episomal propagation, but segregation of the 
plasmids at mitosis is poorly regulated, leading to increased copy number in some cells and loss 
of the plasmid in others. Yeast centromeres were first cloned by their ability to mitotically 
stabilise such plasmids, and also to direct segregation in the first division of meiosis (reviewed 
by Newlon, 1988). The yeast centromere consists of three conserved regions. CDEI is an 8 bp 
conserved palindrome, separated from a 25 bp conserved sequence, CDEIII, which is an 
imperfect palindrome, by CDEII, which is an A-T rich region some 78-86 bp in length. Deletion 
studies suggest that the central nucleotide of CDEIH is essential, since point mutations of it 
decrease chromosome stability by 1000 fold. CDEI is important but not-essential, while the 
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length and A-T content of CDEII are more important than its sequence (reviewed by Hieter et al. 
1990). 
The structure of yeast centromeres is less complex than that of higher eukaryotic centromeres. 
For example, no specialised sequence motifs surround yeast centromeres, and yeast centromeres 
do not form the classic constricted kinetochore of higher eukaryotes, but bind a single 
microtubule in mitosis in an otherwise undifferentiated structure. Interestingly, yeast 
centromeres can be inactivated by transcription across them, a feature which was originally used 
in the study of centromere function and has recently given rise to a system for inducing an 
increase in YAC copy number (Smith et al. 1990, 1992). 
Telomeres serve two functions in chromosome maintenance. Firstly, they protect a linear 
molecule from degradation or repair by the cell, and secondly, they allow the end of the 
chromosome to be replicated without net loss. Telomere function is exceedingly conserved and 
heterologous telomeres are functional in yeast, even if they have different sequences to yeast 
telomeres (reviewed by Newlon, 1988; Blackburn, 1990; Hieter et al. 1990). In general, 
telomeres have a G-rich strand orientated 5' to 3' towards the end of the chromosome, and a C-
rich strand. In yeast the sequence is several hundred nucleotides of the repeat (C 1 . 3A). When 
heterologous telomeres (e.g. Tetrahymena, (C 4A2)) are introduced into yeast on the ends of linear 
DNA molecules, yeast telomeric sequences are added on, presumably by a telomerase. Most 
endogenous yeast telomeres are flanked by highly conserved repetitive 6.7 kb Y' elements, but 
these are of unknown significance and are not essential for telomere function. Another 
seemingly redundant element, the X element (3.0 - 3.75 kb) is also found at most yeast 
telomeres, in which it is separated from any Y' sequences present by CI-3A  repeats. Both X and 
Y' elements contain ARSs. 
The de novo synthesis of yeast telomere sequences on heterologous telomeres suggests that the 
process is functionally separate from normal template-dependent polymerisation. Telomerases 
from several organisms have been studied in detail and found to be riboproteins, the RNA 
component of which has a sequence complementary to the G-rich strand sequence of the 
telomere of that organism, and mutated RNA components lead to correspondingly altered 
telomere repeat sequences. Thus the telomerase is a reverse transcriptase which carries its own 
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RNA template. The mechanism by which telomerases recognise divergent telomeres is thought 
to involve specialised secondary structures formed by non-Watson-Crick pairing between G 
residues in the 3' overhang (reviewed by Blackburn, 1990). 
Following the description by Burke et al (1987) of a series of YAC cloning vectors (the pYAC 
vectors) the use of YACs in genomic library construction has become widespread, due to the 
large insert size and therefore relatively few numbers of clones needed for a representative 
library. Construction of a YAC library is accomplished by ligation of both YAC arms to 
fragmented genomic DNA, followed by transformation into yeast and selection for cells carrying 
both arms of the YAC (reviewed by Hieter et al. 1990). 
Since the insert size in YACs has no practical upper limit, the introduction of multiple inserts 
into single YACs during library construction is common. In addition, co-transformation of 
homologous YACs into single yeast cells can result in chimaerism by recombination between 
them (Larionov et al. 1994). Establishing that a YAC clone contains a single YAC representing 
a single contiguous intact piece of genomic DNA is an essential step following isolation of a 
library clone. 
1.61 Transgenic animals and YACs 
The production of transgenic animals from YACs is essentially the same as for more 
conventional constructs. A major obstacle is the generation of sufficient quantities of suitably 
pure and intact YAC DNA, since it is by definition present only at single copy in yeast cells. 
The pCGS966 - type vector presents a useful means of amplifying new YAC clones, and a 
derivative of pCGS966 can be used to retrofit existing pYAC-based YACs to introduce the 
inducible promoter and TK marker necessary for amplification. 
There are now several reports from different groups in the literature describing the generation of 
transgenic mice from YACs via ES cells (Jakobovits et al. 1993; Strauss et al. 1993; Choi et al. 
1993) and pronuclear injection (Peterson et al. 1993; Schedl et al. 1992; Schedl et al. 1993a). 
The YAC transgenes are maintained without significant rearrangement although initial 
rearrangement before integration seems high, and there are no deleterious effects due to the yeast 
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CEN and TEL sequences (reviewed by Forget, 1993). Therefore YACs represent a workable 
means of introducing very large segments of genomic DNA into transgenic mice. 
1.7 The milk protein genes 
The major milk proteins are the caseins and the whey proteins. Together these make up >90 % 
of the total milk protein by mass (reviewed by Mercier and Vilotte, 1993). In general, the 
regulation of these genes is under tissue-specific and hormonal control, with synergy of 
hormonal induction a key feature. Extracellular matrices and cell-cell interactions are also 
- important, and there is evidence that induction of several milk genes involves the removal of 
specific repressor proteins that silence the genes in appropriate tissues and stages. 
1.7.1 6 lactoglobulin 
3 lactoglobulin (BLG) is the major whey protein in ruminants, but is absent from rodents. The 
162 residue protein is encoded by a 7 exon gene spanning some 5 kb (Ali and Clark, 1988). In 
sheep, BLG RNA is already transcribed in mid-gestation. Steady-state BLG mRNA levels 
increase slowly before and then rapidly after parturition, reaching 5 % of total mammary mRNA 
by day 20 of lactation. The function of BLG is not clear, but it is thought to play a role in 
transport of small fatty acids within the mammary gland. 
BLG transcription is regulated developmentally and tissue specifically. Like other milk protein 
genes, it is induced synergistically by prolactin in the presence of glucocorticoid, though it is 
less responsive to these lactogenic hormones than other genes such as P casein (reviewed by 
Mercier and Vilotte, 1993). A 16.2 kb construct comprising the BLG gene with 4.2 kb of 5' and 
varying 3' flanks was expressed at high levels in transgenic mice, and the expression pattern 
approximately followed that of the endogenous BLG gene in sheep (Simons et al. 1987; Harris 
et at. 1991). 406 bp 5' and 1.9 kb 3' to the BLG promoter are the minimum flanking sequences 
necessary for high level mammary gland specific expression in mice (Whitelaw et al. 1992). 
Dissection of the promoter reveals binding sites for a variety of transcription factors, including 
the mammary gland factor (MGF or MBPF), which has subsequently been included as a member 
of the Stat family of signal transducing transcription factors (Wakao et al. 1994; Darnell et at. 
1994) and has been detected in non-mammary tissues. MGF/Stat5 is necessary for transduction 
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of prolactin activation to the promoters of milk protein genes. (Wakao et al. 1994; Gouilleux et 
al. 1994; Demmer et al. 1995). 
The BLG promoter has been used to direct high levels of mammary specific expression of 
several transgenes in the mammary gland of mice and sheep (Simons et al. 1988; Clark et al. 
1989; Archibald et al. 1990; Wright et al. 1991; Shani et al. 1992; Dobrovoisky et al. 1993; 
Hurwitz et al. 1994; Clark et al. 1997a,b; Korhonen et al. 1997; Butler et al. 1997; McKee et al. 
1998; Sola etal. 1998; Hyttinen et al. 1998). When driven by a BLG promoter, levels of the 
serine-protease inhibitor a-i antitrypsin (AAT) have reached 33 mg/ml in transgenic sheep milk, 
which represents 50 % of the total milk protein (Wright etal. 1991; Carver et al. 1992; Carver et 
al. 1993). However, expression levels are variable with integration position and do not usually 
correlate with copy number. In particular, cDNA-based BLG constructs are not expressed well. 
In addition to the inclusion of introns (see Section 1.2.2), a strategy has been developed where 
the poor cDNA expression is "rescued" by the presence of an entire BLG transgene in cis (Clark 
et al. 1992). Initial experiments with the human AAT cDNA demonstrated that if the BLG-
cDNA construct was microinjected in the presence of a BLG transgene, the expression level of 
the cDNA was higher and more consistent than if it was injected without the BLG cointegrant 
(Clark et al. 1992). Three possible models were proposed to explain the rescue effect, suggesting 
that either the BLG transcription unit had some direct enhancing or insulating effect on the 
linked transgene, or else that the rescue was an indirect consequence of active transcription of 
the BLG gene. More recently it has been reported that the BLG transgene must be transcribed 
but need not be translated to effect the rescue (Yull et al. 1997). This suggests that functional 
elements within the transcription unit are not directly responsible for the rescue, but rather that 
active transcription of the rescuing transgene somehow confers activation of the rescued 
transgene. However, in order to abolish transcription the construct used by Yull et al (1997) was 
significantly altered relative to that which was transcribed, and other effects of this perturbation 
such as altered nucleosome phasing (Lui et al. 1995) cannot be ruled out. 
Initial rescue experiments used the BLG gene to rescue BLG-driven constructs, and introduced 
the two constructs by coinjection. Although this undeniably rescued the expression of the 
coinjected transgene, the expression levels of the rescued and rescuing transgenes were poorly 
correlated and unpredictable, which has been attributed to varying arrangements at the 
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transgenic locus (Clark et al. 1992). Clark et al (1997a) therefore injected double constructs 
consisting of a BLG gene linked covalently to a BLG-FIX (Factor IX) or BLG-CAT gene. This 
resulted in silencing of the linked BLG gene itself, which was unexpected. It was postulated that 
the regular arrangement of rescued and rescuing transgenes might result in some form of repeat-
induced silencing. However, there are many examples of transgenes which are not obviously 
silenced in this manner (e.g. Grosveld et al. 1987; Greaves et al. 1989; Wright et al. 1991; 
Whitelaw et al. 1992). The most striking of these are those which are expressed position-
independently. It may be argued that in this case whatever function relieved the transgene from 
position effects would also overcome repeat-induced silencing, and yet BLG has been reported 
to express position-independently (Whitelaw et al. 1992). In addition, although a FIX construct 
has been successfully rescued by a coinjected BLG transgene in two previous studies (Clark et 
al. 1992; Yull et al. 1995) both used a larger BLG construct incorporating some 4.2 kb of the 
BLG promoter, and also more 5' and 3' BLG DNA flanking the FIX transgene. Thus, there is 
no direct evidence that the minimal BLG transgene used in the later study would be expected to 
rescue a coinjected transgene. In the earlier study with AATD (Clark et al. 1992) which also 
used the larger BLG transgene there were two out of the nine BLG-AATD (Clark et al. 1992) 
cointegrated lines which did not express AATD or BLG. This may be taken as evidence that the 
silencing of BLG by a linked transgene may extend across the larger BLG flanks (Clark et al. 
1997a) but it seems more likely that these lines were simply silenced by some other means, such 
as integration of the injected DNA into centromeric heterochromatin. Nevertheless, this is an 
intriguing result which may reveal new aspects of gene control if repeated. 
Rescue of BLG-transgenes by an entire BLG gene has been convincingly demonstrated, at least 
in mice. However, rescue of other promoters with BLG has been less successful, as have efforts 
to use other rescuing transgenes. Langley et a! (1998) cointegrated the entire BLG gene with a 
ribozyme construct under the control of the mouse mammary tumour virus long terminal repeat 
(MMTV-LTR). In this case one line was generated by coinjection and six more by injection of a 
double construct consisting of the MMTV-LTR driving the ribozyme (MMTV-RZ5) linked tail-
to-tail with the BLG gene including 4.2 kb of 5' and 1.9 kb of 3' flanking DNA. The BLG gene 
successfully rescued MMTV-RZ5 expression in the mammary gland, but both the ribozyme and 
BLG mRNA were also detected in a range of other tissues, corresponding to some of those 
which would normally express MMTV-RZ5 but not significant levels of BLG. In addition, the 
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temporal control of BLG expression was lost. This may indicate that BLG expression is not 
after all immune to position effects (Whitelaw et al. 1992) as clearly its expression here is 
influenced by neighbouring chromatin. However, this may be a unique case since the 
influencing DNA in this instance is not packaged into chromatin when it first encounters the 
BLG gene and the nuclear environment. For practical purposes, this experiment demonstrates 
that the BLG transgene rescue is not mammary-specific, which may limit its use for production 
of bioactive molecules or other proteins which would be deleterious outside the mammary gland. 
In addition, these data call into question the proposal that BLG transcription is required for 
rescue (Yull et al. 1997). The BLG transgene would not ordinarily be transcribed outside the 
lactating mammary gland (Simons et al. 1987; Whitelaw et al. 1992), so it is difficult to see how 
BLG transcription could lead to rescue in non-mammary tissues. Possibly transcription of the 
MMTV-RZ5 transgene rescues transcription of BLG in these tissues and the two feed back on 
each other, but MMTV-RZ5 has been shown to be silent in these tissues in the majority of lines 
generated in the absence of a BLG cointegrant (L'Hullier et al. 1996, Langley et al. 1998). 
Thus, the mechanism of transgene rescue remains obscure. 
1.72 alacralbumin 
a lactalbumin ((xlac) is found in most mammalian milks, and is a calcium metallo-protein, 
structurally related to lysozyme. alac functions to convert galactosyl transferase to lactose 
synthase in the mammary gland (reviewed by Sawyer and Holt, 1993; see also Stinnakre et al. 
1994). cxlac is encoded by a 2 kb gene of 4 exons, and bovine alac genomic constructs with as 
little as 750 bp of 5' and 350 bp of 3' flanking sequences are expressed at levels and in a pattern 
similar to the endogenous gene in transgenic mice (Vilotte et al. 1989). In vitro studies have 
identified binding sites for several mammary nuclear factors including Stat5 (reviewed by 
Mercier and Vilotte, 1993). 
1. 7.3 Whey acidic protein 
Whey acidic protein (WAP) is the major whey protein in rodents. WAP mRNA constitutes 10 - 
15 % of total mRNA in lactating rat, rabbit and mouse mammary epithelial cells. Low levels 
(1000 fold less) of mRNA are also detectable in virgin and early gestating animals. WAP is 
poorly expressed in cell culture, which probably reflects a requirement for cell morphology and 
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cell-cell interaction within the mammary gland which is not replicated in cell culture. There is 
evidence that post-transcriptional repression may play a part in silencing WAP expression in cell 
culture (Chen and Bissel, 1989). 
A rat WAP genomic fragment with 950 bp of 5' and 1.4 kb of 3' flanking sequence was 
expressed at 1 - 95 % of endogenous levels in transgenic mice, but expression was initiated 
earlier in gestation than the endogenous gene. Interestingly, deletion of the 3' flank to 70 bp 
improved the copy number dependence and frequency of expression, but did not alter the 
premature initiation. 
Two lactating mammary gland specific DNase I hypersensitive sites have been described 
upstream of WAP. The distal site, at -0.8 kb, is essential for WAP expression in transgenic 
mice. Glucocorticoid response elements are located within this HS, and the hypersensitivity is 
dependent upon glucocorticoid induction (Li and Rosen, 1994). Sites binding mammary nuclear 
proteins in vitro have been mapped to the region from -175 to -88 bp, and recently a negative 
element has been described which is essential for silencing of WAP in non-mammary cell lines 
(Kolb et al. 1994). The WAP promoter has been used to drive expression of a variety of 
transgenes (e.g. Gordon et al. 1987; Yu et al. 1989; Velander et al. 1992; Devinoy et al. 1994). 
However, expression levels have generally been low and variable, and subject to position 
dependent ectopic expression compared to the endogenous WAP gene. Nevertheless the WAP 
promoter has been used to express significant levels of a number of heterologous proteins in the 
transgenic mammary gland (Pittius et al. 1988; Bayna and Rosen, 1990; Reddy et al. 1991; 
Velander et al. 1992; Bischoff et al. 1992; Hansson et al. 1994; Thepot et al. 1995; Paleyanda et 
al. 1997; Castilla etal. 1998; Butler et al. 1997; Lee et al. 1998). 
As discussed elsewhere, McKnight et a! (1992, 1995) report the position independent expression 
of a WAP construct (2.6 kb of 5' and 1.6 kb of 3' flank) when flanked by chicken lysozyme 5' A 
elements, although copy number dependence was not observed. Thus, existing WAP constructs 
seem to lack essential flanking elements necessary for insulation of the gene from ectopic 
stimulation as well as elements necessary for consistently high levels of expression. 
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1. 7.4 The caseins 
The caseins are the major mammalian milk proteins. They are thought to perform two main 
functions, providing a dietary supply of amino acids to the infant and increasing the solubility of 
calcium (essential for bone growth) as calcium phosphate in the milk. In the presence of 
calcium, the so-called calcium sensitive caseins of the a and 0 types form loose, non-crystalline, 
heavily phosphorylated metallo-protein aggregates termed micelles, which are stabilised by the 
calcium insensitive K casein. In the gut the site-specific cleavage of K casein by rennin causes 
the milk to clot and remain in the stomach, facilitating digestion (reviewed by Mercier and 
Vilotte, 1993). 
The calcium sensitive caseins are variable in primary and secondary structure, but all possess 
three basic functional domains. The hydrophobic domain is important in micelle formation, the 
phosphorylation sites are important in calcium binding, and the highly conserved signal peptide 
allows efficient secretion of the caseins into the mammary lumen. 
In contrast, K casein is unrelated to the other caseins and does not bind calcium. It is necessary 
to stabilise the micelle, and the ratio of K to the other caseins is important in determining micelle 
size and therefore milk quality (Lin et al. 1989; Rollema, 1992). The site-specific cleavage of 
K casein in the gut causes the milk to clot and remain in the stomach, facilitating digestion. K 
casein may be structurally and functionally related to y fibrinogen, which performs a similar 
cleavage-induced clotting function in the blood (Jolles et al. 1974; Thompson et al. 1985; 
Alexander et al. 1988). 
All of the bovine casein genes have been cloned and sequenced (Alexander et al. 1988; Bonsing 
et al. 1988; Koczan etal. 1991; Groenan et al. 1993). While the sequences of the casein genes 
are divergent, certain features of the genes and proteins show the calcium sensitive caseins to be 
evolutionarily related (Bonsing and McKinlay, 1987). There is clear compartmentalisation of 
functional domains into discrete exons; no codon in any cloned casein gene is split by an intron. 
The 3 casein gene is the smallest of the three bovine genes at 8.5 kb, compared to 17.5 kb for 
asl and 18.5 kb for as2, but nevertheless has features common to all. Exon I encodes the 5' 
untranslated region except for 6 nt which are encoded by exon II along with the highly 
conserved signal peptide. The hydrophobic site is encoded by exon VII, while four minor 
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phosphorylation sites are encoded by the small exons III, IV, V and VI. The major 
phosphorylation site is formed by a splice event between exons Ill and IV, an event which may 
be selected for since the canonical splice sequence favours the formation of such a site (Jones et 
al. 1985). Exons VIII and IX encode the stop codon and polyadenylation signal. The exon-
intron structure of P casein led Rosen and colleagues to propose a model for calcium sensitive 
casein evolution, where recruitment of functional domains on exons was followed by intragenic 
and intergenic duplications of an ancestral gene to generate the present genes (Jones et al. 1985; 
Yu-Lee et al. 1986; see also Groenan et al. 1993). There is no evidence that K casein is 
evolutionarily or functionally related to the other caseins. 
The caseins of humans, mice, cattle, sheep and rabbits are tightly linked (summarised by Mercier 
and Vilotte, 1993), and at the start of this project the bovine casein locus had already been 
mapped by restriction digest (Ferretti et al. 1990; Threadgill and Womack, 1990). All of the 
bovine caseins are present on 200 kb of chromatin. This is not surprising for the calcium 
sensitive caseins, but the finding that the unrelated K casein gene is so closely linked to the other 
members of the family is unexpected, though suggested by the linkage data. It may be that this 
linkage is indicative of some form of locus control for the caseins, as noted by Alexander et al 
(1988). The murine (this thesis; Tomlinson et al. 1996; Rijnkels et al. 1997a) and human 
(Rijnkels et al. 1997b) casein loci have since been restriction mapped, and show similar 
organisation. 
Expression studies have focused on 0 casein, which is the most abundant protein in murine milk. 
By the start of this project the synergistic action of the lactogenic hormones, demonstrated for 
the whey proteins, had also been shown for 0 casein (Schmidhauser et al. 1990). Elements of 
the extracellular matrix are also important (reviewed by Mercier and Vilotte, 1993). Among 
numerous protein binding sites in the promoter, a Stat5 binding site is essential for prolactin 
induction, and there is evidence that prolactin induction involves displacement of a repressor 
protein from the promoter, which may also be the case for WAP (Schmitt-Ney et al. 1991; Lee 
and Oka, 1992). The first intron of 0 casein is also important for proper expression (Lee et al. 
1989a, b). More recent advances in the study of P casein expression are discussed in chapter 7. 
Casein promoters have been used with some success to direct heterologous gene expression to 
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the mammary gland (Buhier et al. 1990; Meade et at. 1990; Greenberg et al. 1991; Krimpenfort 
et at. 1991; DiTullio etal. 1992; Brem et al. 1994; Ebert et al. 1994; Maga et al. 1994; Uusi-
Oukari et al. 1997; Cerdan et al. 1998; Edmunds et al. 1998; Bijvoet et al. 1998). Interleukin-2 
has been expressed at up to 430 ng/ml in rabbit milk from a 2 kb rabbit 0 casein promoter 
(BUhier et al. 1990). Using a 21 kb bovine asl promoter Meade et a! (1990) obtained 
expression of human urokinase at 1-2 mg/ml in the milk of a transgenic mouse. Similarly, 
Platenburg et al. (1994) report the expression of 36pg/mi of human iactoferrin in transgenic 
mouse milk from a eDNA driven by a bovine a, 1 promoter, and Brem et al (1994) used the same 
promoter to obtain 1 mg/ml of human IGF- 1 in transgenic rabbit milk, again from a cDNA Both 
subunits of follicle stimulating hormone and the membrane protein cystic fibrosis 
transmembrane conductance regulator have been expressed under the control of the P casein 
promoter (Greenberg et at. 1991; DiTullo et al. 1992). In all these cases expression levels were 
very variable with the site of integration, which would suggest that there are regulatory 
sequences outside the region of the casein promoters used in these experiments. 
1.8 Summary of project aims 
The basic aim of this project was to assay for position-independent, copy number-dependent, 
physiological levels of gene expression from a YAC carrying the entire mouse or human casein 
locus in transgenic mice. As well as providing another instance of locus control to add to the 
growing body of data, this might ultimately lead to improved targeting of transgene expression 
to the lactating mammary gland. This could have important benefits in biotechnology, where the 
mammary gland is currently the system of choice for production of biomedical proteins in 
transgenic animals. Existing casein constructs have been subject to profound position effects, 
despite using up to 21 kb of 5' flanking DNA in the case of 0 casein. This suggests that there are 
other important control elements in the casein locus which have been omitted from the casein 
constructs used to date. In addition, the fact that the K casein gene is structurally unrelated to the 
other casein genes but is tightly linked may be an indication that some coordination of casein 
gene expression is vested at the locus level. Therefore, a strategy was devised to use a YAC to 
introduce the entire casein locus into transgenic mice, so that any long range control elements 
would hopefully be included. The aim was to assay gene expression from the YAC in transgenic 
mice and tissue culture, with a view to relating expression level to copy number. If copy 
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number-dependent expression was observed, molecular dissection of the YAC sequences would 
hopefully identify functionally significant regions. 
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2. Chapter 2- Materials and methods 
2.1 Suppliers of materials 
All laboratory reagents were obtained from Fisons Chemicals, Sigma Chemical Co, BDH, Gibco 
BRL Life Technologies and FMC, except where listed below. 
2.1.1 Bacterial and yeast media 
Bio 101 Inc. 
Sigma Chemical Co. 
Gibco BRL Life Technologies 
2.1.2 PFGE reagents 
2.1.2.1 Restriction and other enzymes 
New England Biolabs 
2.1.2.2 Agarose 
Gibco BRL (Rapid Agarose) 
FMC (SeaKem Gold, SeaPlaque, Nusieve GTG) 
2.1.3 Enzymes 
All enzymes were purchased from Boehringer Mannheim except where otherwise stated. 
2.1.4 Southern blotting materials 
Schleicher and Schuell 
Sartorius 
40 
Chapter 2- Materials and methods 
2.1.5 Radiolabelled reagents 
[a-32P]dCTP 3000CiJmmol, NEN Life Science Products 
[y-32P]dATP 6000CiJmmol, NEN Life Science Products 
2.1.6 Mice 
C57b16/CBACA F 1 hybrids, Harlan UK. 
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2.2 Buffers and solutions - Table 2.1 
1M NaPi: 	1M NaH2PO4 , pH adjusted to 7.2 with 1M Na2HPO4 
50x TAB: 	2M Tris, 1M acetic acid, 50mM EDTA, p118.0 
lOx TBE: 	890mM Tris, 890mM boric acid, 20mM EDTA, pH 8.0 
lOx TB: 	 100mM Tris.HC1, 10mM EDTA, pH8.0 
Ix ET: 	 10mM Tris, 50mM EDTA. pH8.0 
lOx TiowE: 	100mM Tris, 1mM EDTA, pH8.0 
1 Ox HEPES buffer 0.5M HEPES (N- [2-Hydroxyethyl]piperazine-N'- [2-ethanesulfonic 
acid]), 10mM EDTA, pH 8.0 
20x SSPE 	3M NaCl, 177mMJ NaH2PO4, 20mM EDTA, pH7.4 via NaOH 
C&G buffer: 	0.5M NaPi pH7.2, 7% SDS, 1mM EDTA 
Denaturant: 	0.5M NaOH, 1 .5M NaC1 
GTE 	 50mM glucose, 10mM EDTA, 25mM Tns-HC1 pH 8.0 
KOAc 	 60 ml 5M potassium acetate, 11.5 ml glacial acetic acid per lOOmis. 
The resultant solution is 3M potassium and 5M acetate, pH4.8 
NaOHJSDS 	0.2N NaOH, 1% SDS, made fresh 
NDS 	 50mM Tris.HC1 pH9.0, 3% N-lauroylsarcosine, 0.5M EDTA, 1mg/mI 
proteinase K (added fresh). 
Neutralising 	3M NaCl, 0.5M Tris.HC1, pH7.0 
buffer: 
PEG solution: 	10mM Tris, 1.0mM EDTA, 100mM LiAc, 40% w/v PEG 3350 
lOx TE/LiAC: 	100mM Tris, 10mM EDTA, 100mM LiAc 
Tail buffer: 	0.3M NaOAc, 50mM KC1, 1.5mM MgC12, 10mM Tris.HC1 (pH 8.5), 
0.5% NP40, 0.5% Tween-20 
SE 	 IM Sorbitol, 50mM EDTA 
SCE 	 1M Sorbitoi, 50mM EDTA, 0. 1M sodium citrate, pH5.8 via citric acid. 
CaCl2 solution 	0. 1M Tris.HC1, pH7.4, 0. 1M CaCl2 
PEG/CaC12 	45% (w/v) PEG3350 , 10mM Tris.Cl pH7.4, 10mM Ca1C1 2 
Yeast 	lysis 0.5M Tris.HC1 pH9.0, 3% N-lauroylsarcosine, 0.2M EDTA, 1mg/mi 
solution (YLS) 	proteinase K (added fresh). 
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2.3 Media for yeast and bacterial culture 
Table 2.2: Bacterial and yeast media 
Lauria Broth (LB) 	lOg bacto-tryptone, 5g bacto-yeast extract, 5g NaCl per litre, pH 7.,2 
(NaOH) 
purchased in gelatin pellets from Bio101 Inc. 
Launa Agar (L) 	As above but with 15g agar per litre 
2YT 	 1 6g bactotryptone, 1 Og yeast extract, 5g NaCl per litre. 
Terrific Broth (TB) 	12g bacto-tryptone, 24g bacto-yeast extract, 4m1 glycerol per 900 ml, 
plus lOOml 0. 17M KH2PO4/0.72M K2HPO4 (added after autoclaving) 
L-Amp plates 	L-agar plus 100 Vg/ml ampicillin, added when molten at 60°C after 
autoclaving 
LAXI plates 	L-Amp plus 0.004% X-Gal (5-bromo-4-chloro 3-indolyl 
galactosidase, 2% stock in dimethylformamide) and 100iM IPTG 
(isopropyl--D-thiogalactopyranoside, lOOmlvI stock in water), added 
at 60°C after autoclaving. 
YPD broth 	 lOg yeast extract, 20g peptone, 20g dextrose per litre. Purchased 
from Bio 101 Inc. 
YPD agar 	 As above but with 2% select agar 
Dropout base (DOB) 1.7g yeast nitrogen base, 20g dextrose, 5g ammonium sulphate per 
litre. Purchasd from Bio 101 Inc. 
Dropout base agar 	As above but with 1.7% agar 
(DOBA) 
Synthetic defined 	6.7g yeast nitrogen base, 20g dextrose per litre, pH5.8. 
medium (SD) Supplemented with at least lysine, adenine, histidine and isoleucine. 
2.3.1 Yeast "dropout" powders 
These are blends of all essential nutrients in the concentrations below except for the "dropout" 
nutrient, and are used to select for prototrophy for that nutrient. Dropout powders were 
purchased from Bio 101. 
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Table 2.3: Yeast medium supplements 













2.4 Plasmid DNA stocks 
All proprietary plasmids were obtained from the appropriate supplier or subcultured from 
purchased plasmid stocks. Stocks of all plasmids were stored as E. coli aliquots at —70°C, as 
frozen DNA at —20°C or as precipitated DNA under ethanol at —70°C. All of these methods 
store plasmids essentially indefinitely, but of the three storage under ethanol is the most robust in 
that accidental thawing would not harm the sample. Aliquots of plasmids in use were 
maintained in TB at either 4°C or —20°C. 
2.5 Genomic DNA stocks 
Stocks of genomic DNA were stored at 4°C in TB. 
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2.6 Bacterial and yeast host strains 
Bacterial host strains were obtained from Stratagene or Boehringer Mannheim. Yeast strain 
AB1380 was obtained from the American Type Culture Collection. YPH499 and YPH500 were 
obtained from Stratagene. 
Table 2.4: Yeast and bacterial host strains 
Strain Genotype Reference 
DH5aF' supE44, AlacUl69(f8OlacZiiJvIl5), hsdRl7, recAl, Hanahan 1983 
endAl, gyrA96, thi-1 
XL1 -Blue recAl, endAl, gyrA96, thi-1, hsdRl 7, supE44, relAl, lac Bullock et al. 
[F', proAB, lac"ZAM]5, TWO (te?)] 1987 
scsi io rpsL (Sti'), thr, leu, endA, thi-1, lacY, galK, gaiT, ara, Yanish-Perron 
tonA, tsx, dam, dcm, supE44, A(lac-proAB), [F', traD36, et al. 1985 
proAB, iacJ'Z4M15] 
AB1380 MA Ta, ura3-5, trpl, ade2-1, can] -100, lys2,1, hisS Burke et al. 
1987 
YPH499 MA Ta, ura3-52, iys2-801°" 	ade2101o,  trp1463, Sikorski and 
his3-,1200, leu2-41 Hieter 1989 
YPH500 M4Ta, ura3-52, 	 aber ade2-101°", trplA63, Sikorski and 
his3 -4200, leu2-i.11 Hieter 1989 
2.7 Plasmid DNA preparation 
Plasmid DNA was prepared by a number of different protocols. Generally, large numbers of 
clones were prepared by a "miniprep" method, either alkaline lysis and phenol or using the 
Wizard kit from Promega. Wizard, Wizard 377 and Wizard Plus were all used with no 
appreciable difference being observed between DNAs prepared by any of the three kits. 
2.7. 1 Alkaline Lysis miniprep 
E. Coli was grown at 37 °C overnight, with shaking, in 3 ml of rich medium (e.g. 2YT + 10 
pg/ml ampicillin) in a 14 ml culture tube (Falcon). 
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1.5 ml of culture were transferred to a 1.5 ml microcentrifuge tube and centrifuged for 2 min at 
full speed (13,500 rpm) in a benchtop microfuge. The supernatant was removed and the cell 
pellet resuspended in 100 p1 of ice cold GTE (50mM glucose, 25mM Tris pH8.0, 10mM 
EDTA) supplemented with 4 mg/ml lysozyme. 
After incubation for a few minutes at RT, 200 p1 of NaOHISDS (0.2N NaOH, 1% SDS) were 
added. The tubes were mixed by inversion. The tubes were left on ice for 5 mm. 
150 p1 of KOAc solution (pH4.8) were added, and the tubes mixed by vigorous inversion or by 
gentle vortexing while inverted. The tubes were left on ice for 5 mm. 
The tubes were centrifuged for 5 min at 13,500 rpm in a microfuge, after which the supernatant 
was carefully removed to a fresh tube, taking care not to disturb the pellet of cell debris and 
genomic DNA. 
An equal volume of phenollchloroformllAA (25:24:1) was added to each tube, and mixed by 
vortexing. After centrifugation for 2 min at 13,500 rpm, the upper (aqueous) phase was 
transferred to a fresh tube. This was repeated using 24:1 chloroformflAA to remove traces of 
phenol, and then the plasmid DNA was precipitated by the addition of 2 vol of 100 % ethanol. 
After incubation on ice or at -20 °C for 10 mm, the DNA was pelleted by centrifugation for at 
least 10 min at 13,500 rpm, washed once with 70 % ethanol, and air-dried briefly RT 
(overdrying renders plasmid DNA difficult to redissolve). The DNA was then redissolved in 100 
p1 of TE or TiowE. 
2.7.2 Large scale "midi" plasmid DNA prep 
Large quantities of plasmid DNA were either prepared by alkaline lysis followed by CsC1 
gradient centrifugation, or by Qiagen column using the tip-500 kit. 
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2.72.1 CsC'lprotocoll 
An overnight culture in 50 ml was inoculated with a single colony from a fresh plate. Medium 
was typically 2YT supplemented with 10 pg/ml ampicillin. The culture was incubated at 37 °C 
overnight, with shaking, before pelleting the cells for 15' at 3000 rpm in a benchtop centrifuge 
such as the Beckman GPR. The cell pellet was resuspended in 5 ml of GTE, 10 pg/mI lysozyme 
and incubated on ice for 5 mm. 
10 ml of freshly made 0.2 N NaOH, 1% SDS was added and mixed by gentle inversion. 
Following 10 minutes on ice, 7.5 ml of solution Ill were added and the tubes left on ice for a 
further 10 mm, before centrifugation at 3,000 rpm for 20 min to pellet the cell debris and 
genomic DNA. 
To the supernatant was added 0.5 vol of 7.5 M NH40Ac, and the tubes were mixed by inversion 
and left at RT for 20 mm. The precipitated protein was then pelleted by centrifugation at 3,000 
rpm for 20 mm. 
2/3 vol of isopropanol was added to the supernatant and left at RT for 30 min to precipitate 
nucleic acids. After a 20 min centrifugation at 3,000 rpm, the nucleic acid pellet was washed 
with 70 % ethanol and redissolved in TB supplemented with 10 .tg/ml RNase A. The solution 
was incubated for 1 h at 37 °C. 
1.5 g of CsC1 was added to each tube, and the resultant solution was transferred to a Beckman .2 
ml polyallomer ultracentrifuge tube. 120 .tl of 10 mg/ml EtBr were added to each tube, and the 
tubes balanced and heat-sealed then mixed by inversion. 
The plasmid DNA was banded by centrifugation at 80,000 g for 16 h in a Beckman TL100 
ultracentrifuge using the TL-A 100 rotor. 
The plasmid band was visualised with UV light (at 320 nm) if necessary, and removed by 
piercing the tube with a syringe. The DNA was recovered by 2-fold dilution with water, 
repeated washing with an equal volume of isoamyl alcohol to remove the EtBr, and precipitation 
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with 0.1 vol of 3 M NaOAc and 2 vol of 100 % ethanol. The pellet was washed in 70 % ethanol 
and redissolved in TB or TiowE. 
2.7.2.2 CsCI protocol!! - "Triton protocol" 
200ml of overnight culture (in rich medium) were centrifuged in a Beckman J2-21 centrifuge, 
and the cell pellet was resuspended in 3 ml of 15% sucrose, 50mM EDTA, 50mM Tris (pH 8.0), 
3 mg/ml lysozyme. The cells were transferred to an Oakridge tube and incubated on ice for 15 
mm. 6 ml of triton mix were added and mixed gently, and left on ice for 20 min or until lysis 
was complete. Following centrifugation at 18,000 rpm for 45 mm, the supernatant was added to 
9.5g CsC1 and imi of 10 mg/ml EtBr. The tubes were centrifuged for 10 min at 15,000 rpm. 
The supernatant was decanted from under the resultant pellicle, and loaded into 13 ml 
ultracentrifuge tubes. Following balancing and sealing, the tubes were centrifuged for 16h at 
55,000 rpm followed by 40,000 rpm for lh. The plasmid DNA band was removed and dialysed 
against 51 of TE for at least 2h, then phenol/chloroform extracted and precipitated with 
isopropanol. The DNA pellet was washed with 70% ethanol and redissolved in TE. 
2.7.2.3 Qiagen rnaxiprep for plasmid DNA 
This protocol followed the Qiagen protocol booklet, using the Qiafilter units and the proprietary 
reagents. 
2.8 Genomic DNA preparation 
2.8.1 From mouse tail biopsy 
Mouse tail tissue was incubated in 3 ml Tail Buffer supplemented with 250pg/ml proteinase K 
for 16h at 55°C with vigorous shaking. 0.5 ml of the digested material was transferred to a 
microcentrifuge tube and extracted twice with 700 i.tl of TE-saturated phenol/chloroform 
(50:50), then once with chloroformIlAA (24:1). The DNA was precipitated with 700 p1 of 
isopropanol and pelleted by centrifugation in a microcentrifuge. The DNA pellet was washed 
twice with ice-cold 70% ethanol and resuspended in TB. 
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2.8.2 From yeast - DNA in agarose plugs 
Yeast cells were grown in rich medium overnight. 50 ml of cells were pelleted by centrifugation 
at 3000 rpm in a Beckman GPR benchtop centrifuge. The cell pellet was washed twice with 20 
ml water and then twice with 20 ml SE, and then transferred to an Eppendorf tube by the 
addition of 300 sl SE. Zymolyase 20T (ICN Biomedicals) was added to a final concentration of 
2mg/ml, and 1 p1 of P mercaptoethanol was added. Occasionally the Zymolyase treatment was 
omitted with little effect, but more usually it was found to be necessary for release of the DNA 
from the agarose plug. An equal volume of molten 1.6 % InCert agarose (FMC) was added at 
50°C and the mixture was cast either into a BioRad plug former or by taking up into 1 ml 
syringes. Once set the agarose could be released from the syringe by cutting off the nozzle and 
extruding the agarose, slicing it into 2mm (-20 p1) slices with a backed razor blade. The plugs 
or slices were incubated in NDS with 2mg/ml proteinase K at 55°C for at least 48h, with gentle 
shaking. Following proteinase K digestion the plugs or slices were washed at least 4 times in a 
large volume (typically SOx the agarose volume) of 0.5M EDTA. Plugs were stored at 4°C in 
0.5M EDTA for up to a year. Aliquots were equilibrated in TiowE for digestion and maintained 
in this at 4°C for a few months without visible degradation. 
2.9 Ethanol precipitation of DNA 
0.1 vol of 3 M NaOAc were added to the DNA (if necessary), followed by 2 to 2.5 vol of 100 % 
ethanol. If the quantity of DNA was very small (typically less than 1 pg) 10 pg glycogen were 
also added. Following incubation for at least 10 min on ice or at -20 °C, the precipitated DNA 
was recovered by centrifugation, typically at 13,500 rpm in a microfuge, but larger volumes 
were centrifuged for 30 min at 3000 rpm in a Beckman GPR centrifuge, or at 15,000 rpm for 30 
mm in a Beckman J2-2 I centrifuge using the JA-20 rotor. 
Precipitated DNA was typically washed once or twice with 70 % ethanol before brief (if any) air 
drying and redissolving in TE or TlowE, or occasionally water. 
2.10 Quantification of DNA 
DNA was usually quantified using the GeneQuant spectrophotometer from Pharmacia, using the 
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capillary cuvette and following the manufacturer's instructions. 
YAC DNA was quantified by electrophoresis alongside samples of lambda bacteriophage 
(X) DNA of known concentration, from a proprietary stock (Boehringer Mannheim). 
2.11 Enzymatic modifications of DNA - restriction digests, ligations etc 
Restriction digests of low MW DNA were carried out according to the supplier of the restriction 
enzyme and using the supplier's restriction buffer unless otherwise stated. Double digests were 
performed on a trial and error basis having consulted manufacturer's literature as to the most 
suitable restriction buffer. 
Restriction digestion of yeast DNA in agarose plugs was essentially according to Hamvas et al. 
(1994). Restriction digests were supplemented with 0.5mg/mi BSA (NEB), 1.25pM DTT and 
2.5jiM spermidine. Reaction volumes were 200.tl per 20p1 plug, and plugs were pre-
equilibrated in reaction buffer on ice once for 20 min before the enzyme was added, then again 
for 20 min on ice before transfer to 37°C. This was to allow the enzyme to enter the agarose; 
some enzymes have short half lives at 37°C. Partial digests were typically incubated for 30 mm. 
Complete digests were incubated overnight. Digestion was stopped by the addition of 0.5 
volumes 0.5M EDTA. 
Ligations were performed using the Ready To Go Ligase lyophilised reaction mix tubes from 
Pharmacia (now Amersham Pharmacia Biotech Inc.) and according to the manufacturer's 
instructions. 
Dephosphorylation was performed using shrimp alkaline phosphatase (SAP) from New England 
Biolabs according to the manufacturer's instructions except that a 10 fold excess of enzyme was 
used. SAP reactions were stopped by heating for 15 min at 75°C. 
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Filling in of 5' overhangs was performed with the Kienow enzyme (Boehringer Mannheim) 
according to the manufacturer's recommendations. 3' overhangs were removed with the same 
enzyme. 
2.12 Gel-purification of small DNA fragments 
This was done using the Prepagene kit from BioRad. The DNA band was excised from the 
agarose gel and incubated with 3 volumes of Prep-A-gene binding buffer (50mM Tris pH 7.4, 
1mM EDTA, 6M NaC104) for 5mm, at 550C. 5p1 of Prep-A-gene matrix was added per pg of 
DNA and incubated for 5-10min at room temperature followed by centrifugation in a microfuge 
for 30sec. The pellet was washed 3 times in 50x volume of binding buffer, followed by three 
washes in 20mM Tris pH 7.4, 2mM EDTA, 0.4M NaCl, 50% Ethanol. After a final spin 
to dry the pellet, the DNA was eluted from the matrix in 1 pellet volume of either H 20 or TE, 
5mm, at 55°C. Two elutions were usually performed to improve yield. The eluted material was 
recovered by centrifugation. 
2.13 DNA Sequencing 
Double stranded DNA was sequenced using a Perkin Elmer AB1377 Automated DNA Sequencer 
with 48 cm well-to-read gel plates and a 36-well comb. Sequencing reactions were prepared 
using either the Dye Terminator, dRhodamine Dye Terminator or BigDye Ready Reaction 
sequencing kits from Perkin Elmer and following the manufacturer's instructions. Typically I to 
2 pg of plasmid DNA was included with 4 pmol of primer. Reactions were cycled on an MJ 
Research PTC-200 thermal cycler without oil and using the heated lid as follows: 
25 cycles: 	94°C, 30 sec; 50 °C, 30 sec; 60°C, 1 mm. 
The block was preheated to 95°C before adding the reaction tubes and starting the reaction. 
Completed reactions were precipitated by the addition of 0.1 vol 3M NaOAc and 2.5 vol of 90% 
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ethanol and incubation on ice for 10 mm. Following centrifugation at 13,500 rpm in a benchtop 
microcentrifuge the supernatant was removed and the pellet resuspended in 4 il of ABI Loading 
Dye and stored frozen for up to two weeks before electrophoresis. Samples were denatured at 
95°C in a thermal cycler for 2 min and snap cooled on ice immediately prior to loading onto the 
gel. 
The sequencing gel was prepared according to the manufacturer's instructions, using the Long 
Ranger Singel single-pack gel kits from FMC. 1 .50 of each reaction was loaded onto the gel 
and run out for 10 h using the 48 cm standard conditions recommended by the manufacturer. 
Sequencing data was generated from the raw data (ABI gel file) using Sequence Analysis, 
trimmed for ambiguous sequences or vector sequences using Factura; and aligned into contigs 
using AutoAssembler, all from Perkin Elmer. Other sequence analysis software was from 
Lasergene. 
It was generally found that miniprep DNA prepared by alkaline lysis/phenol sequenced well, but 
Wizard miniprep DNA did not. This may be due to high salt carryover, or to resin fines which 
escape some batches of Wizard columns. In most cases good sequence could be obtained after a 
clean-up step on a proprietary column such as the High Pure kit from Behringer Mannheim. 
CsCl- and Qiagen-purified DNA gave very high quality sequence data. 
2.14 Radiolabelling of double-stranded DNA 
The "Random Primed DNA Labelling Kit" (Boehringer Mannheim) was employed for 
incorporation of 32P into the randomly primed, and newly synthesised complementary DNA 
strand. The reaction was carried out as recommended by the supplier. Typically a 20j.tl reaction 
contained 20-50ng of DNA, 0.5 nmol each of dATP, dGTP and dTTP, and 0.5nmol of 
[cx-32P]dCTP (NEN). Unincorporated 32P nucleotides were separated from the DNA using a 
Sephadex G-50 column according to the manufactures recommendations (Nick Column, 
Pharmacia). Specific activity of probes was measured by liquid scintillation using a Beckman 
LS500 CE. Typically 5x107 cpm were added to each hybridisation. The labelled probe was 
denatured by a 10 min incubation at RT with 0.1 volumes of 5M NaOH. 
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2.15 Radiotabelling of oligonucleotides 
Oligonucleotides were labelled with r- 32pusing polynucleotide kinase (PNK) from Boehringer 
Mannheim. 50 pmol of oligonucleotide in 19 il of water were added to 3.0 p1 of lOx PNK 
buffer (Boehnnger Mannheim), and 5.0 p1 of [y-32P]dATP (NEN). 2.0 p1 of PNK were added 
and the reaction was incubated at 37°C for 30 min before being added directly to the 
prehybridised filter in hybridisation solution. 
2.16 Polymerase chain reactions (PCR) 
2.16.1 Amplification of murine /3 casein probes 83 and /35. 
The reaction was carried out in a lOOpi volume overlaid with silicone oil in a Hybaid Omnigene 
thermal cycler. The reaction comtained lx PCR buffer (2.25mM MgC12, 50mM Tris.HCL pH 
9.2, 160mM (NH4)2SO4, Boehringer Mannheim), 200ng of murine genomic DNA, 200 pmol of 
dNTPs, 0.4 pmol of each oligonucleotide primer, and 2 U of Taq DNA polymerase. The cycling 
conditions were as follows: 
icycle: 94°C, 2mm; 53°C, 30 sec; 70°C, 90 sec; 
39 cycles: 	94°C, 1 mm; 53°C, 30 sec; 70°C, 90 sec. 
2.162 Amplification of human /3 casein probe from human genomic DNA 
The reaction was carried out as above except that the template was 200ng of human placental 
DNA, and the cycling conditions were as follows: 
icycle: 94°C, 2mm; 46°C, 30 sec; 70°C, 50 sec; 
39 cycles: 	94°C, 1 mm; 46°C, 30 sec; 70°C, 50 sec. 
2.163 Amplification of TRP1 for construction ofpURACorp3 
The reaction conditions were as above, except that 1 ng of pRS3 14 (Sikorski and Hieter, 1989) 
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plasmid DNA was used as template. The completed PCR reaction was passed over a PCR Select 
HI column (5-3 Prime Inc.) in accordance with the manufacturer's instructions to purify the 
amplified DNA before cloning. 
2.16.4 Amplification of HTS3 for retrofitting ofyATSi 
HIS3 was amplified from pRS3 13 (Sikorski and Hieter, 1989) as described for TRP1 above. 
Prior to transformation into yATS 1 yeast cells (Section 5.4.2) the PCR product was passed over 
a Microcon column (Amicon) in accordance with the manufacturer's instructions. 
2.17 Reverse transcription polymerase chain reactions (RTPCR) 
2.17.1 Amplification of murine casein cDNA probes 
Murine casein cDNA probes were amplified from lactating mammary gland total .RNA using 
Superscript II RNaseH reverse transcriptase (Life Technologies). The first strand reaction was 
carried out in a 0.5m1 microcentrifuge tube containing 1 pg total RNA, lx PCR buffer (2.25mM 
MgC12, 50mM Tris.HC1 pH 9.2, 160mM (NH 4)2SO4, Boehringer Mannheim), 25 pmol 3' primer 
and 1mM dNTPs, in a 20 p1 volume overlaid with silicone oil. The reaction mix was heated in 
an Omnigene thermal cycler (Hybaid) to 95°C for 5 mm, followed by snap cooling on ice. 200U 
of Superscript II Rnaseff reverse transcriptase were added, and the reaction incubated at 42°C 
for 30 mm. To the completed first strand reaction was then added 25 pmol of the 5' primer, 8 p1 
of lOx PCR buffer, 2U of Taq DNA polymerase, and the volume made up to 100 p1  with water. 
The PCR cycles used were as follows: 
'to amplify a casein cDNA: 
1 cycle: 94°C, 2 mm; 62°C, 30 sec; 72°C, 1 mm; 
39 cycles: 	94°C, 1 mm; 62°C, 30 sec; 72°C, 1 mm; 
to amplify 'y, F, or ic casein: 
1 cycle: 94°C, 2 mm; 62°C, 30 sec; 72°C, 42 see; 
39 cycle 	94°C, 1 mm; 62°C, 30 see; 72°C, 42 sec. 
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2.172 RTPCR to detect human casein gene expression in HP8 mice 
RTPCR to detect human casein transcripts in HP8 mouse lactating mammary gland total RNA 
was performed using the Superscript II RNaseH reverse transcriptase (Life Technologies) and 
following the manufacturer's protocol for random primed first strand generation and subsequent 
PCR amplification. The PCR reaction was carried out in 0.5ml thin-walled reaction tubes 
(Perkin Elmer) using an MJ Research PTC200 DNA Engine thermal cycler with a heated lid. A 
hot start was effected by omitting the Taq DNA polymerase until after the first 94°C step. The. 
conditions were as follows: 
94°C, 3 mm, then hold at 80°C (add Taq polymerase); 
40 cycles: 	94°C, 20 sec; 55°C, 25 sec; 72°C, 30 sec. 
2.18 Electrophoresis of DNA 
Except where stated (for RNA gels and PFGE), DNA gels were poured and run in appropriate 
concentrations of agarose (MP agarose from Gibco BRL Life Technologies or FMC) according 
to standard methods. The running buffer was TAE. DNA was visualised in agarose gels by the 
inclusion of lOpglml EtBr in the gel and subsequent photography with a Polaroid. land camera 
on a Srtatagene UV transilluminator. Where migration of the EtBr out of the gel necessitated it, 
the gel was restained in running buffer containing lpg/ml EtBr. 
2.19 Southern transfer of DNA 
Agarose gels were treated with 1 2OmJ/cm 2 of 254nm UV light in a Spectronics Spectrolinker 
UV crosslinker to nick the DNA. The DNA was denatured by a 30 min incubation in 0.5M 
NaOH/1.5M NaCl and neutralised in Neutralising solution. Transfer in 1OxSSPE was by 
conventrional Southern blot or downward transfer using the TurboBlotter from Schleicher and 
Schuell. PFGE gels were transferred exclusively by downward transfer as the reduced pressure 
on the gel reduces crushing and results in more complete transfer. All transfers were carried out 
overnight. In conventional Southern blotting, a weight of no more than -300g was used to avoid 
crushing the gel. Filters used were either Duralon UV (Stratagene), Nytran (Schleicher and 
Schuell) or Sartolon (Sartorius). DNA was crosslinked to the filter with l20mJ/cm 2 of 245nm 
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UV light. 
2.20 Hybridisation of Southern blots and colony lift filters 
Southern blots and colony lift filters were hyrbidised according to Church and Gilbert (1984). 
Prehybridisation and hybridisation were at 65°C in 0.5 M NaPiJ7% SDS/l mM EDTA. Filters 
were washed twice for 10 min at 65°C in 2x SSPEI0.1% SDS, followed by one or more washes 
of 10 min at 65°C in 0.2x SSPEI0.1% SDS. 
2.21 Autoradiography 
Autoradiography was carried out at —70°C with intensifying screens, using either Kodak X-
OMAT-AR or Amersham Hyperfilm MP autoradiography. Of these Hyperfilm MP gave better 
results owing to its high transparency with sensitivity equal to that of X-OMAT-AR. 
2.22 RNA preparation 
Total RNA was prepared from tissue or cultured cells using either RNAzol (Invitrogen) or 1'RI 
reagent (Sigma). In each case the manufacturer's protocols were followed. RNA was stored at - 
70°C or, for short periods, at -20°C, in 1mM EDTA. Tissue was homogenised in an Ultraturrax 
homogeniser at 23,000 rpm in RNAzo1 or TRI reagent. 
2.23 Northern blots 
RNA was prepared at least 2.5 pg4tl. If more dilute, the RNA sample was concentrated bybrief 
drying in a Speed Vac vacuum centrifuge (Savant) on low heat. 
To l0.tg of RNA in either 2 or 4pl of 1mM EDTA, two volumes of buffer A (2.9x. HEPES 
buffer pH7.8 1 71% v/v formamide) and 2.3 volumes of F/F (9.7% v/v formaldehyde, 74% v/v 
formamide) were added and the mixture heated for 10 min at 70°C then quenched on ice. Either 
1.5 or 3.Opl of RNA loading buffer (lx HEPES, pH7.8, 50% v/v formamide, 8% v/v 
formaldehyde, 5mg/mi bromocresol green, 400mg/ml sucrose) was added and mixed well. 
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Denaturing agarose gels were prepared in lx HEPES buffer with formamide at 6%. The gel was 
allowed to set for at least an hour in a fume hood wrapped in Saranwrap (Dow Corning). 
Electrophoresis was at 10 v/cm for 3 to 4 hours, using RNA markers from Gibco BRL Life 
Technologies to monitor migration. In some cases the gel was EtBr-stained to visualise the 
RNA, but in others it was prepared unstained. No difference in RNA integrity was observed 
between these two procedures. The gel was then transferred to Nytran (Schleicher and Schuell) 
membrane overnight in lOx SSPE using the TurboBlotter downward transfer system from 
Schleicher and Schuell. The filter was crosslinked by 120 mJ CM-2  of 254nm UV light in a 
Spectrolinker UV crosslinker from Spectronics Corp. Prehybridisation and hybridisation were 
performed according to Church and Gilbert (1984) at 42°C. 
Blots probed with double stranded DNA were washed for 10 min at RT in 2x SSPE, followed by 
2 washes at 55°C in 2xSSPE/0.1% SDS. High stringency washes were performed at 60°C with 
0.2xSSPE./0. 1% SDS 
Blots probed with oligonucleotides were washed twice at RT for 10 min in 6x SSPE, 0.1% SDS, 
followed by a single 10 min wash in 6x SSPE, 0.1% SDS at 42°C. 
2.24 Pulsed Field Gel Electrophoresis 
PFGE was performed using a CHEF DRII contour-clamped homogenous electric field PFGE 
apparatus from BioRad. Gels were prepared in 18 M92 water as 1% Rapid Agarose or 1% 
SeaKem Gold; Rapid Agarose was no longer available after 1996. SeaKem Gold gives very 
similar results but results in slightly reduced mobilities, such that geL conditions were adjusted 
slightly. Gels were prepared and run in 0.5x TBE buffer. 
For a separation, of 50-500 kb fragments in Rapid agarose, such as is shown in Figure 4.2, the 
gel was run at 14°C for 22h at 200V with the switch time ramped from 5s to 30s. Preparative 
PFGE was performed with these conditions (see chapter 6). With SeaKem Gold the final switch 
time was raised to 35s (as in Figure 5.6). 
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Gel conditions for lower MW separation (as in Figure 4.5) also involved 1% Rapid Agarose cast 
and run in 0.5x TBE. The gel was run for 15h at 200V with switch time ramped from 0.5s to 
2.5s. 
Pulsed field gels were stained for 30 min in 1 pg/mi EtBr and photographed using either a CCD 
camera (Mitsubishi) or a Polaroid land camera, both from UVP, on a longwave UV 
transilluminator (Stratagene). Pulsed field gels were Southern blotted onto Nytran membrane 
(Schleicher and Schuell) by downward transfer using a TurboBlotter apparatus (Schleicher and 
Schuell) as for normal gels (Section 2.19). 
2.25 Preparation of chemically competent E. coil for transformation. 
A 10 ml overnight culture of bacteria was inoculated into 250 ml of prewarmed LB and grown 
until the OD6w reached 0.5 (for DH5(x and XL1 -Blue strains). This is indicative of the late-log 
phase of growth. The cells were then chilled on ice for 5 mm and harvested in a precooled rotor 
in a Beckman J2-21 centrifuge for 5 min at 10,000 rpm. Subsequent steps were performed in a 
cold room (4 °C). 
The cells were resuspended in 100 ml ice-cold TFBI (30mM potassium acetate, 100mM RbC1, 
10mM CaC12, SOmIvI McC12, 15% w/v glycerol, pH 5.8 via acetic acid) and incubated on ice for 
10 min before being harvested as before. The pellet was resuspended in 10 ml ice-cold TFBII 
(10mM MOPS (3-[N-Morpholino]butanesulfonic acid), 75mM CaCl 2, 10mM RbCl, 15% w/v 
glycerol, pH 6.5 via KOH) and incubated on ice for 15 mm, then snap-frozen in liquid nitrogen 
as 200 jil aliquots in prechilled Eppendorf tubes. The tubes were stored at -70 °C and thawed on 
ice immediately before use. The transformation efficiency was tested by transformation with a 
known quantity of a test plasmid as below. 
2.26 Transformation of chemically competent E. coil 
Competent cells were thawed on ice and split into 100 p1 aliquots. Up to 1 pg of transforming 
DNA was added and mixed gently, and the tube was incubated on ice for 20 mm. Following a 
90 sec heat shock at 42 °C, 400 p1 LB or 2YT were added and the transformations were 
incubated at 37 °C with agitation for 30 min to 1 h, then plated at an appropriate density 
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(depending on postulated transformation efficiency) onto selective medium (typically LB plates 
supplemented with 50 .ig/ml ampicillin). 
2.27 Yeast colony lift protocol 
Yeast colony lifts were performed from freshly grpwn plates. Yeast cells were patched or 
spotted onto a rich medium plate and grown for 1-2 d. However, it was found that overgrowth 
of the patched cells could inhibit lysis after transfer (Section 3.4). A 90 mm disk of Hybond N+ 
membrane (Stratagene) was laid onto the plate for 10 minutes, and marked for orientation. The 
filter was then laid yeast side up onto Whatman 3MM paper soaked in SCE supplemented with 
8mg/mi Novozym 234 (Novo Nordisk) and 10mM DTT, and incubated in wrapped dishes for 4 
h at 37°C to allow digestion of the yeast cell walls. The filter was then transferred to 3MM 
paper soaked in denaturant (0.5N NaOH, 1.5M NaC1) for 5 mm, then air dried for 5 min on fresh 
3MM paper. The filter was then floated on neutralising solution (1M Tris pH 7.5, 1.5M NaCl) 
for 5 mm, then on 0.1M Tris (pH 7.5), 0.15M NaCl for 5 mm, then submerged in this solution 
for 2 mm. The filter was then incubated in fresh 0.1M Tris (pH 7.5), 0.15M NaCl supplemented 
with 0.25mg/ml Proteinase K at 55°C for 1 hour with gentle agitation. Any remaining colony 
debris was wiped off with a tissue soaked in 0.1M Tris (pH7.5), 0.15M NaCl and the filter was 
briefly rinsed in this solution before the DNA was UV-crosslinked onto the filter. 
2.28 Yeast Strain Mating 
2.28.1 Mating on solid medium 
Haploid strains of opposite mating types (a and a) were patched onto the same region of a plate 
of suitable selective medium (e.g. histidine selection for mating of his3 and hisS strains). This 
plate was incubated at 30 °C for 3-4 h, after which the mated cells were inoculated into 100 .tl 
YPDA and plated onto dropout medium (typically selecting for histidine prototrophy which 
would mark diploid cells). 
After incubation overnight at 30 °C, single colonies were picked and patched onto selective 
plates to confirm the desired phenotype. Clones of this phenotype were then sporulated as 
follows. 
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2.28.2 Random sporulation 
A large freshly grown diploid colony was inoculated into 5 ml of YPDA and grown at 30 °C for 
2 d with shaking. The cells were then peileted and resuspended in 2 ml sporulation medium, 
supplemented as required for the particular strain. The cells were incubated in this medium for 3 
d with shaking. 
The cells were then pelleted and resuspended in 0.5 ml water, to which was added 0.5 ml diethyl 
ether. The tube was vortexed for 1 mm, and left at RT for 5 mm. The aqueous phase was then 
removed into a fresh tube and 100 p1 was spread onto a YPDA plate. 100 p1 water was 
pippetted onto two more YPDA plates, and a rough dilution series was achieved by spreading 
this water with the spreader from the first plate, without flaming. 
The plates were incubated for 7-10 d, after which colonies were patched onto dropout plates to 
screen for the desired phenotype. In some cases backcrosses were useful, such as to distinguish 
between his3 and his5, and these were performed by mating on solid medium. 
2.29 Yeast transformation 
Yeast cells were transformed by lithium acetate transformation or spheropiast transformation. 
2.29.1 Lithium acetate transformation 
This is based on the method of Ito et aL (1983) with modifications based on those of Markie 
(1997). The host strain was grown overnight in YPD broth supplemented with adenine. The 20 
ml overnight culture was diluted to an 0D600 of 0.1 in YPDA and grown to an 0D600 of 
approximately 1.0. The cells were then harvested by centrifugation at 2000 rpm for 5 min in a 
50 ml Falcon tube in a Beckman GPR centrifuge, washed twice with UHP water, and transferred 
to an Eppendorf tube in 1 ml water. The cells were then washed with 1 ml of freshly made 
TEILiOAc and resuspended in TEILiOAc at about 2x109 cells/mi. 
50 p1 of cells were mixed with up to 1 pg of transforming DNA and 50 pg of sheared, single 
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stranded herring sperm DNA (average size 500 bp). 300 pg of PEG Solution were added and 
mixed well, and the cells were incubated at 30 °C for 30 min with agitation. Following a 15 mm 
heatshock at 42 °C, the cells were spun down for 5 sec at top speed in a microfuge and 
resuspended in 1 ml TB, then plated onto selective medium, 200 p1/plate. Plating the cells more 
densely than this results in fewer colonies due to cell death. Transformation efficiencies of 10 3 
to 104 cfu/pg were achieved by this method. 
2.29.2 Yeast spheroplast transformation 
A single freshly-grown yeast cell colony was picked from a rich medium plate, and used to 
inoculate a 30 °C overnight culture in YPDA. The following morning this was diluted for a 
starting OD6w of 0.5, and grown until the OD6w reached 2.0. 
The cells were pelleted in 50 ml Falcon tubes by centrifugation in a GPR centrifuge (Beckman), 
or similar, at 1000g for 5 minutes. The cells were washed once with 20 ml/tube of UHP water 
and then 10 ml 1M sorbitol, then resuspended in 10 ml SCE plus 0 mercaptoethanol (20 p1110 
ml SCE). 
25 p1 of 10 mg/ml Zymolyase 20T (ICN Biomedicals Inc.) were added to each tube, and the 
tubes were incubated at 30 °C for about 20 mins. The percentage spheroplasting was assessed as 
follows (protocol kindly provided by Brenda Grimes): 
lOOpl cells (using cell saver tips) were added to 900pl water, mixing well. 
1 OOpI cells were added to 900pl 1 M sorbitol, mixing well. 
The OD660  of cells in water (c.w) and of cells in sorbitol (c.$) was read, using a water blank. 
The percentage spheroplasting is given by: 
%age spheroplasting = 100 - [(OD. / OD . ) x 100] 
The digestion was continued until the percentage of spheroplasts reached about 50%. The cells 
were then pelleted at 400g for 3 mins, and resuspended gently in lOml STC (1M Sorbitol, 
10mM Tris pH7.4, 10mM CaC1 2). At this point the cells were usually examined under a 
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microscope to look for contamination and to check the spheroplasting by the addition of 10% 
SDS (the spheroplasts burst, whereas the walled cells do not). 
The spheroplasted cells were then transferred to 1 ml STC, and either used in a transformation, 
or DMSO was added to the cells to 7%, and 100 p1 aliquots of the cells were stored at -70 °C. 
Some loss of transformation efficiency was seen after freezing. It was found that snap-freezing 
in N20) was detrimental to the transformation efficiency compared to simply transferring to a 
—70°C freezer. 
2.29.2.1 Transformation of spheroplasts 
100111 of spheroplasts were mixed with lpg transforming DNA plus SOpg carrier DNA in no 
more than 10111. After 10 min at RT 10 volumes of PEG/CaC1 2 (20% w/v PEG3350, 10mM Tris 
pH 7.4, 10 mM CaC12) were added and mixed thoroughly. After a further 10 min at RT the cells 
were pelleted by gentle centrifugation (2000 rpm for 3 mm). The cells were gently taken up in 
0.5ml of SOS (1M Sorbitol, 6.5mM CACL2, 0.25% yeast extract, 0.5% bactopeptone) and added 
to molten top agar (SD agar plus 1M Sorbitol) at 55 °C. The top agar was immediately poured 
onto the surface of a regeneration plate (SD agar plus 1M Sorbitol) with the appropriate 
selection. Transformation efficiencies of 10 4 cfu/pg were achieved by this method. 
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3. Chapter 3 - Screening and clone characterisation 
3.1 Summary 
The C3H mouse YAC library generated by Larin et al. (1991) was screened by colony 
hybridisation using two murine Ocasein genomic probes. Fifteen positive clones were 
identified. These 15 clones were screened with cDNA probes for murine a, y, E and K caseins by 
colony hybridisation and Southern blotting. Two clones which hybridised to all probes were 
selected for further characterisation. 
The large insert size of YACs has led to some developments in the methods of maintenance and 
screening of YAC libraries relative to libraries of smaller insert size. YACs can achieve the 
same coverage as lambda (A.) or cosmid libraries with a tenth of the number of recombinants. 
This has resulted in YAC libraries being stored and screened as arrays of individual clones rather 
than as random collections of recombinants. Libraries of smaller inserts are randomly plated out 
and screened by hybridisation to replicas. In contrast, YAC libraries are stored as single clones 
in individual microtitre plate wells. Screening of these clones can be accomplished via PCR-
based strategies first reported by Green and Olson (1990), where specific superpools of clones 
form multidimensional arrays, allowing the screen to isolate a single YAC clone in a 
manageable number of steps; the exact number of steps depends on the size of the library and the 
screening strategy. An alternative and often complementary strategy involves screening the 
library by colony filter hybridisation. The reliability of this strategy has been greatly enhanced 
by the use of specialised robotic equipment for gridding the clones out onto the filter in 
precisely-defined high-density arrays (Nizetic et al. 1991; Bentley et al. 1992; McKeown et al. 
1993). Screening of these arrays can isolate a single clone in one step, and depending on the 
gridding pattern the use of duplicate clones on the same array can greatly reduce false positives. 
To obtain the clones used in this project the ICRF mouse YAC library (Larin et al. 1991) was 
screened by colony filter hybridisation. This work was done by M. Dalrymple and R. Cox. 
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3.2 Probes 
3.2.1 Genomic probes 
The genomic murine 13 casein probes were prepared from murine genomic DNA by polymerase 
chain reaction (PCR) as described in Chapter 2. The oligonucleotide primers used are given in 
Table 3.1. The PCR products were cloned into pGemT (Promega) and sequenced using an 
AB1377 automated DNA sequencer (chapter 2). No significant differences were found between 
the PCR products and the published sequence for murine 13 casein (Genbank accession numbers 
X13484 X15991 X15992). The extent of the murine 13 casein probes is shown in Figure 3.1. 135 
includes exons 2, 3 and 4 and extends into intron 4; 133 includes part of intron 6, all of exon 7 
and intron 7, and part of exon 8. Each of the two probes was hybridised to a Southern blot of 
genomic murine DNA to assess specificity (Figure 3.1). The bands obtained were as expected. 
In particular, the small portion of 133 which was 3' to the internal EcoRI site detected the 
expected 1.4 kb band, demonstrating the sensitivity of the blot. 
The murine a, y, aind Kcasein probes were amplified from lactating mouse mammary gland 
total RNA using the Superscriptll RTPCR kit from Life Technologies (See Chapter 2). The 
RTPCR primers used are shown in Table 3.1. The RTPCR products were cloned into pGemT 
(Promega) and sequenced as above. No significant changes from the published sequences were 
found. 
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Figure 3.1: Murine P casein probes 
Lower panel: the murine 0 casein gene. Exons are represented by black boxes. The two 
screening probes 03 and 05 are shown below. Sizes of predicted restriction fragments are in kb. 
Upper panel: P3 and 05 were used to probe two replica blots of mouse genomic DNA digested 
with various restriction enzymes. All of the bands were as expected (no data are available 
concerning Bamlil sites within the mouse P casein gene). 
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3.3 Primary library screening 
The genomic murine 0 casein probes were used to screen the C3H (male) murine YAC library of 
Larin et al. (1991) by colony hybridisation (Church and Gilbert 1984). This work was carried 
out by M. Dalrymple and R. Cox at the ICRF by kind permission of R. Cox and H. Lehrach. 
The screen produced 15 positive clones. These were brought back as stabs in YPD agar. 
3.4 Secondary screening 
The 15 primary positive clones were renumbered MP08 to MP22 (Table 3.2). Initial secondary 
screening was by colony filter hybridisation (Church and Gilbert, 1984; Figure 3.2). However, 
colony lifts proved unreliable and gave false negatives. There was no evidence of false positives 
(after comparison of several lifts and later PFGE data), which suggests that transfer of DNA onto 
the membrane was inefficient. Supporting this was the observation that some colonies failed to 
hybridise to a pYAC4 probe. Therefore the 14 samples were screened by PFGE and Southern 
blotting. Later it was appreciated that it is important not to overgrow the yeast colonies before 
transfer onto the filters, as lysis of the yeast is inhibited in the centre of large colonies, resulting 
in a faint halo-shaped signal after hybridisation (Cole et al. 1996). For the small number of 
clones screened here PFGE and Southern blotting proved practicable and extremely robust. In 
addition, PFGE would be necessary in any case to check for clones with more than one YAC, 
and gives information about YAC size. 
It can be seen from Figure 3.2 that MP12 and MP20 are positive for murine a, 3, yid 
iccaseins. MP18 hybridised to a, 1 and ybut not to iccasein. The bovine iccasein gene had by 
this time been mapped to one end of the bovine locus (Ferretti et al. 1990; Threadgill and 
Womack, 1990). The fact that MP18 hybridised to all casein probes except K casein may 
indicate that the murine ic casein gene is organised similarly. However, given the variability of 
the colony hybridisation results in general the possibility that this is a false negative cannot be 
ruled out, although it seems unlikely given the strong hybridisation of the same MP1 8 DNA to 
the other,  probes in Figure 3.2, The number of samples not hybridising to the 
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Figure 3.2: Screening YAC clones by colony hybridisation 
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Figure 3.2: Screening of YAC clones by colony hybridisation 
Four successive probings (not in order) of the same filter are shown. The probes were the cDNA probes 
for murine (x, 'y  and K casein (a, 'y, K panels) and P5 (). Three colonies of MP clones 12 to 22 were 
screened such that each clone is represented by three vertically-aligned colonies; the clone numbers 
appear above and below each panel. MPI 2 and MP20 are positive for murine a, f3, 'y and K casein. 
MPI8 is positive for a, P and 'y  but appears to be negative for K casein. It was not possible to screen 
this filter with E casein due to buildup of noise. 
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Figure 3.3: Screening of YAC clones by PFGE and Southern blotting 
DNA was separated by PFGE, Southern blotted and hybridised to eDNA probes for a, y, t and K caseins 
(panels a, y, c, ic) and 135 (13). MPI2 spans approximately 430 kb, MPI4 380 kb, MPI6 360 kb, MP20 
380 kb, and MP22 420 kb. Marker sizes are shown in kb. The markers used were Lammbda Ladder 
from NEB. 
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casein probes in these lifts is at odds with other lifts (not shown), while MP20 was negative for 
13 casein in a previous lift. 
Southern blotting was then used as a more robust screen of the MP clones. MPI4, which 
appears negative in Figure 3.2, hybridised to all murine casein probes in subsequent Southern 
blots (Figure 3.3). MP12 hybridised to Ecasein (Figure 3.3), which together with the data from 
Figure 3.2 mean that MP12 is positive for all five murine caseins, as is MP14. From these blots 
MP12 was estimated at 430 kb, and MP14 at 380 kb. MP16 (360 kb) hybridised to all casein 
probes except K. This supports the inference from the MP18 results that Kcasein is on one end 
of the gene locus. 
In total four clones were identified which, were positive for all casein genes (Table 3.2). At this 
stage the screening was halted and MP14 (380 kb) and MP12 (430 kb) were selected for further 
work as they were the first two clones to hybridise to all casein probes. An initial partial 
restriction digest (shown in Figure 4.4 panel A) probed with the a casein cDNA probe indicates 
that the two YACs overlapped extensively. The difference between the sizes of the two YACs 
demonstrates that MP14 and MP12 are independent recombinants. Mapping of the two in 
parallel would therefore convincingly demonstrate whether either was rearranged with respect to 
the genome in the region of overlap. No further screening was done. 
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Probe Type Size Primer sequences (5'-3') Accession 
(kb) numbers 

























Table 3.1 - Murine casein screening probes 
Upper primers are displayed above lower primers for each probe. 
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Library clone In-house name Positive for Negative for YAC size 
ICRFy902C0438 MP08 a, 
ICRFy902C0338 MP09 a, f 
ICRFy902H0629 MP1O a, 
ICRFy902B1232 MPh I a, 
ICRFy9O2GO781 MP12 a, 	, y, ic,c 430 kb 
ICRFy9O2E1115 MP13 
ICRFy9O2C11I16 MP14 380 kb 
ICRFy9O2BO621 MP15 a, 	, y, K 
ICRFy9O2BO721 MP16 a, 	, y, E, K 360 kb 
ICRFy9O2EO540 MP17 a, 1, Y, K 
ICRFy9O2B0583 MP18 a, 	, y K 
ICRFy9O2A0587 MP19 a, f, y, K 
ICRFy902B0469 MP20 a, 3, y, 1c,E 380 kb 
ICRFy902GO579 MP21 a, y, K 
ICRFy902H0556 MP22 a, f, y, K, E 420 kb 
Table 3.2 - Murine casein YAC clones 
Empty cells indicate screens which were not performed or were inconclusive. 
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4. Chapter 4 - Mapping the mouse casein gene locus 
4.1 Introduction 
As discussed in the introduction to this thesis, YACs are often rearranged or deleted 
spontaneously. For this reason it is paramount to ascertain that any YAC represents a single 
contiguous genomic region. Some form of physical characterisation of the YAC and comparison 
to the genomic region is therefore indicated. Fluorescent in situ hybridisation (FISH) of the 
entire YAC to genomic metaphase DNA can indicate whether or not the YAC contains a single 
contiguous genomic region since a chimaeric YAC would be expected to hybridise to morethan 
one chromosomal locus. However, FISH is technically demanding and expensive, and moreover 
was not an established technique within the group or facility. Screening for markers gives some 
indication, especially if several overlapping clones are screened, of the structure of each clone. 
However, restriction mapping using internal and end-probes gives the same information as 
marker scoring with additional information about the physical structure of each clone. Since 
four YACs had already been scored for all five casein genes in Chapter 3, restriction mapping 
was chosen to characterise them further. 
Restriction mapping of YACs and comparison of the data with data from genomic DNA is the 
most direct method of comparing YAC and genome. However, mapping single-copy genes by 
PFGE and Southern blotting of large genomic DNA fragments is less straightforward than with 
yeast DNA, because the smaller size the yeast genome effectively concentrates the target 
sequence. A faster, more convenient method is to map two or more similar YACs and compare 
the maps. If the maps are essentially collinear within the region where the YACs overlap, it 
would be very unlikely that any YAC contained any deletions or rearrangements within that 
region. This is the approach that is reported here. 
MP12 (ICRFy9O2GO781) and MP14 (ICRFy9O2C1 I 116), which hybridised to all five of the 
known murine casein genes (chapter 3) were restriction mapped in parallel and compared to each 
other. Partial restriction digest and the LA and RAJ probes were used to rapidly generate a 
restriction map from a single Southern blot (Hamvas et al. 1994; Figure 4.2). To further 
enhance the accuracy of the map, the same Southern blot was reprobed wherever possible. 
Although this leads to some diminution in signal quality from later probings it has the advantage 
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that gel to gel variation is minimised, and direct ordering of adjacent restriction sites is 
facilitated. The two YACs overlapped extensively and within the region of overlap (some 
300kb) are collinear. The casein genes are arranged on approximately 250 kb of DNA in the 
order a——y—E--K; a and 0 casein are convergently transcribed. This work constitutes the first 
report of the physical structure of the murine casein locus (Tomlinson et al. 1996; Appendix I). 
Two more reports have followed (Rijnkels et al. 1997a; George et al. 1997) which are broadly in 
agreement. The discrepancies are discussed. 
4.2 Probes 
The left and right arm probes (LA and RA 1 respectively) were derived from pBR322 (Genbank 
accession: 701749; Sutcliffe, 1979; Stratagene), which is the base vector used in the construction. 
of the pYAC4 cloning vector which is the basis for the YACs in the ICRF library. pBR322 was 
cut with EcoRI and PvuII, which bisects the plasmid. The 2.3 kb fragment was purified as the 
LA probe, and the 2.1 kb fragment as the RA 1 probe. Unfortunately, it was noted after the 
completion of this work that the RA 1 probe in fact contains a small amount of sequence, between 
the EcoRI site and the BamHI site, which is homologous to the sequence between the 
centromere and cloning site on the right arm of pYAC4. This region will therefore map to the 
left of the insert in pYAC4-derived YACs and might be expected to yield some faint spurious 
bands (see section 4.5) However, comparison with other published maps suggests that this has 
not substantially compromised the results presented here. 
The murine casein gene probes are described in more detail in Chapter 3. The probes for murine 
casein are shown in Figure 4.2. 03 and 0 5 were generated by PCR from murine genomic 
DNA (Table 3.1). The probes for mouse a, y, Eand ic casein were cDNA probes generated by 
RTPCR from total lactating mouse mammary gland RNA using the primers in Table 3.1. 
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Figure 4.1: Genomic YAC mapping probes 
Mouse 13 casein gene 
P5 	 P3 
Figure 4.1: Genomic YAC mapping probes 
Two genomic probes for murine 3 casein, fi5 and [33, were amplified by PCR. Exons are shown as black boxes. Probes 
are shown as shaded boxes. The Sail site within the 133 probe is shown. 
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4.3 Calculation of restriction fragment sizes 
Band mobilities were measured manually. A third order polynomial standard curve of 
bacteriophage lambda DNA (?.) concatemer mobility against size was generated using plotting 
software (Cricket Graph) on an Apple Macintosh. The fitted curve formula from this plot was 
used to calculate fragment sizes from mobilities of the sample bands. Due to slight differences 
between the standard curves from the ? ladders on the left and right sides of the gels used, the 
digests which ran on the left of the gel were calibrated using the standard curve from the left 
ladder while those on the right were calibrated using the right hand ladder standard curve. Table 
4.1 shows the fragment sizes calculated from Figure 4.2. 
4.4 A restriction map of the mouse casein gene locus 
A single blot (Figure 4.2) was used to generate the restriction map of the locus The filter was 
probed with the LA and RA  probes separately. The restriction fragments detected by LA and 
RA1 are listed below. When the MP12 and MP14 PmeI band patterns are represented as maps 
(Figure 4.3), it is clear that the two maps can be aligned so that the 121 kb MP14 PmeI band is 
aligned with the 105 kb MP12 PmeI band. The alignment is almost perfect over the region of 
overlap, varying by less than 5 kb. By this analysis the 26 kb MP14 PmeI band should fall some 
10 kb from the left telomere of MP1 2 and therefore give a band in the MP1 2 lanes, but, given 
that there are 6 kb of vector sequence at this end, it is possible, within the accuracy of the blot 
below 48.5 kb, that MP12 does not contain this PmeI site. Because of the gel conditions and the 
? markers used in this gel, the accuracy of the blot is compromised below 48.5 kb. 
The Sail, XhoI and Cial patterns were treated the same way, to generate a four enzyme map of 
the locus from the LA autoradiograph. The same was done for the RAJ band patterns, and then 
the two maps were aligned about a central site; the PmeI site 206 kb from the left arm of MPI4 
was chosen arbitrarily, and aligned with the PmeI site 249 kb from the right arm of MP12 
(Figure 4.2). The agreement between the two maps is almost perfect with an error of about 5 - 
10 kb (Figure 4.3). However, the following ambiguities remain: the XhoI site at 220 kb was 
positioned at 230 kb by the RA1 map, but at 215 kb by the LA map (this was the only site that 
diverged to this extent between the two maps); the pattern of MP14 bands cut with XhoI was 
76 
Chapter 4 - Mapping the mouse casein gene locus 
PmeI 	Sail 	XhoI 	CIa! 
13 	2 	1 4 12 	14 1 2 14 	12 
U 
. . 
• .iil• 	291.0 
242.5 
Jf 	 94.0 






Figure 4.2: Restriction mapping of MPI4 and MPI2 
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Figure 4.2: Restriction mapping of MPI4 and MPI2 
MP14 (14) and MPI2 (12) DNA was partially digested with Pmel (P), Sail (S). Xhoi (X) and Cia! (C), 
separated by PFGE, Southern blotted and hybridised to the LA (A) and RA (B) YAC arm probes. The 
same blot was probed with RA, stripped and reprobed with LA. The sizes of the lambda DNA concatemers 
(A) are shown. The derived restriction map of the two YACs is shown below (see also Figure 4.3). 
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Figure 4.3: Aligning restriction maps of MPI4 and MPI2 
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incomplete in this gel due to over-digestion, but the MP12 XhoI digest allowed the map to be 
generated, with good agreement between the LA and RA 1 band patterns; RA 1 detected a Clal 
doublet in MP14 and MP12, at 200 kb and 210 kb respectively in Figure 4.2, but only a single 
diffuse band could be discerned in the LA pattern. The RAJ autoradiograph is clearer than the 
LA autoradiograph, so this doublet is considered to be genuine. 
Probe YAC 	PmeI 	 Sal! 	 XhOIb 	 Clal 
LA 	MP14 	26a, 121, 179, 59, 	85, 	251, 28a,114 23a, 	92 124, 
206, 279, 350, 293, 350, 381 137, 	154, 167, 
381 210,382 
MP12 	105, 164, 193, 4P, 	70, 	236, 3, 	102, 124, 78, 	109, 122, 
265, 336, 381, 276,343,437 159, 206, 286, 139, 	152, 195, 
437 327 437 
RA1 	MP14 	22a, 98, 164, 20, 	88, 	126, 32 3 	23, 161, 172, 
196, 251, 365, 293,322,381 206, 221, 240, 
381 253, 289, 355, 
382 
MP12 	77, 116, 179, 8,  65, 74, 90, 23a, 	119, 156, 23a, 	100, 114, 
249, 281, 343, 109, 	168, 206, 233, 283, 323, 242, 255, 295, 
437 377,402,437 351,437 307, 320, 340, 
370,437 
Table 4.1: Restriction fragment sizes calculated from Figure 4.2. 
'Fragments denoted as less than 50 kb are subject to significant error (See text). 
"Me XhoI digest of MP14 was excessive, leading to an incomplete partial band pattern. 
4.4.1 Organisation of the murine casein genes 
The a casein and both 0 casein probes detected the same pattern of PmeI bands (Figure 4.4), 
which for MP12 was identical to that obtained with LA. In MP14, a and 0 probes detected PmeI 
bands identical to the LA bands, with the exception of the 26 kb PmeI band. a and 0 also 
detected another MP14 PmeI band some 25 kb below each LA-identical PmeI band. From these 
data a and P caseins were mapped to the same 95 kb PmeI fragment near the left arm of both 
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Figure 4.4: Mapping the murine a and P casein genes 
Figure 4.4: Mapping the murine a and 3 casein genes 
Partial PrneI digests of MP14 and MP12 probed for a (panel A) and 3 (panel B) casein. The 
sizes in kb of the 2 concaterner markers are shown. Note that two separate filters are represented 
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Figure 4.5: Resolving the murine a and 3 casein genes 
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Figure 4.5: resolving the murine a and 3 casein genes. 
The same filter was successively probed with one probe for a casein and two for 0 casein, denoted 
a, P5 and 33. Sizes of A monocut markers (NEB) are shown in kilobases. Restriction enzymes used 
are displayed above each panel. 14 - MPI4 DNA; 12- MP12 DNA. 
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YACs, and subsequently to an 85 kb XhoI fragment and a 65 kb Clal fragment within this PmeI 
fragment. 
Sail proved useful in resolving a from 0 (Figure 4.5). In complete digests, a gave identical 25 
kb Sail, PmeJJSail, and SailJClaI fragments. The two genomic 3 casein probes, 0 5 and 03 were 
used separately. 03 detected the same bands as a, plus a very faint Sail band above 100 kb (the 
low MW gel used resolved up to 100 kb), a very faint PmeIJSalI band at 34 kb and a very faint 
Sall/Clal band of much less than 10 kb. f5 detected this high MW Sail band, the 34 kb 
PmeLISail band, and the small SalJJClaI band. Taking these results together and referring to the 
map in Figure 4.2, it appears that 0 casein lies to the right of a, that the Sail site at 85 kb on the 
map lies within the P casein gene, and that 0 is transcribed from right to left in Figure 4:2. In the 
published fcasein genomic sequence (EMBL accession X13484) there is a Sail site some 200 
bp from the 5' end of the 1.5 kb 3' probe; the very faint bands detected by P3 were presumably 
detected by the short portion of the probe that is 5' of this Sail site and map to the right of the 
Sail site at 85 kb, while the strong bands map to the left of this site. This suggests that the gene 
is transcribed from right to left in the map. This inference might not be valid since probe 
labelling intensity can vary sequence dependently and signal strength may therefore not reflect 
the proportion of the probe that is bound. However, MfC5' maps to the right of the Sail site, 
confirming the orientation of the gene. 
From the pattern of partial PmeI bands detected by y in each YAC (Figure 4.6), it was possible 
to locate the gene on one of two PmeI fragments, either that between the sites at 120 and 180 kb, 
or that between those at 205 and 280 kb (Figure 4.2). The data favour the former, but are not 
conclusive. However, the latter PmeI fragment contains a Sal! site, so if y was used to probe 
complete PmeI and PmeIJSail digests, the PmeI/Sail band would be expected to be smallerthan 
the PmeI band. As can be seen in Figure 4.7, PmeI/Sail and PmeI bands detected by y were in 
fact identical at 65 kb, suggesting that there is no Sail site within the PmeI fragment containing 'y 
and therefore that y  cannot be located between the PmeI sites at 205 and 280 kb. A similar 
experiment with XhoIJPmeI double digests suggested that y is located on a 38 kb XhoI fragment 
within the PmeI fragment, again ruling out the latter PmeI fragment which contains no such 
XhoI fragment (Figures 4.6 and 4.7). XhoI partial digests suggest that y is located between the 
XhoI sites at 135 and 170 kb in Figure 4.2. In complete digests, y detected Clal and ClaJJSalI 
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Figure 4.6: Mapping theniurine y  casein gene 
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Figure 4.6: Mapping themurine ? casein gene 
Partial restriction digests probed fory casein. 14: MP 14; 12: MP 12. The sizes of X concatemer markers 






Chapter 4 - Mapping the murine casein gene locus 
Figure 4.7: Mapping murine y casein 
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Figure 4.7: Mapping murine y  casein 
Complete digests were probed for y case in. The sizes of A Monocut markers (NEB) are shown in kb. 
14. MP 14; 12: NIP 12. Single digests are on the left of the figure, double digests on the right. 
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Figure 4.8: Mapping the murine E casein gene 
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Figure 4.8: Mapping the murine r casein gene 
Partial restriction digests probed for c casein. 14: MPI4; 12: MPI2. The sizes of A. concatemer markers 
are shown in kb. Little can be inferred from these data except that the gene is near the centre of the YAC, 
hence the profusion of bands. 
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Figure 4.9: Complete digests probed for E casein. 
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Figure 4.9: Complete digests probed for c casein. 
The sizes of? Monocut markers (NEB) are shown in kb. 14: MPI4; 12: MP12. Single digests are on 
the left of the figure, double digests on the right. 
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Figure 4.10: Partial restriction digests probed for ic casein. 
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Figure 4.10: Partial restriction digests probed for K casein. 
Sizes of X concateme (NEB are shown in kb. 14. MPI4; 12: MPI2. 
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Figure 4.11: Complete restriction digests probed for K casein. 
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Figure 4.11: Complete restriction digests probed for x casein. 
Sizes of X Monocut markers (NEB) are shown in kb. 14: MPI4; 12: MPI2. Single digests are on the 
left of the figure, double digests on the right. 
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bands of 35 kb, and a PmeI/ClaI band of 15 kb (Figure 4.7). This places the gene between the 
PmeI site at 180 kb and the Clal site at 165 kb (Figure 4.2). The implied position of y on a very 
small ClaIJXhoI fragment has not been confirmed. 
The partial restriction fragment band pattern detected by the ccasein probe is too dense to be 
resolved by the gel conditions used (figure 4.8). However, the E probe detected a 20 kb partial 
PmeI band in both YACs, suggesting that it is internal to both (Figure 4.8). The only PmeI 
fragment of that size within the map lies between the sites at 180 and 205 kb (Figure 4.2). The 
partial Sail pattern starting at 160 kb also suggests that £ lies near the centre of the map. The 
XhoI pattern is consistent with this position. However, there were bands in the PmeI profile that 
suggested that E casein may span the site at 205 kb, in particular a band of 70 kb which may 
represent the fragment between the PmeI sites at 205 and 280 kb (Figure 4.2). In complete 
digests (Figure 4.9), c detected identical PmeI and PmeL 1SalI bands of 27 kb (though the PmeI 
data are poor), plus a PmeIJS all band of 40 kb and PmeIJXhoI bands of 13 and 27 kb. £ also 
detected identical Clal and ClauS all bands of less than 10 kb, a PmelJClaI band of much less 
than 10 kb (smaller than the SallJClaI band) and an even smaller SallJClaI band (very close to 
the bottom of the gel); the lower limit of resolution on this gel was 10 kb. This very small 
C1aL'Sall band is difficult to account for unless there is another Clal site very close to the site 
very close to the two at 200 and 210 kb in Figure 4.2. A double site of this nature would not be 
detected by partial digest. Nevertheless, these data suggest that £ lies around the small (less than 
10 kb) Clal fragment between the sites at 200 and 210 kb in Figure 4.2, and contains the PmeI 
site at 205 kb. Unfortunately the blot of the complete digests was rather poor (Figure 4.9) and 
the expected second PmeI band was not seen. Moreover, the £ gene might be expected to exceed 
10 kb (as do the characterised casein genes) and therefore seems unlikely to reside entirely 
within the 10 kb ClaT fragment, though to date this has not been tested. The putative extra Clal 
site has also not been tested for. 
K casein was located using PmeI and confirmed with XhoI and daT. The relationship between 
the K pattern of PmeI bands and the RA1 pattern was similar in MP14 to that between the W 
and LA patterns (Figure 4.10), suggesting that K maps between the PmeI sites at 280 and 340 kb 
in Figure 4.2. In complete digests, K detected identical XhoI and PmeI/XhoI bands of 34 kb, a 
Sail band of 60 kb and a 55 kb Pmel/Sall band, again consistent with this location (Figure 4.11). 
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Figure 4.12: Comparison of reported casein locus maps 
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Figure 4.12: Comparison of reported casein locus maps 
Seven casein locus maps are compared above. A: this thesis; B: murine, Rijnkels eta!, 1997b; C: munne, 
George eta!, 1997; D: bovine, Rijnkels etal. 1997a; E: bovine, Threadgill and Womack. 1990; F: bovine, 
Ferretti ci a!, 1990: G: human, Rijnkels eta!, 1997c. The maps are aligned at the a—I3  gene pair; the 
mouse maps are specifically aligned at the Sail site within the 0 casein gene. The three maps published 
by Rijnkels and associates are aligned with each other as in Rijnkels eta!, 1997c. S: Sail; P: PmeI; X: 
XhoI; C: Clal. The genes are represented by Greek letters labelling either boxes or shaded minimal 
restriction fragments, depending on how they have been reported. 
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In this chapter two YACs bearing the murine casein locus were mapped by a combination of 
partial and complete restriction digest. The two YACs overlap by approximately 350 kb, and are 
essentially collinear within the region of overlap. This precludes the possibility of either being 
substantially rearranged relative to the genome. The casein genes were also localised on this 
restriction map by combined partial and complete restriction digest. In maps general partial 
digests were only informative when the gene was close to one end of the YAC; internal probes 
simply hybridised to too many bands for unequivocal interpretation. The completed map, with 
the positions of the murine casein genes, is shown in Figure 4.12a. Beneath the map are 
representations of two other casein locus maps reported in the literature (Rijnkeis et al. 1997a; 
George et al. 1997). A comparison of the three published maps (Figure 4.12) indicates broad 
agreement, but with some notable discrepancies. 
Rijnkels et al (1 997a) restriction mapped ICRFy9O2GO78 1, which corresponds to MP1 2 (Figure 
4.12 B). Two enzymes, XhoI and Sail, are shared between the work reported here and that 
reported by Rijnkels et a! (1997a). The XhoI digests agree, although in general Rijnkels et al 
found the locus to be somewhat smaller than was found in this project. Rijnkels et al report 
MP 12 (mYAC9) to cover 460 kb, whereas here it was found to be approximately 430-440 kb in 
length (see for example, Figure 4.2). The resolution of the gels used here was not high at that-
Range however, and an error of up to 20-30 kb would not be surprising. The slightly smaller 
size of the murine locus is in agreement with the other reported map (George et al. 1997). 
Allowing for this discrepancy, the XhoI maps reported here and in Rijnkels et a! (1997a) are in 
agreement. In contrast, George et al do not report the presence of a XhoI site close to the 5' end 
of the k casein gene. This site corresponds to that at approximately 300 kb in Figure 4.12A, and 
at approximately 270 kb in Figure 4.12B. This site was assigned based on the 156 kb XhoI 
fragment detected in MP12 DNA by RA1 (Figure 4.2; Table 4.1). It is difficult to discount this 
band as an artefact. As noted in section 4.x, the RA1 probe contains some sequence homologous 
to the YAC left arm, and so the possibility must be considered that some bands detected by RAJ 
might in fact be spurious, belonging to the LA pattern instead. A 159 kb band was detected in 
the LA pattern. The two bands do not directly overlay each other; nevertheless, on this basis it is 
impossible to rule out the possibility that this band is indeed spurious. However, Rijnkels et al 
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(1997a) also report the existence of this site. Since both reports describe the same YAC clone 
there might be some possibility that this clone contains an extra site, but Rijnkels et a! (1997a) 
also mapped genomic DNA. Although XhoI digests of genomic DNA were not performed, the 
YAC did not differ from genomic DNA in any digest that was performed on both. In addition, 
the XhoI and PmeIIXhoI bands detected by the k probe in MP12 and MP14 DNA in complete 
digests (Figure 4.11) are consistent with the existence of this XhoI site, and are inconsistent with 
its absence given the independent evidence for the location of the k casein gene (Figures 4.10, 
4.11). Taken together, these results argue strongly for the presence of this XhoI site immediately 
5' to the K casein gene. Further work would utilise an uncontaminated right arm probe (such as 
the 1.7 kb BamHI-PvuII fragment of pBR322 - see chapter 6) to test the validity of the XhoI 
data presented here. 
In Figure 4.12A four Sall sites are indicated 3' to the K casein gene. However, Rijnkels et al 
(1997a) report only two Sall sites in this region. The four Sall sites in Figure 4.12A are 
indicated by the four Sail bands detected in MP12 DNA by RA1 (Figure 4.2) at 65, 74, 90 and 
109 kb (Table 4.1). Since a Sall band of 70 kb was detected by LA in MP12 DNA one of the 
RA1 bands could be caused by the impure nature of the probe. In MP14 DNA digested with 
Sail, RA1 detected a single band of an appropriate size (Figure 4.2), which argues against the 
existence of the Sall site at 365 kb in Figure 4.12A. Further work is required .to resolve this 
discrepancy. 
The bovine genomic casein region has been restriction mapped (Ferretti et al. 1990; Threadgill 
& Womack, 1990; Rijnkels et al. 1997d; Figure 4.12). The spatial arrangement of the genes is 
largely conserved between the two species, allowing for the presence of the second a 52-like 
casein gene in mice. The bovine a 1 , P and Kcasein genes are homologous to the murine 
a, Pand K genes,while bovine a2 shows sequence homology with the munne £ and ycasein 
genes. If the presence of this extra gene in mice represents a deletion or duplication/insertion 
event within the locus, one might expect some difference in the spatial positions of the genes. 
Given the variation between the published bovine maps it is difficult to posit a significant 
difference between the two species. However, Rijnkels and associates have mapped both loci 
(Rijnkels et al. 1997a, d) and show the murine locus to be approximately 20 kb larger than the 
bovine locus. 
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The human casein gene locus has also recently been characterised (Rijnkels et al. 1997b). 
Human milk has been reported to contain three caseins, a, f3and K (Cavaletto et al. 1994; 
Rasmussen et al. 1995) and nucleic acid sequence is available for the human P (Hansson et al. 
1993 unpublished)and K (dlund et al. 1996) casein genes and for the human acasein cDNA 
(Johnsen et al. 1995). Rijnkels et al (1997b) found evidence for the existence of a fourth human 
casein gene by hybridisation to cDNA probes of bovine a2 casein. This gene maps to a point. 
approximately 80 kb from the K casein gene, which is in keeping with its position in other 
species. However, there is approximately 100 kb of extra intergenic DNA between the 0 and a2 
genes relative to the other species analysed, possibly as a result of an insertion event (Rijnkels et 
al. 1997b). 
It is interesting to note the spatial arrangement of the munne casein genes (Figure 4.12). a and 
are both present on a 25 kb Sall fragment, although 0 contains the right hand Sall site, with 
approximately 2.5 kb of the published sequence falling within the 25 kb fragment on the map 
(Figure 4.12). The sensitivity of the low molecular weight blot has been demonstrated by the 
data' obtained with 03', and it therefore seems likely that at least the majority of the a casein 
gene lies within the 25 kb Sail fragment. There are no data concerning the murine a casein gene 
structure, but the bovine asi gene covers 17.5 kb (Koczan et al. 199 1) which suggests that there 
is no more than 5 - 10 kb between the mouse a and b genes. Leroux and Martin (1996) 
performed long-range PCR on goat DNA using primers from within the 3' ends of the aand 
J casein genes and isolated a 13.4 kb product. They estimate the distance between the a and 
casein genes as 12 kb. By a similar method George et al. (1997) estimated the murine aand 
casein genes to be 8 kb apart, which is in keeping with the results presented here. 
Similarly, the murine E and ycasein genes map to the same 45 kb Clal fragment in Figure 4.12. 
There is no reported genomic sequence for murine y casein, but the rat y casein exon/intron 
structure has been mapped by restriction and R-loop analyses (Yu-Lee & Rosen, 1983) from 
which the primary transcript is estimated at 15 kb. Similarly, although there is no murine E 
casein sequence, the bovine homologue a, 2 has been sequenced (Groenen et al. 1993) and spans 
18.5 kb from transcription start to polyadenylation signal. Thus these two genes are also likely 
to be very close to one another. The calcium sensitive caseins are proposed to have evolved from 
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a common ancestor by gene duplication followed by rapid sequence divergence and exon 
shuffling (Bonsing and Mackinlay 1987; Groenen et al. 1993). Sequence analysis supports this 
(Groenen et al. 1993; Rijnkels et al. 1997a,d). The calcium sensitive caseins are unusual in 
having few constraints on the primary structure of the protein (Mercier and Vilotte, 1993), and 
this is reflected in their rapid sequence divergence. 
In contrast to the paired calcium sensitive caseins, the murine K casein gene is situated 95 - 155 
kb from c, the nearest neighbouring casein gene. K casein is believed to be evolutionarily 
unrelated to the other caseins, being evolutionarily and functionally related to y fibrinogen 
(Alexander et al. 1988). The physical distance between the K gene and the others has been said 
to reflect this phylogenetic distance (Ferretti et al. 1990), but it must be noted that the distance 
between the murine a/P pair and y/c pair in Figure 4.12 is some 75 kb, which is roughly 
comparable to the 95 - 130 kb separating K from E. Moreover, the distance between the four 
calcium sensitive casein genes and the K gene is remarkably small given that they are 
evolutionarily unrelated. Interestingly, the yfibrinogen gene and the casein genes are located on 
the same chromosome in pigs (SSC8) and humans (HSA4) but not in mice. In pigs the 
y fibrinogen gene is approximately 5 cM away from the caseins, while in humans the distance is 
approximately 40 cM. In mice the caseins are on chromosome 5, while yfibrinogen is on 
chromosome 3. It would appear, then, that Kcasein and yfibrinogen have arisen from a 
duplication of an ancestral gene. Subsequently the two genes became separated in some taxa, 
with one becoming recruited into the casein gene family. The subsequent co-segregation of 
K with the other casein genes lends t further support to the idea that their coordinate expression. is 
controlled at the chromatin level. 
The ratio of K casein to the calcium sensitive caseins in milk is believed to play a significant role 
in determining micelle size, milk volume and milk quality (Sullivan et al. 1959; Dalgleish et al. 
1989; Lin et al. 1989). Naturally occurring bovine genetic variants display a correlation between 
increased K casein levels and decreased casein micelle diameter (reviewed • in Gutiérrez-Adán et 
al. 1996) Transgenic mice expressing a bovine K casein cDNA under the control of a caprine 
casein promoter and 3' flank (Gutiérrez et al. 1996) showed a marked decrease in micelle size 
which was correlated with dosage of the transgenic locus (Gutiérrez-Adán et al. 1996). This is 
consistent with the prevailing view of casein micelle structure, where the micelle interior 
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consists of calcium sensitive caseins and the surface is made up of K casein and calcium. An 
increase in K casein concentration relative to that of the calcium sensitive caseins might therefore 
be expected to result in micelles with an increased ratio of surface area to volume, and therefore 
a decreased diameter. 
As has been suggested (Alexander et al. 1988; Mercier & Vilotte, 1993; Rijnkels et al. 1997a) 
the presence of the K casein gene close to the other casein genes may indicate that coordination 
of casein gene expression is effected at the chromatin level, and thus may be indicative of the 
existence of casein locus control. This view is strengthened by the finding that the structure of 
the locus as a whole is conserved between distant taxa, despite the variation in the number of 
calcium sensitive casein genes. It must be noted that the pattern of casein gene expression is not 
invariant between these taxa. For example, bovine milk contains a far greater proportion of 
a caseins than does human milk (Kunz and Lönnerdal, 1989). In addition, the calcium sensitive 
casein genes are highly divergent between taxa; However, the exon structure and the sequence 
of functional sequence motifs (especially the signal peptide) is highly conserved. In addition, 
since the caseins serve merely to raise the protein and mineral concentration of milk whilst 
maintaining a low viscosity through the colloid of micelles, the structure and even the number of 
the calcium sensitive caseins is open to considerable neutral variation. In contrast, the ratio of 
K casein to the calcium sensitive caseins is critical for maintaining the colloid, and the cleavage 
of K casein in the gut by rennin is critical for effective digestion of the milk proteins by the 
suckling infant. Therefore, while evolutionary divergence among the calcium sensitive casein 
genes would not be remarkable, the Kcasein gene ought to be under considerable selective 
pressure. This appears to be the case (Ward etal. 1997). 
In summary, the murine casein gene locus has been mapped in this project and by two other 
groups (Rijnkels et al. 1997a; George et al. 1997). The three maps are in broad agreement over 
the structure of the locus. The murine casein genes are arranged a—--'y-.E—K, and the a—P pair 
and the -j--F pair are convergently transcribed. The close proximity of the structurally unrelated 
K casein gene to the other members of the family is conserved in mammals. The K casein gene 
appears to have arisen as a result of a duplication of the ancestral 'yfibrinogen gene. The 
subsequent conservation of the structure of the casein locus may be related to the importance of 
coordinate casein expression in determining the characteristics of the milk. 
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5. Chapter 5- Mouse YAC manipulations 
5.1 Introduction 
Chapters 3 and 4 descibe the isolation and mapping of two YACs bearing the murine casein 
locus, MP12 and MP14. Both carry all five murine genes and appear to be unrearranged with 
respect to the mouse genome. The principal aim of this project was to use one of these YACs to 
investigate the expression of the murine casein genes after transfer into mice or cultured cells, 
with a view to assaying for copy number dependent variation in gene expression betweerilines 
of animals or cells. MP14 was chosen over MP12 because it extends farther to the left of the 
casein locus. 
The decision to use a mouse YAC was based on the desire to carry out as "clean" an experiment 
as possible. It was hoped that the use of murine DNA in a transgenic mouse would maximise 
the probability of detecting any transcriptional control functions, however subtle. However, 
detection of transgenic murine caseins in the lactating mouse mammary gland would be 
essentially impossible, and at this point casein knockout mice (Kumar et al. 1994) were 
unavailable. The YAC was therefore modified to carry a reporter gene. The protein C minigene 
construct pCorp3 (Figure 5.1) has been used extensively at PPL Therapeutics Ltd. It consists of 
a protein C cDNA inserted into an ovine f3 lactoglobulin (BLG) minigene containing the BLG 
transcription start sequence, part of exon 6 and all of intron VI and exon 7. This construct has 
given generally low levels of protein C expression in transgenic mouse milk, of the order of 10 
pg/ml. Rescue of this transgene with a BLG genomic construct (Clark et al. 1992) raised these 
levels slightly (Table 5.1). There appears to be no correlation between transgene copy number 
and expression level. pCorp3 was chosen as a reporter for several reasons. Firstly, the wealth of 
previous data would provide a clear backdrop to this experiment so that any change in the 
pattern of pCorp3 expression would be apparent. Secondly, pCorp3 is generally expressed at 
low but detectable levels. This would facilitate detection of any improvement in expression (an 
important practical objective) while still allowing variation in expression between lines to be 
monitored. Thirdly, expression of pCorp3 appears to be position-dependent and thus sensitive to 
the influence of surrounding chromatin, which is important in an assay for functional chromatin 
elements. Fourthly, an ELISA assay for protein C in mouse milk has been developed and 
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validated at PPL Therapeutics by J. Percy (unpublished). Lastly, at the start of this project a 
parallel experiment was underway at PPL Therapeutics which aimed to target pCorp3 to the 
mouse P casein locus via ES cells (A. Kind, unpublished). The mouse P casein locus is highly 
transcribed during lactation; 50 % of mRNA in the mouse mammary gland is P casein mRNA 
(Mercier and Vilotte 1993). This locus therefore represents an attractive target for transgenesis. 
Replacement of the P casein coding region with that for an exogenous gene might cause the 
transgene to be expressed at levels close to those of P casein itself. However, the removal of the 
casein gene from this locus might alternatively reduce the transcriptional activity of the locus 
if elements within the J3casein gene are required for full expression, or if the active 
transcriptional status of the Ocasein gene has an overall enhancing effect on the transcriptional. 
activity of the locus as a whole (see chapter 1). Therefore two targeting constructs were planned 
(Figure 5.1). CPC-A is designed to target pCorp3 to within the P casein gene, replacing the 
casein gene from transcriptional start to 300 bp 3' to the polyadenylation (polyA) site. CPC-D 
is designed to insert pCorp3 into a BclI site 300 bp 3' to the polyA of P casein. Both of these 
constructs were made and kindly donated by J. Howcroft. The success of this targeting 
experiment would also provide an excellent positive control for the YAC transgenic study. 
Expression of the same transgene in the same context via the two routes of gene targeting and 
YAC-mediated transgenesis would convincingly demonstrate whether the YAC contained all of 
the relevant elements present in the genome. For this reason, the same CPC-A and CPC-D 
targeting constructs were used to conduct modification of the mouse germline (A. Kind, 
unpublished) and the murine casein YAC MP14. 
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Construct Copy number Expression level of protein C in milk (jig/ml) 
Total Expression per copy 
pCorp3 rescue 3 14.1 4.7 
pCorp3 3 17.2 8.6 
rescue 
pCorp3 2 16.8 8.4 
rescue 
pCorp3 10 9.5 0.95 
rescue 
pCorp3 10 S 5.7 
rescue - 
Table 5.1: pCorp3 expression data from previous work 
Data reproduced with permission from PPL Therapeutics Ltd."Rescue" experiments involved co-injection 
of pCorp3 with gnomic ovine BLG in a 2:1 molar ratio. Copy numbers were estimated by Southern blot. 
Protein C levels were estimated by ELISA (J. Percy, unpublished). 
In order to insert pCorp3 into MP14, a selection system was required. Since the aim was to 
replicate the murine gene targeting work in MP14 the permanent insertion of a yeast selectable 
marker was undesirable and a counterselectable marker was therefore sought. The yeast. 
counterselectable marker of choice is URA3, which is present on the right arm of pYAC4-
derived YACs. URA3 can be selected for on growth medium lacking uracil (-ura) or against by 
inclusion of 5-fluoro-orotic acid (5-FOA; Boeke et al. 1984) in the growth medium. The first 
step in modifying NIP 14 was therefore to remove URA3 from the right arm so that it could then. 
be used in inserting pCorp3 within the 0 casein locus. Following this UR.A3 could be 
reintroduced as part of a two-step gene replacement ending with the insertion of pCorp3. An 
alternative to two-step gene replacement in yeast is the so-called pop in-pop out (PIPO) strategy 
(Scherer and Davis 1979). This involves a single targeting construct containing the' 
counterselectabie marker flanked by direct repeats of the sequence to be modified. Yeast cells 
are transformed with this construct under positive selection (selection for the marker). The 
marker is then selected against, and cells in which the marker has been deleted by recombination 
between the flanking direct repeats are recovered. In this project both two-step and PIPO 
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Figure 5.1: Constructs used in 11P14 manipulation 
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Figure 5.1: Constructs used in MPI4 manipulation 
The murine P casein locus is shown in red except for exons which are shown as black boxes. The protein 
C cDNA is shown in green. BLG exons are in dark blue; part of exon 1, part of exon 6 and all of exon 
7 are present. BLG intron VI is pale blue. BLG non-transcribed sequence is grey. Restriction sites are 
provided for orientation. B: BclI; H: 1-lindlil; E: EcoRV. CPC-A and CPC-D were constructed by J. 
Howcroft. CPC-D targets pCorp3 to a BclI site 300 bp 3' to the polyadenylation signal of the 3 casein 
gene. CPC-A targets pCorp3 to replace the P casein coding region from - 379 relative to the transcription 
start to the same BclI site. pMAD6 and pCorp3 were constructed by M. Dalrymple. 
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replacement strategies were attempted. However, the PIPO vector was more complicated to 
construct than the two-step vector and initial work therefore concentrated on the two-step 
strategy. 
An additional hurdle to be overcome in the generation of YAC transgenic mice is the technical 
difficulty associated with purifying and handling YAC DNA (see chapter 6). YACs are 
necessarily present in single copy in the host cell, which facilitates genetic manipulation but 
hinders purification of YAC DNA in large amounts. Smith et al. (1990, 1992) have devised a 
system for inducibly amplifying YAC copy number, based on the use of a new YAC cloning 
vector, pCGS966 (Figure 5.2). The insertion of a GAL] promoter upstream of the CEN1 
centromere allows galactose-inducible transcription across the centromere, inactivating it. 
Selection for increased dose of a herpes simplex virus thymidine kinase (HSV-TK) gene present 
on the right arm of pCGS966 then selects for increased copy number of the YAC. A derivative 
of pCGS966 designed to retrofit the ampification system to MP14 was constructed in this 
project. The construction and use of this plasmid, pAR 1, is described below. 
5.2 Retrofitting MP14 for copy number amplification 
5.2.1 Construction ofpARl retrofitting construct 
The cloning strategy for construction of pAR1 is show in Figure 5.2. The finished plasmid 
constitutes a replacement left YAC arm containing the amplification components from 
pCGS966, the HIS3 yeast selectable marker and the 550 bp Clal-EcoRl fragment from the 
centromere to the cloning site of pYAC4 for homology. It was constructed in pBSllsk+ 
(Stratagene), 
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Figure 5.2a: Construction of pAR1 retrofitting construct part I 
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Figure 5.2b: Construction of pAR1 retrofitting construct part 11 
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PCGS966 was digested with EcoRV and SnaBI and the 2.6 kb fragment from the EcoRV site 
within TRP1 to the SnaBI site 3' to the centromere was purified. This was ligated to a derivative 
of pBSllsk+ called pLinker2. pBSlinker, which was made by introducing new Nod, BgllI, XhoI 
and Clal sites between the EcoRV site and Hindifi site of pBSllsk+ on a synthetic linker, was 
kindly donated by E. Emslie. PBSlinker was modified by digestion with XhoI and religation, 
deleting the Clal-Hindlil-Clal-Sall fragment between the two XhoI sites and generating 
pLinker2. Plinker2 was digested with Smal and ligated to the 2.6 kb EcoRV-SnaBI fragment of 
pCGS966, generating pBSGaI. 
The HIS3 marker from pCGS966 was cloned into the unique BamHI site of pBSGa1 as a 1.8 kb 
BamRI fragment, generating pBSHisGal. 
The synthetic linker CPR1 (Table 5.2) was designed to insert a Clal site and a PmeI site into the 
unique EcoRI site of pBSHisGal, regenerating the EcoRl site 3' to the linker. pBSHisGal was 
digested with EcoRl and ligated to CPR1, generating pBSHGC1a. pBSHGC1a was digested with 
Cia! and EcoRI and ligated to a 550 bp Clal-EcoRl fragment of pYAC4, corresponding to the 
region between the centromere and the cloning site immediately to the left of the insert of 
pYAC-derived YACs. This 550 bp region was intended to serve as homology for targeting 
MP14. The resultant plasmid was named pBSHGhom. 
Finally, pCGS966 (Smith et al. 1990) was digested with BamHI and XbaI (Figure 5.2a), and the 
6.5 kb band from the left telomere to the XbaI site in TRP1 was purified. The synthetic linker 
MCS 1 was ligated to this fragment to generate pAMPTK. PAmpTK was then digested with 
XbaI and Nod and the 6.5 kb fragment was ligated to pBSHGhom digested with XbaJ and Not!, 
generating pARi (Figure 5.2b). All cloning junctions and synthetic regions of pARl were 
sequenced. 
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Oligonucleotide 	Sequence 	 - 
GGCAGAACATATCCATCGCGTCCGCCATCFCCAGCAGccGcACGCGGcGCAG 





URAMCS 1 	 GTAGTCGACGGCGCGCCTCTAGA 
URAMCS2 CGCGTCTAGAGGCGCGCCGTCGACrAC 
CPR 1 a 	 AAT7ATCGATG1TFAAACG 
CPR1b AATrCG1TTAAACATCGAT 
HisAmpi 	 GCCCFGTGGGCACGCGTGCAGATFGTACFGAGAGTGCACC 
HisAmp2 GGCCCFGTGGGCCG1TrAAACGGCGCGCCTGCGGTA1TFCACACCGCATA 
Table 5.2: Oligonucleotides used in YAC manipulations 
5.2.2 Change of MP14 yeast host strain 
PAR1 was intended to replace the left arm of MP14, and carries a HIS3 yeast selectable marker. 
HIS3 was chosen because the available mutations in this gene are non-reverting, unlike the other 
obvious choices of selectable marker. This would greatly facilitate selection for HIS3. 
However, the AB1380 host strain of MP14 is not his3, it is his5. Therefore the host strain was 
changed to his3 00 by mating. MP14 cells (hisS MATa) were mated to yPH500 (his3 00  MATx; 
Sikorski and Hieter, 1989) cells on solid medium as in chapter 2; diploids were selected for by 
complementation of the his alleles. His' clones were randomly sporulated. Haploid clones 
were screened for the presence of the TRP1 and URA3 YAC markers and the ability to 
complement MP14 on medium lacking histidine, demonstrating a his3 phenotype. MP14 is hisS 
MA Ta; no hisS Mata strain was available. Five clones complemented MP14 but did not 
complement either yPH499 (his3 00 MA Ta) or yPH500 (his3 00 MA To) on histidine dropout 
medium, and so were classified as his3 MA Ta. DNA from these five clones was tested by PFGE 
and Southern blotting for the continued presence of an intact YAC matching the size of MP14. 
Unfortunately, none matched the expected MP14 YAC size of 380 kb. Four gave a single band 
of approximately 440 kb; the other gave a single band of approximately 240 kb. Moreover, the 
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sample of MP14 DNA that was run alongside them also gave a single band of 440 kb. This 
DNA was prepared from the same frozen MP 14 stock which was used to obtain material for 
mating with yPH500, so the most likely explanation for this result is that MP14 had somehow 
become perturbed prior to the mating, and this altered clone had been used both in the mating 
and to prepare DNA. A subsequent Southern blot of a PmeI digest of this "MP14" clone reveals 
no resemblance to MP14 when probed with LA. This sample did not hybridise to the murine 
casein genomic probe 03. This indicates that this clone is not MP14, and indeed does not 
contain any murine 0 casein DNA. Therefore, rather than a perturbation it appears that some 
contamination of MP14 with another yeast strain has occurred at some point. 
In light of the above result, further work with these his3 clones was inappropriate. Moreover, by 
this time the functionality of pARl was in question. 
5.2.3 Use of pAR] 
The first use of the retrofitting vector pAR1 was in human YAC strains which had been 
transferred into a his3 background. This work was done by M. Dalrymple. No amplification. 
was observed in four attempts. The decision was therefore made to test the function of pARl by 
transforming the plasmid into yPH499 and testing for amplification under inducing conditions. 
No amplification was seen. In the same experiment pCGS966 plasmid DNA was transformed 
into yPH499 and successfully amplified, though only by a factor of approximately 4. This may 
suggest that pARl is not functional, but it seems equally likely that the experimental protocol 
was not correct as amplification of 20 fold or greater has been reported using this system (Schedi 
et al. 1993). However, the status of pAR1 was nevertheless uncertain. In addition, the 
derivation of his3 MP14 strains had not so far been successful due to an unforeseen perturbation 
or contamination of the starting material (above). At this point work along these lines was 
abandoned in favour of an alternative strategy which did not require any YAC amplification. It 
had been suggested that purification of single copy YACs is in fact straightforward provided 
care is taken (personal communications from T. Umland, M. Antoniou and D. Markie). Two 
streamlined strategies were therefore devised to attempt to quickly prepare MP14 for generation 
of transgenic mice. 
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5.3 Insertion of pCorp3 into MP14 vector arm 
As a means of introducing the protein C reporter construct pCorp3 into MP14 as quickly as 
possible, a construct was made which targets pCorp3 to the right arm vector sequences of MP14, 
replacing the URA3 marker. URA3 can be selected against using 5-FOA, so the replacement of 
URA3 with pCorp3 could proceed in one step. 
5.3.1 Construction ofpURACorp3 
The cloning strategy for construct pURACorp3 is shown in Figure 5.3. pURACorp3 contains the 
pCorp3 construct flanked by sequences homologous to pYAC4 flanking the URA3 marker, such 
that transformation of MP14 with linearised pURACorp3 should result in the replacement of 
URA3 by pCorp3. 
The TRPJ gene was amplified from pRS314 (Sikorski and Hieter, 1989; purchased from 
Stratagene) using the primers RSPCR5' and RSPCR3'2 (Table 5.2). The PCR product was 
cloned into pCRScript (Invitrogen) and sequenced to confirm identity. This plasmid was named 
pURAKOB. In order to obtain the desired flanking restriction sites the PCR product was 
subcloned from pCRScript into pGem5 on a SacII-PstI fragment, generating pURAKOC. 
pURAKOC was digested with SnaBI and BssHTI and ligated to the synthetic linker MCS 1 which 
was made by annealing the oligonucleotides URAMCS 1 and URAMCS2 (Table 5.2). The 
replacement of the TRP1 insert by MCS 1 in pURAKOC generated the plasmid pURAREP. This 
was digested with AscI and ligated to the 10.5 kb Miul fragment of pCorp3, containing the entire 
insert of pCorp3. The resultant plasmid was named pURACorp3. PURACorp3+ targets pCorp3 
in a forwards direction within MP14; pURACorp3- targets pCorp3 in the opposite orientation. 
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Figure 5.3: Construction of the retrofitting vector pURACorp3 
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5.3.2 Transformation ofpURACorp3 into MP14 
MP14 yeast was transformed with linearised pURACorp3+ by the spheroplast method. 
Transformants were selected on 5-FOA medium. From several hundred colonies which were 
resistant to 5-FOA, 36 colonies were picked onto replica plates lacking tryptophan, lacking 
uracil, or supplemented with 5-FOA. Eight of these 36 clones had the desired Trp Ura 
phenotype. These 8 clones were screened for YAC integrity by PFGE and Southern blotting. 
However, when hybridised to the murine 3 casein probe 0 5 none gave a band of the expected 
size (380 kb). Only two samples hybridised to the probe; in these cases the YAC was 
approximately 160 kb. The remaining 6 clones did not hybridise to the probe. This was not due 
to lack of DNA in the samples as evidenced by the EtBr-stained gel (not shown). A further 144 
colonies were picked and screened for the appropriate marker phenotype. Eighteen Trp Ura 
clones were identified and screened by PFGE and Southern blotting (Figure 5.4). Again, none 
gave a band consistent with an intact copy of MP14. Four YAC species were detected, at —110 
kb, —155 kb or —320 kb. One YAC had increased in size to —420 kb, while in 10 clones there 
was no hybridisation to the probe. 
The number of Ura Trp clones isolated here was very low compared to the number of Trp 
clones isolated in the initial screen. In future work the selection against URA3 would be 
combined with selection for TRP1, which would hopefully isolate Ura Trp clones more 
efficiently. The inclusion of Trp selection is not usual because the TRPJ gene in pYAC4 has a 
truncated promoter such that growth on medium lacking tryptophan is inhibited (Markie 1996). 
However, in this case the large percentage of Ura clones which were also Trp hindered the 
isolation of large numbers of clones for further analysis. Selection for the loss of a gene function 
(URA3 in this case) can be satisfied in several different ways. Loss of the marker via the desired 
targeting event is one way. Loss of the marker via a non-specific YAC rearrangement is 
another. A third route is mutation of another gene in the same physiological pathway, in this 
case uracil biosynthesis. In this experiment no Ura colonies resulted from yeast transformed 
with carrier DNA only or from untransformed yeast, whereas over 200 colonies were seen in the 
experimental plates. This suggests that the presence of pURACopr3 is responsible for the 
change in resistance to 5-FOA in these cells. Since the structural changes to the YAC in those 
clones which were screened are various but mainly involve large deletions, it is reasonable to 
108 
Chapter 5- Mouse YAC manipulations 
assume that pURACorp3 has mediated large deletions in the YAC. The reasons for this remain 
unclear. There may be a repeat sequence within pURACorp3 which has recombined with 
similar sequences in the YAC. A similar mechanism has been exploited to create deletion series 
of YACs (Heard et al. 1994). The existence of repeat elements within pURACorp3 and MP14 
has not been investigated. Further work would involve probing MP14 digests with repeat 
elements and also with pURACorp3 to investigate this possibility. In support of the idea that 
pURACorp3 has recombined at specific sites in the YAC is the observation that the resultant 
YACs are grouped into discrete sizes (Figure 5.4) as would be expected of a repeat-induced 
deletion series. 
At this point a considerable effort had been made to modify MP14 for transgenesis, without 
success. However, two remaining strategies were pursued as far as possible in the remaining 
time. One strategy was designed to place pCorp3 into the 0 casein locus of MP14 by either two 
step gene targeting or PIPO, whichever succeeded first. From work with pURACorp3 it 
appeared that pCorpi could cause fragmentation of the MP14 YAC when introduced into yeast 
cells (Figure 5.4), which rendered pCorp3 an undesirable choice of reporter gene. However, by 
this time pCorp3 had been targeted to the P casein locus in transgenic mice (A. Kind, 
Unpublished). The targeting construct CPC-A (Figure 5.1) was used to replace the P casein 
coding region with pCorp3 in murine ES cells by a two-step gene replacement strategy, and 
these ES cells had been successfully used to generate transgenic mice. The control for this 
project was therefore in place, and abandoning work with pCorp3 was not an attractive option, 
despite the apparent tendency of pCorp3-derived constructs to recombine with multiple sites 
within MP14. 
The second remaining strategy was to insert a different reporter gene encoding enhanced green 
fluorescent protein (eGFP1; purchased from Stratagene) into MP14 and attempt to transfer the 
resultant YAC into cultured mammary epithelial cells. This work did not utilise pCorp3, and it 
was hoped that it would yield data more rapidly via tissue culture. 
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Figure 5.4: Clones produced by transforming MP14 with pURACorp3 
Linearised pURACorp3 was transformed into MP14. Ura- Trp+ clones were analysed by PFGE. Panel 
A: first round of clones, digested with Pmel and uncut. Panel B: second round of clones, uncut. The 
probe in each case is 35. No clone gave a band consistent with the parental YAC. Sizes are shown in 
kb of the X markers. 
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5.4 Two-step gene targeting of pCorp3 to the MP14 0 casein locus 
This strategy aimed to introduce the reporter construct pCorp3 into the Ocasein locus of MP14 
via the counterselectable yeast marker URA3. Both two-step targeting and PIPO strategies were 
pursued. As the first step in both URA3 was removed from the right arm vector sequences of 
MP14, replacing it with HIS3. 
5.4.1 New his3 MPI4 derivative strain 
MP14 was mated to yPH500 as before. After sporulation, screening and backcrossing, two 
clones were identified. YATS 1 was His Ura Trp' and complemented histidine auxotrophy in 
another clone which had been designated hisS MATa. YATS1 therefore appears to be his3 
MATa. YATS2 is His UraTrp and complemented histidine auxotrophy in MPI4, and is 
therefore designated his3 MA Ta. However, a Southern blot to assess the integrity of the YAC in 
these strains was poor and inconclusive, although it did suggest that the YAC was intact. This 
blot was to be repeated, but in the meantime yATS 1 was transformed with HIS3 to replace 
URA3 on the right arm of the YAC. 
5.4.2 Replacement of URA3 with HIS3 on yATS1 
The HIS3 gene was amplified from pRS313 (Sikorski and Hieter, 1989; Stratagene) using the 
primers pRSPCR5' and pRSPCR3'2 (Table 5.1). This PCR product was purified ona Microcon 
column (Amicon) and used to transform yATS1 cells. Very good stimulation over 
untransformed controls (>500 cfu vs. 0 cfu) was observed on medium lacking histidine. 
However, subsequent selection of 144 clones with 5-FOA revealed only 5 which were also Ura. 
These 5 clones were analysed by Southern blot. Initially uncut YACs were analysed (Figure 
5.5a). yE32 and yE67 clearly contain two bands which hybridise to the RA probe, and therefore 
two YACs. These clones were not investigate further. Clones yEll, yE43 and yE92 gave single 
YAC bands, but of different sizes. The YAC in yEll and yE43 appears larger than expected 
(-400 kb rather than —380 kb) while yE92 gave a band of the expected size for MP14. These 
three clones were analysed by partial restriction digest (Figures 5.5b and 5.6). MP14 and yATS 1 
DNA were included as controls. The MP14 band profile was as expected (see chapter 4). 
However, the profile of yATS1 did not match that of MP14 (Figure 5.5b). In addition to each 
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MP14 band, yATSI exhibits a second set of bands. The most logical explanation for this is that 
yATS1 carries two YACs. Since yEl 1 and yE43 contain the bands which are in yATS1 but not 
in MP14, these clones appear to have lost the MP14-identical YAC. Bands which are shared 
between yEl 1IyE43 and MP14 are presumably comigrating fragments in the two YACs. 
In contrast, yE92 exhibited the same partial restriction fragment band pattern as MP14 (Figure 
5.6a), suggesting that while yE43 and yEl 1 appear to have lost the murine casein YAC present 
in yATS1, yE92 has lost the spurious YAC. To further test this, DNA from yE92 and MPI4 was 
digested with Clal and probed with the whole MPI4 YAC to generate a detailed fingerprint of 
the YAC (Figure 5.6b). The two band profiles appear to match within the limits of the blot. The 
small (-'7 kb) Clal band that appears to be present in MP14 (Figure 5.6 lane 10) but inconclusive 
in yE92 (Figure 5.6 lane 11) is discernible in the autoradiograph. 
A standard Southern blot was performed to analyse the fine structure of the right arm of yE92 
(Figure 5.6). This blot was unfortunately probed with RA1 which carries a small region of the 
left arm of pYAC4, but the results are nevertheless consistent with a bona fide replacement 
event. The bands which are presumably detected within the left arm of the YAC by RAJ are 
arrowed in Figure 5.7. All are consistent with the fragments expected to be detected within the 
left arm of the YAC by this small region of the probe. 
The structure of the right arm of yE92 is therefore consistent with the expected recombination 
event replacing URA3 with HJS3. On the basis of these results, it appears that although yATS 1 
is not as expected and contains a second YAC in addition to MPI4, in yE92 the replacement of 
URA3 with HIS3 in the MP14 YAC has been accompanied by the loss of the second spurious 
YAC. Although this event appears serendipitous, it is perhaps not surprising. YE92 was 
isolated after a screen for His Trp' Ura clones among those which had incorporated the HIS3 
targeting construct. Out of 144 clones screened all were Trp His', but only 5 were identified 
which were Ura. Among these 5 clones three carried only one YAC. In the presence of the 
HIS3 PCR product, uracil auxotrophy could be achieved by targeting of both YACs, loss of both 
YACs, or targeting of one and loss of the other. Loss of both YACs would result in a negative 
screening result however, while the other two outcomes could both result in Trp His" Ura 
clones. It appears that in yE32 and yE67, both YACs have been targeted, although in yE32 the 
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spurious YAC appears deleted relative to yEll, yE43 and yE67 (Figure 5.5) which may indicate 
spontaneous loss of URA3 rather than targeting. In yEll, yE43 and yE92, targeting of one YAC 
appears to have been accompanied by loss of the other YAC. In yEll and yE43 the murine 
casein YAC was lost, while in yE92 the spurious YAC was lost. By using 5-FOA selection the 
loss of URA3 has in fact been used to deliberately reduce the number of YACs in a clone 
(Heikoop et al. 1994). In contrast to the initial selection for histidine prototrophy described here, 
5-FOA would apply the more stringent selection first and allow a far greater number of Ura 
clones to be isolated. In this experiment only 144 clones were screened, which is consistent with 
the isolation of only 5 clones of the desired phenotype, since rather than a recombination event 
as expected the 5-FOA selection was for a spontaneous deletion event. 
5.4.3 Two-step gene targeting 
The clone yE92 appeared to be as desired, and was therefore transformed with a construct 
designed to target URA3 to the 0 casein locus. A. new plasmid, pBCURA3, was constructed to 
target URA3 to the 3casein locus in MP14. The URA3 gene was amplified from pRS306 
(Sikorsky and Hieter, 1989; Stratagene) using the primers HisAmpi and HisAmp2 (Table 5.2). 
The PCR product was cloned into pGemT (Promega) and sequenced. The PCR product was 
then excised from pGemT with MluI and AscI, which cut in the primer sequences, and cloned 
into MluI-digested pJH3; Miul and AscI are compatible. pJH3 is a derivative of CPCA carrying 
a multiple cloning site in place of Corp3 (Figure 5.1), and was kindly donated by J. Howcroft. 
This plasmid was called pBCURA3. 
PBCURA3 was linearised with NotI and XhoI and transformed into yE92 cells by the LiAc 
method. The transformants were selected on medium lacking uracil and tryptophan. A large 
number of Ure Trp colonies developed, and screening of 18 of these 16 proved to carry a YAC 
of the same size as MP14 when analysed by Southern blot of undigested DNA probed with 
URA3 (Figure 5.8). There was a second band in all lanes which did not resolve from the limiting 
mobility region of the gel. This band is presumed to result from hybridisation of the probe to the 
remainder of the endogenous copy of URA3 in this yeast strain. This band was also seen in 
yE92 (Figure 5.8), further suggesting that it is not related to the presence of the targeting 
construct in the transformed clones. As expected, the yE92 YAC did not hybridise to the probe. 
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Figure 5.5: Structure of yE clones and yATSI 
A HJS3 PCR product targeted to replace URA3 was transformed into the his3 strain yATS I. Five clones 
were isolated following marker screening. 
Panel A: The five clones were separated by PFGE and probed with RA. yE32 and yE 67 contain two 
YACs are were discarded. 
Panel B: yEll and yE43 were compared to yATS I and MP 14 by partial restriction digest and hybridisation 
to LA. Neither yEll nor yE43 resemble MP 14. yATS1 appears to harbour an additional YAC to MP14. 
The MPI4 YAC appears to have been lost in yEll and yE43, leaving the spurious YAC. 
Sizes of lambda concatemer markers (NEB) are shown in kb. 
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Figure 5.6: Structure of yE92 
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Figure 5.6: Structure of yE92 
yE92 was generated by transforming a HIS3 PCR product targeted to replace URA3 into yATS I (not 
shown above). The structure of yATS I is shown in Figure 5.5. 
Panel A: Partial digests of yE92 and MPI4 (and yATS2) probed with LA. 
Panel B: Complete digest of yE92 and MP 14 probed with MP 14. 
Sizes of lambda markers are given in kb. With the exception of a small CIa! fragment (less than 10 kb), 
the structure of yE92 matches that of MP 14. The small mobility difference seen in lane 6 compared to 
lanes 4 and 5 is a loading artefact. 
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Figure 5.7: Fine structure of right arm of yE92 
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Figure 5.7: Fine structure of right arm of yE92 
yE92 and MPI4 DNA was digested completely and hybridised to RA! to compare right arm fine structure. 
The fragments detected are consistent with the replacement of URA3 by HIS3 in yE92. Thebands which 
are presumably detected in the left arm of the YAC by RA I are arrowed. See text. 
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The second step was to remove URA3 from the P casein locus of the YAC and insert pCorp3, by 
means of the targeting constructs CPC-D or CPC-A. Work in mice had yielded a transgenic 
mouse carrying CPC-A targeted to its 0 casein locus, replacing the Pcasein coding region. 
CPC-D chimaeric mice had yet to transmit the targeted locus to the germline. Therefore, it was 
attractive to pursue CPC-A in the YAC clones. 
Clone 1 from Figure 5.8 was transformed with NotI-linearised CPC-A by electroporation. It was 
envisaged that spontaneous mutation of the Ura phenotype to a Ura7 phenotype in both 
transformed and untransformed cells would give a high background in this experiment. 
Electroporation was therefore used to maximise the transformation efficiency and therefore the 
proportion of plated cells competent to carry out the desired recombination. No significant 
stimulation was seen over background (150 vs. 100 cfu). Given the number of cells plated (5 x 
108) this background equates to a reversion rate of 2 x 10-7  . The transformation efficiency in this 
experiment was found to be approximately 103  cfu/g, which is fairly low for electroporated 
yeast cells where 104  to 105 cfu/pg are routinely expected. Attempts were made to improve the 
transformation efficiency by using high purity DNA, plating fewer transformants per plate, and 
different transformation protocols, but the efficiency remained at approximately 10 3 cfu/pg. It is 
not known if this is due to the yeast strain used, which was generated here from MP14 and 
yPH500 and is largely uncharacterised, or if a technical problem is responsible. Transformation 
of a proprietary strain by the same protocol failed on the one occasion that it was attempted. 
117 
Chapter 5 - Mouse YAC manipulations 
Figure 5.8: Insertion of URA3 into the (3 casein locus of yE92 
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Figure 5.8: Insertion of URA3 into the (3 casein locus of yE92 
pBCURA3 was used to target URA3 to the (3 casein gene in yE92. Undigested DNA from Trp+Ura+ 
transformants was hybridised to a URA3 probe. The probe hybridised to a band of the expected size 
of 380 kb in all but two clones. 14 and 18. The second band in all lanes is presumably the endogenous 
copy of URA3. Sizes of A. concatemer markers are shown in kb. Note that the 48.5 kb marker band 
is not present on this filter. 
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At this point in the project, there was no time available for further manipulations of the MP14 
YAC. Had more time been available, there are several additional avenues which could be 
pursued. The second step of the targeting experiment could be optimised with respect to 
transformation efficiency with the aid of proprietary yeast strains to monitor progress. However, 
there is no guarantee that they would respond as would the in-house strain. Transfer of the 
URA3-targeted YAC to a defined highly transformable yeast strain would further facilitate this 
work. The karl yeast transfer system (Hugerat et al. 1994; Spencer et al. 1994) allows 
straightforward transfer of YACs between host strains by exploiting the karl415 mutation 
(Spencer and Simchen, 1996). This mutation prevents proper karyogamy during yeast mating, 
resulting in rare but selectable events in which a YAC is transferred during mating between two 
otherwise unaltered host strains. In retrospect this would have been a better method than 
traditional mating for changing the MP14 host strain to his3. However, karl transfer was a 
newly-described technique at the start of this project and not widely tested. 
Transfer of the URA3 targeted YAC to a highly-transformable strain would not solve the 
inherent defect of two-step targeting with URA3. This is caused by the relatively high rate, of 
spontaneous mutation to 5-FOA resistance. In addition to loss of URA3, 5-FOA resistance can 
occur by other loss-of-function mutations in the uracil biosynthesis pathway. These so-called 
"forward" mutations occur at a sufficiently high frequency to hinder efficient selection of the 
desired clone after transformation with a construct which removes or deletes URA3 without also 
introducing a second means of selection. PIPO procedures are more efficient than two-step gene 
replacement when using URA3. This is because in a PIPO experiment, the clone carrying the 
PIPO construct is isolated before selection against URA3, so that every cell in the selective 
medium is competent to carry out the desired second-step recombination. In the second step of a 
two-step strategy, only those cells which have taken up the transforming DNA are competent to 
recombine as desired, while every cell is competent to acquire 5-FOA resistance by spontaneous 
mutation. In addition, the proximity of direct repeat DNA flanking URA3 in the PIPO construct 
increases the probablility that URA3 will excise, further increasing the proportion of 5-FOA-
resistant clones which have recombined as intended. A PIPO vector was planned and 
constructed in this project, but insufficient time remained in which to characterise and use the 
completed construct. 
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In light of the failure of the work to manipulate the mouse casein YAC, alternative means of 
studying casein expression in transgenic animals was sought. The human casein locus is present 
on the 400 kb YAC HP8 (ICRFy9OCO518) which was isolated from the ICRF human YAC 
library (T. Monaco, unpublished). This YAC was isolated and partly characterised by M. 
Dalrymple. A restriction map and comparison with genomic material has also been reported for 
this YAC (Rijnkels, 1997b), which concluded that it represents a single unrearranged region of 
the human genome harbouring the entire human casein gene locus. Detection of human casein 
RNA and protein in transgenic mice is straightforward. Thus, no additional characterisation or 
manipulations of HP8 were required. The emphasis of this project therefore switched from 
studying and modifying the MP14 murine casein YAC, to generating transgenic mice from HP8 
by microinjection and analysing the expression of the human caseins as transgenes. 
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6. Chapter 6- Human YAC transgenic mice 
6.1 Introduction 
As described in chapter 5, the mouse YAC MP14 proved refractory to rapid retrofitting and thus 
was unavailable for generating transgenic mice within the period of this project. As an 
alternative, the decision was taken to generate mice with a human casein YAC. No. YAC 
modifications were required, since the expression of the human casein genes would be readily 
detectable in a transgenic mouse. The 400 kb human casein YAC HP8 (JCRFy9O1CO5 18) was a 
kind gift from M. Dalrymple. HP8 has been previously characterised by restriction mapping (M. 
Dalrymple and A. Tomlinson, unpublished). Rijnkels et al. (1997b) have also restriction 
mapped this clone and report that it is unrearranged relative to genomic DNA. The structure of 
our isolate of HP8 matches that reported by Rijnkels et at. (1997b). The HP8 YAC DNA was 
therefore purified and used to generate transgenic mice by pronuclear microinjection. Initially, 
no transgenic lines were obtained from screening of 255 founder (G0) pups generated by 
microinjection of HP8 YAC DNA protected against shear by spermine and spermidine. A 
second round of microinjection used HP8 YAC DNA protected by hexamine-cobalt chloride 
(HCC). Seven transgenic lines were established after screening of 313 G 0 animals., The 
expression of human a, band K casein was investigated in five of these lines by northern blot 
and RTPCR. The expression of all three genes was below the detection threshold of the northern 
blot. This appears to be due to fragmentation of the YAC transgene. Expression of K casein was 
detected by RTPCR in four lines. 
In 1993 several reports appeared describing the generation of transgenic mice from YACs via 
embryonic stem (ES) cells (Choi et al. 1993; Davis et al. 1993; Jakobovits et al. 1993; Lamb et 
al. 1993; Pearson and Choi, 1993; Strauss et al. 1993) and pronuclear microinjection (Schedl et 
al. 1992; Peterson et al. 1993b; Schedl et al. 1993a, 1993b). The YAC transgenes appeared to 
be maintained without significant rearrangement although initial rearrangement before 
integration seemed higher than that of smaller constructs, and there were no deleterious effects 
due to the yeast CEN and TEL sequences (reviews: Forget, 1993; Peterson et al. 1997). 
Therefore YACs represent a workable means of introducing very large segments of genomic 
DNA into transgenic mice. 
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The introduction of YACs into murine ES cells by spheroblast fusion was first reported by 
Jakobovitz et al (1993) and has the advantage that the YAC is not subjected to any of the insults 
of DNA purification and handling, since the whole yeast cell is simply spheroblasted and fused 
to a murine ES cell. However, as well as being more time consuming than microinjection this 
method has the considerable disadvantage that the entire yeast genome tends to integrate with 
the YAC, which could affect expression of the YAC Since this study was ultimately concerned 
with assessing the functionality of the YAC in a transgenic environment, the presence of other 
heterologous DNA was undesirable and spheroblast fusion was therefore not an attractive 
option. Lipofection of YAC DNA into ES or other cultured cells has also been reported (Choi et 
at. 1993; Lamb et al. 1993; Pearson and Choi, 1993; Strauss et al. 1993), but this method does 
not appear to increase the frequency of intact transgenes over that expected from microinjection 
(D Markie, personal communication; Vassilopoulos et al. 1999). Furthermore, both cell-
mediated methods require G418 selection of the transfectants, which might select for cells in 
which the YAC had integrated into active chromatin, prejudicing the expression data. This 
would be undesirable in this study. Microinjection of purified YAC DNA was first reported by 
Schedi et a! (1992). Compared to cell-mediated methods, microinjection of purified YAC DNA 
is faster and has the obvious advantage that gel-purified YAC DNA is relatively free of 
contaminating yeast sequences, unless the YAC comigrates with a yeast chromosome. 
However, purification and handling of appreciable quantities of intact, pure YAC DNA present 
several technical difficulties. Perhaps the greatest challenge is presented by the relative scarcity 
of the YAC in the yeast cell. YACs are present at single copy, which means in the case of HP8 
that the YAC only makes up approximately 2.5% of the total yeast DNA. This may be 
overcome to an extent by the use of YACs containing inducible amplification cassettes which 
allow the copy number to be increased (Smith et al. 1990; Chapter 5), but this requires 
retrofitting of pYAC-based YACs. In addition to being time-consuming, this may result in 
unstable copy number which would render the YAC refractory to further manipulation by 
homologous recombination. Some experiments suggest that the amplification of YAC copy 
number by this method may be low and unpredictable (M Dalrymple, personal communication). 
Finally, YAC modification by homologous recombination (HR) involves a risk to the integrity 
of the insert. In this chapter purification of a single copy YAC is reported, which circumvented 
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the need for any YAC modification. 
A second problem is caused by the size of YACs. DNA of several hundred kilobases is 
extremely sensitive to shear and other damage such as nicking by ethidium bromide (EtBr), 
damage by heavy metal ions often present in trace amounts in impure water and enzymatic 
digestion. To protect against shear, the buffers used to dissolve the purified YAC DNA were 
supplemented with polyamines which protect DNA from shear by intra- and intermolecular ionic 
interactions (Kaiser et al. 1963). Initially 70pM spermidine and 30iM spermine were used 
(Schedi et al. 1993b) to supplement the microinjection buffer. In later experiments hexamine 
cobalt chloride (HCC; Kovacic et al., 1995) was used, as this has been shown to effect a similar 
protection against shear in vitro (Kovacic et al. .1995) and has no apparent effect on mouse 
embryo survival (P Shiels and Y Gibson, personal communication). Standard precautions were 
taken against heavy metal damage and enzymatic digestion such as using ultra high purity water 
(impedance at least 15 M) and always wearing gloves. Efforts were also made to prevent EtBr 
coming into contact with the YAC preparation, by using washed electrophoresis equipment (the 
PFGE equipment has never been exposed to EtBr) and removing the gel regions to be stained 
from the unstained preparative section. 
Finally, the risk of fragmentation associated with YAC transgenes was starting to become clear 
at the time of this study (Forget, 1993; see also Peterson et al. 1998a). In an effort to ensure an 
intact YAC transgene a large number of embryos were injected. The numbers were limited by 
convenience - more injections could only have been advantageous. 
6.2 YAC DNA preparation 
YAC DNA was prepared essentially according to Schedi et al (1993b, 1996; for details see 
Chapter 2), except that single copy YAC DNA was purified. This method involves purifying the 
YAC DNA by excising it as a band from a pulsed field gel, and then concentrating it by a second 
round of electrophoresis at 900  to the first (Figure 6.1). For clear resolution and high yield very 
high quality DNA is required. The best method for obtaining this was found to be that given in 
section 2.8.2, with the optional Zymolyase treatment included. DNA was prepared in agarose 
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plugs by this method and subjected to the initial round of PFGE in 1% Rapid agarose (Life 
Technologies). Several batches of YAC DNA were prepared and pooled for microinjection. 
The preparation of one such batch is shown in Figure 6.1. The edges of the PFG were cut off 
and stained, then reassembled once the YAC band had been excised from the stained region. 
EtBr nicks DNA in the presence of UV light, so every effort was made to keep EtBr away from 
the YAC DNA being prepared. With the stained region for reference the YAC band was cut out 
of the unstained portion of the gel. The same was done for a yeast chromosome which served as 
a marker during the procedure (Figure 6.1). 
The PFG slice was then cast in a 4% NuSieve agarose (FMC) gel and subjected to the second 
round of electrophoresis at 900  to the first, to concentrate the DNA in the NuSieve agarose at the 
end of the Rapid agarose slice (Figure 6.1). The portion of the gel containing the marker 
chromosome was cut off and stained with EtBr to monitor this migration; the YAC DNA was 
excised from the NuSieve agarose without staining. After equilibration in lx TE, 0.1mM HCC, 
or lx TE, 70iiM spermidine, 30iM spermine, the agarose was digested with agarase to release 
the YAC DNA and the solution was briefly spun to pellet any undigested agarose before 
microdialysis against injection buffer/0. 1 mlvi HCC or microinjection buffer/70"M spermidine, 
30pM spermine. An aliquot was analysed by electrophoresis to assess the concentration and 
integrity of the YAC before several batches were pooled to obtain sufficient material for 
microinjection. 
6.3 Constructs and probes 
The physical organisation of HP8 is illustrated in Figure 4.12. The structure of the pYAC4 arms 
and the Trpl and FM probes is shown in the same figure. The Trpl probe was excised from 
pURAKOB (Chapter 5) on a SnaBI-BssHll restriction endonuclease fragment. pURAKOB was 
constructed to replace URA3 with TRP1 on the right arm of pYAC4-derived YACs. The primers 
RSPCR5' and RSPCR3'2 (Table 6.1) were used to amplify TRP1 from pRS314 (Sikorski and 
Hieter, 1989; Genbank accession U03440; purchased from Stratagene) by PCR. The PCR 
product was cloned into pGemT (Promega) creating pURAKOB. The insert was sequenced to 
confirm identity of the PCR product. SnaBI cuts within the PCR product just upstream of the 
TRP1 coding region, while BssFffl cuts within RSPCR3' between the pRS3 14 priming sequence 
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and the pYAC4-homologous sequence. Thus the SnaBI-BssHII fragment of pURAKOB 
contains the TRPJ fragment from basepairs 320 to 1207 of pRS3 14. 
The human 3 casein screening probe used was a PCR product amplified from intron 2 of the 
human Pcasein gene (Figure 6.2) The primers HBC1 and HBC2 (Table 6.1) were used to 
amplify a 770 bp fragment from basepairs 4899 to 5668 of the human 3 casein gene (Genbank 
accession L10615), using human placental DNA (a gift from A Scott) as a template. The PCR 
product was cloned into pGemT and sequenced to confirm identity. 
The RA probe was the 1.7 kb BamHI-PvuII fragment of pBR322 (Genbank accession: 701749; 
Sutcliffe, 1979; Figure 6.2), corresponding to the cloning vector backbone of the right arm of 
pYAC4. 
Probe 	Type 	 Size 	Primers/Comments 
hllcas8 	genomic 	0.8 kb 	HBC1: ACTATATA1T7GTAGAGA 
HBC2: A1T17ACTA1TI'TATGGTFCAT 




RA pBR322 1.7 kb BamFll-PvuII restriction fragment of pBR322 
hticasl cDNA 1.1 kb Human [1 casein cDNA from ATO to polyA 
hacasi cDNA 0.9 kb Human a casein cDNA from ATG to polyA 
HACP2 oligo 23 bp sequence: TCACCACTGTAGCATGACGTFAT 
HKCP2 oligo 23 bp sequence: CCAGGAGAGTGTGAAGTAGTAAT 
Table 6.1: Probes for screening lIPS mice 
The structure of the screening probes is shown in Figure 6.2. RSPCR5' and RSPCR3'2 consist 
of 22 nt of sequence which primes within pRS3 14 (Stratagene; Sikorski and Hieter, 1989) with a 
5' tail of homology to pYAC4 flanking URA3 (see text). Only the primer sequence of 
RSPCR3'2 was included in the probe. 
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Figure 6.1 - HP8 YAC DNA purification 
HP8 total yeast DNA was prepared in agarose plugs and separated by PFGE. The YAC band was excised 
from the unstained portion of the gel, as was a marker chromosome band (indicated above). 
The PFG slices were cast in a 4% low melting point gel and subjected to electrophoresis at 900  to the PFGE. 
The side with the marker chromosome was stained to monitor the progress of the chromosome into the low 
melting point agarose. The YAC DNA was excised from the unstained portion of the gel, and the gel was then 
restained. The staining up the edge of the gel slice indicates DNA that has migrated out of the side of the slice 
when the orientation of the slice was not quite parallel to the electrophoretic field. 
An aliquot of the purified YAC was run out alongside bacteriophage lambda (A) DNA standards to measure 
concentration. This sample is at about 2 ng4tl. 
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Figure 6.2: Probes for screening HP8 mice 
Panel A: A schematic representation of a pYAC4-derived YAC is shown, with the insert DNA removed 
to show the structure of the vector arms. TEL: telomere; on: E. coli origin of replication; Amp: E. coli 
ampicillin resistance (13 lactamase) gene; TRP1: S. cerevisiae TRPJ selectable marker; ARS 1: S. 
cerevisiae ARSI autonomous replication sequence; CEN4: S. cerevisiae CEN4 centromere; Sup4: S. 
cerevisiae Sup4° repressor; URA3: S. cerevisiae URA3 selectable marker. The Trpl and RA probes are 
shown below. 
Panel B: Structure of the human 13 casein gene, including EcoRI restriction sites and h13cas8 probe. Exons 
are represented by black boxes. Probe sequences are represented by grey boxes. 
Panel C: Structure of the human ic casein gene, including EcoRI restriction sites. Exons are represented 
by black boxes. Probe sequences are represented by grey boxes. 
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6.4 HP8 microinjection study I 
HP8 YAC DNA was purified and dissolved in microinjection buffer supplemented with 70pM 
spermidine and 30iM spermine. Microinjection of HP8 YAC DNA into fertilised mouse eggs, 
embryo transfer and subsequent animal husbandry were undertaken by Yvonne Gibson and Scott 
Rhodes in the small animal husbandry unit at PPL Therapeutics. Tail biopsy DNA was prepared 
from pups and screened by Southern blotting for the presence of TRP1 using the Trpl probe. 
The results are shown in Figure 6.3 and summarised in Table 6.2. 
Injection of HP8 YAC DNA into 3399 fertilised eggs led to transfer of 1584 embryos into 54 
pseudopregnant foster animals and the subsequent birth of 261 live pups, with an average litter 
size of 6. 255 pups survived to be biopsied and were screened by SspI digestion, Southern, 
blotting and hybridisation to the Trpl probe. One clear transgenic animal was identified, along 
with two of uncertain status (Figure 6.3). 96/158.23 gave a band of the expected size though 
very weak (the positive control was loaded at approximately single copy), suggesting that this 
animal may be mosaic for the YAC, since the DNA loading was as expected. 96/150.33 gave, an 
aberrant band pattern; in contrast to the expected SspI band of 2340 bp, bands of approximately 
1.8, 3.1, 4.2 and 10kb were detected, along with a high molecular weight smear which was 
outside the sizing range of the gel (Figure 6.3). Given the presence of multiple bands, and 
especially of the high molecular weight smear, it might be that the digestion of 96/150.33 DNA 
was not complete. However, a band of 2340bp would still be expected and the band of 1.8kb 
cannot be explained by this hypothesis unless the YAC has become perturbed. Another 
possibility is that the signal in this lane is a results of an artefact such as contamination of the 
sample or electrophoresis apparatus. The leakage of signal into the adjacent lane suggests that 
whatever has hybridised to the probe was in the sample rather than contaminating the comb. 
Although it is possible that the DNA sample was contaminated, it is not likely. Plugged pipette 
tips were used at all times when pipetting DNA during this screen, and great care was taken not 
to bring control DNA (pYAC4 in this case) into contact with samples; the pYAC4 DNA for the 
control digests was diluted to single-copy concentration separately. Moreover, the bands are not 
consistent with pYAC4 contamination. 96/150.33 was therefore regarded as a putative 
transgenic. 96/150.34 was loaded alongside 96/150.33 and gave bands similar to that sample 
(Figure 6.3) suggesting that this signal was caused by leakage between the lanes. 
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Figure 6.3: Initial screen for HP8 transgenic mice 
Figure 6.3: Initial screen for HP8 transgenic mice. 
5tg of tail biopsy DNA was digested with Sspl and probed with a Trpl probe to detect the left arm of the 
YAC. Markers are 1kb ladder from Life Technologies; sizes are shown in bp. Irrelevant lanes have been 
omitted for clarity. PYAC4 - 20pg of pYAC4 added to an Sspt digest of nontransgenic mouse genomic DNA. 
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Figure 6.4 -Secondary screening of HP8 GO animals 
4 C4 C 










Figure 6.4 -Secondary screening of HN GO animals 
5ig of DNA from animals which were possible transgenics (Figure 6.4) were digested with Sspl and 
probed with Trpl. 1 k - 1kb ladder from Life Technologies, with some sizes shown; NT - non-transgenic 
control. pYAC4 - 20pg pYAC4 added to 5j.tg of nontransgenic mouse DNA and digested with Sspl, 
equating roughly to a single copy gene. Only 96/158.23 appears to be transgenic, and at less than single 
copy. 
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One other sample, 96/150.17, gave a signal when probed with the Trpl probe. This appeared to 
be an artefact as it was not an obvious band (Figure 6.3), but the proximity of the 1 kb marker 
DNA precludes definitive rejection of 96/150.17. 
In light of these results 96/158.23, 96/150.33 and 96/150.17 were mated to produce G 1 animals. 
However, no hybridisation of h3cas8 was detected to DNA from a total of 68 offspring from 
these matings (Table 6.3), and in two subsequent Southern blots DNA from both 96/150.17 and 
96/150.33 failed to hybridise to Trpl (one blot is shown in Figure 6.4). Taking all of these 
results into account it seems likely that only one positive animal was produced, 96/158.23, that 
this animal was mosaic and that the transgene was not present in the gerinline. Therefore a 
second study was initiated to attempt to generate animals harbouring the HP8 YAC transgene in 
the germline. 
6.5 HP8 microinjection study II 
A second preparation of HP8 YAC DNA was made and microinjected as before except that the 
shear-protectant used in this study was HCC. Kovacic et al (1995) reported that 0.1 mM of 
HCC in 0.5x TBE provided complete protection for megabase plant DNA when it was passed 
repeatedly through a standard yellow pipette tip. Subsequently P. Shiels and Y. Gibson 
(personal communication) found that up to 4mM HCC in microinjection buffer had no 
detrimental effect on embryo survival in murine recipient foster mothers, and that 0.1mM HCC 
in TE was sufficient to protect megabase DNA from passage through a yellow pipette tip. Since 
HCC is reported to give fewer problems with precipitation and needle blockage than 
spermine/spermidine (Y. Gibson, personal communication; Kovacic et al., 1995) 0.1 MM HCC 
was added to all solutions used in the manipulation of YAC DNA in solution, to compare its 
effectiveness with that of spennine/spermidine and to assess any effect it might have on long-
term embryo survival and transgenesis. However, another difference from Study I was that in 
this study, owing to time constraints and the low yield of purified YAC DNA from each 
preparation, not every batch was tested for YAC integrity before microinjection. Previous 
batches were tested and displayed degradation amounting to no more than 20%. Nevertheless, 
this remains an omission from this experiment which may have a bearing on the results (below). 
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Figure 6.5 - HP8 YAC transgenic mice 



















Figure 6.5 - HP8 YAC transgenic mice 
tail biopsy DNA was digested with EcoRl and screened for three YAC markers by Southern 
blotting. See text for details. L - probed with hcas8 and then TrpI. R - probed with hbcas8 and then 
RA. B - probed with hl3cas8.  Markers are 1kb ladder from Life Technologies as before. lcp, lOcp - 
copy number controls of pYAC4 DNA in nontransgenic mouse DNA, digested with EcoRl. Only positive 
samples are labelled. * - empty lane, showing some well leakage from adjacent transgenic sample. 
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The results of screening the G 0 animals thus produced are shown in Figure 6.5 and summarised 
in Tables 6.2 and 6.3. Note that Figure 6.5 represents a secondary screen of the putative 
transgenics and any samples of uncertain status from the first screen (not shown). Of 2964 
injected embryos 1890 were transferred to 63 pseudopregnant foster mothers, yielding 327 live 
births from 60 pregnancies. Tail biopsy DNA from 313 animals was screened by Southern blot 
as before, except that the DNA was digested with EcoRI restriction endonuclease. Three gels 
were prepared by splitting a triple digest of each sample, and the blots were hybridised to 
h3cas8. This eliminated any of the ambiguity caused by gel-specific artefacts in the first study. 
Two of the blots were then reprobed with either Trpl or RA. The hcas8 probe was not removed 
before reprobing (Figure 6.5). 
Eight G0 samples hybridised to the human P casein probe hcas8 (Figure 6.5), giving a 
transgenic frequency of 2.4% of live births. A ninth band was seen in the h3cas8 blot (Figure 
6.5, bottom panel), but in only one of the three blots. Also, this apparent band was irregular, 
unlike the bands in the gel, and was not located a discrete number of lanes away from the marker 
lane. Therefore this is assumed to be an artefact. Of the eight positive samples 97/26.4, 
97/26.10, 97/27.12 and 97/28.25 also hybridised to both YAC arm probes, while the other four 
samples hybridised to one arm or the other. This suggests that considerable fragmentation, of the 
YAC has occurred during generation of the animals. Also significant is the finding that the 
animals which screened positive for all three YAC markers were apparently present in multiple 
copy, while the other four animals harboured fewer copies. While copy number determination is 
unreliable in G0 animals due to mosaicism and inherently variable due to problems in estimation, 
autoradiography (small linear response range) and manipulating very low concentration. DNA, 
this result nevertheless undermines any inference from the data that the multiple copy YACs 
may be intact. It may be that the multiple copy animals simply contain multiple YAC fragments, 
including one or more copies of each marker. 
Further evidence that the YACs are not intact in these animals is provided by the band patterns 
detected by the YAC arm probes in Figure 6.5. The gels were not run far enough for accurate 
size determination in the desired range, but some inferences about the structure of the YAC 
transgene arrays can be drawn from them. Although most of the bands discussed below are 
discernible in Figure 6.5, some are only apparent in the original autoradiographs. Work is 
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underway to repeat these blots to obtain clearer data concerning the structure of the YAC in 
these mice. 
As there is a single EcoRI site in each arm of the YAC where it abuts the insert DNA, three 
results are expected when YAC-transgenic mouse DNA is cut with EcoRI and probed for the 
YAC arms, depending on the structure of the array. The left arm of pYAC4 covers 6kb, the 
right 3.7kb (Figure 6.2). A head-head junction of two YAC copies would therefore give an 
EcoRI band of 12kb, a head- tail junction would give a band of 9.7kb and a tail-tail junction 
would give a band of 7.4kb. An intact copy of the YAC juxtaposed with genomic DNA would 
give an EcoRl band of at least 6kb when probed with Trpl and a band of at least 3.7kb when 
probed with RA. 
When probed with Trpl (Figure 6.5 panel L), 97/26.4 gives two bands which might be 9.7kb and 
12kb, consistent with the existence of at least one head-head and one head-tail junction in this 
animal. There is also a very faint band above 12kb which may represent a head-genome 
junction, and another very faint band below the strong 9.7kb band. The 9.7kb band is 
considerably more intense than the other bands. If the faint band above 12kb does represent a 
head-genome junction, then the relatively intensities of these three bands are consistent with the 
existence of a single head-genome junction and several internal head junctions in this animal, 
which has been estimated at 10-copy based on the human P casein signal (Figure 6.5 panel B). 
The RA pattern also seems to contain a band at 9.7kb (Figure 6.5 panel R), indicating a head-tail 
junction. However, the relative strength of the 9.7kb band detected by Trpl is not matched by 
that detected by RA. In addition, RA detected bands at approximately 9kb, 7kb, 4.5kb and 5.5kb. 
The 9kb band is also detected by Trpl, suggesting that this may represent a head-tail junction in 
which some deletion has occurred. The 5.5kb band detected by RA is considerably more intense 
than the other bands, suggesting that this fragment is present in higher copy within the array than 
the other fragments detected. However, this is hard to understand given that this 5.5kb band 
would most likely represent a tail-genome junction of which only one would be expected, and 
which relies on the nearest genomic EcoRI site so that even if there were more than one tail-
genome junction, multiple bands of the same size would still be highly unlikely. Similarly, the 
presence of the 4.5kb and 7kb bands cannot be explained. Neither was detected by Trpl, and the 
7kb band is clearly too small to represent a 7.4kb junction of two intact right arms (Figure 6.5). 
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Thus the structure of this 10-copy array is complex and uncertain. 
97/26.10 appears to carry approximately 2 copies of human 0 casein (Figure 6.5), and gave a 
single large band when probed with Trpl which may represent a head-head junction. RA again 
detected several different bands in this animal. A band of the appropriate size for a head-tail 
junction (expected size 9.7kb) was detected by RA, and there were also bands of approximately 
4kb and 5kb. However, the putative head-tail band is not detected by Trpl, suggesting that this 
does not represent a head-tail junction. 
97/27.12 carries approximately 5 copies of human 0 casein (Figure 6.5). Trpl detected what 
appears to be a 9.7kb head-tail junction in this animal, but also a very strong band at 
approximately 7kb. This could be a head-genome junction, but the intensity is unexpected. This 
band is clearly too small to represent a 9.7kb head-tail junction. In this animal RA detected 
bands of approximately 5, 6 and 7.5 kb. The largest band is consistent with a tail-tail junction, 
but might also be the same size as the 7kb band detected by Trpl, and thus represent a deleted 
head-tail junction. The other two bands cannot be accounted for, but either could represent a 
tail-genome junction. 
Little can be inferred from the pattern obtained from 97/27.46 when probed with Trpl. The 
marker ladder signal obscured any bands which may have been present (Figure 6.5). RA failed 
to detect any signal for this animal. The human 0 casein signal suggests that there is a single 
copy of the gene present (Figure 6.5 panel B). 
In 97/28.24 the human P casein gene is estimated to be present at single copy (Figure 6.5 panel 
B). Trpl detected a single band while RA failed to detect any signal. The Trpl band appears to 
be 8-9kb, and thus may represent a head-genome junction. These data are consistent with the 
presence of a single copy of HP8 truncated at the right arm. 
97/28.25 is estimated to carry 10 copies of the human 0 casein gene (Figure 6.5 panel B). Trpl 
detected bands consistent with head-head and head-tail junctions. The putative head-tail band is 
much more intense than the putative head-head band. However, there is also a band of 
approximately 7kb which is of comparable intensity to the head-tail band. The 7kb band might 
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represent a head-genome junction, but the intensity cannot be explained in that context. RA 
detected bands of approximately 5.5kb, 6.5kb, 9.5-10kb and over 12kb, all of approximately 
equal intensity. The 9.5-10kb band probably represents a head-tail junction, as implied by the 
similar band detected by Trpl. The 6.5kb band may represent a deleted head-tail junction since 
Trpl detected a band of a similar size. 
97/28.27 has approximately 1 copy of the human P casein gene (Figure 6.5). Trpl detected a 
single band of approximately 12kb in this animal, which could be indicative of a head-head 
junction. However, given that the animal is apparently single-copy, this could alternatively 
represent a head-genome junction. RA failed to detect any bands in this animal. Similarly to 
97/28.24, this animal may thus carry a single copy of HP8 truncated at the right arm. 
97/30.5 is apparently single-copy with respect to human P casein (Figure 6.5). Trpl failed to 
detect any bands from this animal. RA detected a single band of approximately 6.5kb,, which 
may represent a tail-genome junction fragment. Thus 97/30.5 may carry a single copy of HP8 
truncated at the left arm. 
In summary, the EcoRI digest data convey a confused picture of the organisation of the 
transgene array in most of the transgenic mice. Although the data are not of high quality, it 
nevertheless seems likely that the arrays are complex and not made up of uniformly-intact YAC 
copies in these animals. Further analysis would be useful in order to elucidate the structure of 
the YAC copies so that any expression data could be viewed in an appropriate context. To 
ascertain the number of copies of the YAC arms, digests which closely bracket the probe 
sequences would be desirable, so that a single band would be expected for each animal. To 
determine more closely the structure of the junctions within the array, EcoRI digests are useful. 
The data in Figure 6.5 are of low quality; a. repeat of these blots should yield clearer information 
about the structure of the ends of the YAC copies. Finally, PFGE is an obvious choice when 
investigating YAC structure. Several reports in the literature detail methods and results using 
PFGE to analyse YAC transgenic arrays (Peterson et al. 1998). In general the frequency of 
intact YAC copies as determined by this method is low. The results presented here would 
concur with this view. 
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6.6 Summary of HP8 transgenic founders 
Table 6.2 summarises the results of the two HP8 microinjection studies. A cursory review of 
these suggests that of the two injection buffers, 11CC leads to a higher transgenic frequency than 
s/s. There also appears to be a significant increase in embryo survival, both in terms of embryos 
implanted and in live births. However, it must be borne in mind that microinjection of YACs 
into mouse eggs is a new technique at this facility, having been performed only once before this 
study, and the HCC study was done soon after the s/s study. It is therefore likely that some 
improvement in technique may have occurred between the two. YAC DNA is difficult to 
microinject, causing significant needle blockage and increased visible damage to the egg relative 
to plasmid DNA (Y. Gibson, personal communication). Nevertheless, these data are intriguing. 
Further work with HCC suggests that transgenic frequency is at least as good as that obtained 
with s/s (A. Tomlinson and P. Shiels, unpublished), although transgene integrity remains to be 
investigated. 
Buffer 	Inj 	2 cell 	Transf 	Preg 	Births 	Ave/F 	Tailed 	TG 	% TG 
s/s 3399 1770 1584 47/54 261 6 255 1 0.4 
HCC 	2964 	2024 	1890 	60/63 	327 	5 	313 	8 	2.4 
Table 6.2 - Summary of HP8 transgenic mouse studies 
s/s - spermidine/spermine microinjéction buffer; HCC - hexamine cobalt chloride microinjection buffer; 
Inj - number of injections; 2 cell - number of embryos surviving to 2 cell stage; Transf - number of 
embryos transferred to foster mothers; Preg - number of pregnancies achieved; Ave/F - mean litter size; 
Tailed - number of pups surviving to tail biopsy at two weeks post parturition; TG - number of transgenics 
detected; % TG - number of transgenics as a percentage of live births (Births). 
Nine transgenic founders were identified in this study, 8 of which were generated using HCC 
and 1 using s/s. The single animal generated from s/s did not transmit the YAC and was 
discarded. Of the remaining 8 animals, 4 possessed all three screening markers. These 4 
animals were apparently multicopy. This correlation together with the unexpected data obtained 
from digests probed for terminal YAC restriction fragments imply that the YAC has become 
fragmented in these animals. Nevertheless, they were bred and used to analyse the expression of 
the human casein transgenes. 
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Screening Copy no. 
Injection Left Right 
Founder Buffer Sex arm casein arm 
(approx.) G ,  TGGG 1 
96/150.17 s/s F nd nd nd 21 
96/150.33 s/s M ? nd nd nd 
21 0 
96/158.23 s/s F + nd nd <1 
26 0 
97/26.4 HCC F + + + 10 
11 
97/26.10 HCC F + + + 2 
97/27.12 11CC F + + + 5 
97/27.46 HCC M nd + - 
97/28.24 HCC M + + - 1 
15 0 
97/28.25 HCC M + + + 10 
14 5 
97/28.27 HCC M + + - 1 
15 3 
97/30.5 11CC F - + + 1 
14 3 
Table 6.3 - BPS transgenic mice 
See text for details. s/s - microinjection buffer! 70pM spermidine, 30IiM spermine. HCC - microinjection 
buffer/O. 1mM hexamine cobalt chloride. nd - not determined; ? - uncertain. G 1 - live offspring surviving 
to be biopsied. TG G 1 - number of transgenic G 1 animals 
6.7 Analysis of human casein gene expression in HP8 transgemc mice 
In order to establish stable transgenic lines and to obtain animals for tissue samples, the nine 
transgenic founders (Table 6.2) were mated to wild-type mice. As discussed above, 96/158.23 
failed to transmit the YAC. 97/28.24 also failed to give rise to any transgenic offspring. The 
other founders transmitted the YAC successfully, so that seven transgenic lines were established 
(Table 6.3). These animals were mated to wild-type mice as necessary to obtain lactating 
mammary tissue. 
6.7.1 Analysis by northern blot 
Day 10-lactating mice were killed and mammary glands recovered and snap frozen in liquid 
nitrogen (N 20)) by Y. Gibson and D. Morrison in the small animal husbandry facility at PPL. 
Total RNA was prepared by the guanidium thyocyanate method (Chomczynski and Sacchi, 
1987) from these glands, using the RNAZo1 kit (Invitrogen) or the TRI reagent kit (Sigma). Five 
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Figure 6.6: Northern blot analysis of human casein transgene expression 
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Figure 6.6: Northern blot analysis of human casein transgene expression 
Total RNA from l-1P8 transgenic mice was analysed for human casein expression by northern blot. Lactating 
mammary gland total RNA was prepared from five lines of HP8 transgenic mice (lanes 1-5), two lines 
of homozygous 13  casein knockout mice (lanes 6 and 7) and a wild-type mouse (lane 8). RNA was also 
prepared from the cell pellet of two samples of human breast milk (lanes 9 and 10). A human 13 casein 
cDNA probe (h13casl) strongly hybridised to the human control RNA and to trausgenic and control mouse 
RNA under low stringency (Panel A). A high stringency wash of the same filter removed nearly all of 
the mouse signal (Panel B). No hybridisation of a human a casein oligonucleotide probe (HACP2) to 
transgenic samples was observed (Panel C). Similarly, no hybridisation of the transgenic samples to a 
human K casein cDNA probe was observed (Panel D). 
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or 1O1g of total RNA was used to assay for the presence of human casein RNAs by northern 
blotting. 
Five lines produced lactating mammary tissue in time to be assayed for human casein gene 
expression (Figure 6.6). Total lactating mammary gland RNA from these lines was northern 
blotted and hybridised to hcas1, which is a human l3casein cDNA fragment from translation 
start to polyadenylation signal and was a kind gift from M. Dalrymple (Figure 6.2). A sample of 
lactating mammary gland total RNA from a wild-type mouse was included as a negative control. 
To control for cross-hybridisation to mouse P casein, two samples of lactating mammary gland 
total RNA from homozygous 0 casein knockout mice (a kind gift from A. Kind) was included. 
In addition, two samples of total RNA prepared from human milk were included HRNA2 was a 
kind gift from M. Dalrymple. HRNA1 was prepared from human breast milk kindly donated by 
J. White. The milk was briefly centrifuged to pellet cells and total RNA was extracted from the 
pellet. 
As can be seen in Figure 6.6a, the human Ocasein cDNA probe hcas 1 hybridised strongly to 
both human RNA samples, although hRNA2 is clearly degraded. There is also some signal from 
the transgenic samples and from the wild-type mouse RNA. The relatively intense signal from 
the 97/2610 sample correlated with an excessive RNA load onto the gel as shown by a later 
probing with murine Kcasein. No hybridisation was detected to the knockout samples. This 
result suggests that the probe has cross-hybridised to an extent to the mouse Ocasein RNA. 
Stringent washing of this filter removed the majority of the signal from the transgenic and wild-
type samples, while the signal from the human RNA samples was undiminished (Figure 6.6b). 
This argues that the signal emanating from the experimental samples is due to cross-
hybridisation of the mouse P casein RNA to the probe, rather than the presence of human 
casein RNA in these samples. A rough examination of this figure would suggest that the 
signal from the HP8 mouse samples is approximately 3 orders of magnitude weaker than that 
from the human controls. Therefore the transgenic mice do not appear to express significant 
quantities of human P casein. 
Human a casein expression was assayed for by Northern blotting as above, except that in this 
case the probe was an end-labelled oligonucleotide, HACP2 (Table 6.1). As can be seen from 
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Figure 6.6c, no human acasein RNA was detected in samples from five transgenic lines. 
However, the sensitivity of this Northern blot was not high. This remained the case in a repeat 
experiment. Therefore an RTPCR assay was performed (below). 
As before, total lactating mammary gland RNA was analysed by Northern blot to assay for 
human K casein expression. In this case the probe used was hkcasl, a human Kcasein cDNA 
fragment from the translation start site to the polyadenylation site, and which was kindly donated 
by M. Dalrymple (Figure 6.2). No Kcasein RNA was detected (Figure 6.6d). However, once 
more the sensitivity of the assay was insufficient to rule out very low levels of Kcasein 
expression. A longer exposure of the same blot failed to show any bands but the background 
was fairly high in this case and may have obscured otherwise detectable K casein hybridisation. 
ic casein expression was therefore analysed by RTPCR along with a casein expression. 
6.7.2 Analysis by RTPCR 
RTPCR was performed to detect human a and Kcasein RNA (Figure 6.7). The RTPCR primers 
and expected product sizes are shown in Table 6.4. In addition to human aand K casein 
primers, primers designed to amplify either mouse or human bile salt-stimulated lipase (BSSL; 
Lidmer et al. 1995; Genbank accession X54457) RNA were also included. BSSL is a milk 
protein and so this amplification served as a positive control of the first strand synthesis reaction. 
A water blank and RNA from a wild-type mouse were included as negative controls. Human 
breast milk RNA was included as a positive control. A 100-fold dilution of the normal human 
first strand aliquot was also amplified, to test the sensitivity of the assay. A band was obtained 
from the human samples in all cases, indicating that the assay would detect RNA at least down 
to 1% of the normal level in humans. No human a casein RNA was detected in the mouse 
samples (Figure 6.7). 
In contrast, an RTPCR product of the expected size was amplified from four out of five of the 
HP8 mouse samples by the human K casein primers (Figure 6.7). To confirm the identity of the 
product these RTPCR products were gel-purified, cloned into pGemT and sequenced using an 
AB1377 automated DNA sequencer (Perkin Elmer). The sequences were aligned using 
MegAlign software (Lasergene). The alignment was almost perfect although with some 
apparently PCR-generated mismatches (Figure 6.8). The 97/28.25.3 sequence contains an A at 
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Figure 6.7: RTPCR on HP8 mammary gland total RNA 
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Figure 6.7: RTI'CR on HI'8 mammary gland total RA 
RTPCR was performed on lactating mammary gland total RNA from five HP8-transgenic lines (lanes 
2-6, 12-16, 24-28), one wild-type mouse line (lanes 7, 17, 29) and one homozygous P casein knockout 
mouse line (lanes 8, 18, 30), and on human breast milk total RNA (lanes 9,10, 19, 22, 31, 32). First 
strand synthesis was carried out and 5% of this reaction was used in the subsequent PCR. A PCR reaction 
with 0.05% of the human RNA first strand reaction was also performed to test the sensititvity of the 
PCR (lanes 10, 22 and 32). A water blank was included (lanes 11, 23, 33. Primers are given in Table 
6.4 and were designed to amplify human a casein, human ic casein or human and mouse bile salt-
stimulated lipase (BSSL) products. The BSSL reaction serves as a positive control of the first strand 
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Figure 6.8 - RTPCR product sequences 
.Ar.. .9 	 .a 	.AA W..Qfl.A 
1 	CI C C A A T a a TC a a C a C I I T TC T T C T A C I T C T C A * T C C C C IC C C a t T a a c C C I C C C I I T I T I C C C T C T C CA C C T I C a a a A C l.l.,n*. 
1 	C T C C a a I a a r a* a C a a r I I T C T I C T a a T T C T C a a I C C C C T C C C a T T a a C C C T C C C I I I T I I C C C T C I C C A C C T I C a a a a C 37/24.4.5 
1 	CTGCaaIaaTCACCACTTTTCTTCTACTTCTCAaTCCCCICCCAITAACCCTCCCTTIIT1CCCICTCCAGCTICAaAAC,7/24.1I.1 
1 	CTGCAATAaIGaACaCITTICITCIAGIICTCAATCCCCICCCAITAACCCICCCIITIITCCCIGICCACCITCaAAAC,?/27.12.4 
I 	C T C c a a T a a I C a a C A C I I I I C T I C T a C T T C 1 C a a I C C C C I C a c a r T a a C C C I C C C I I T T I T a C C I C T C C A C C T T C a a a a C 37/12.25.3 
Ca CA A 	caa CCAC C a TCC AT CA CAC T CA TCAAA CA cCaTIC TA T C A CAAA ACA CC T 	C A T A TCICCCCA I CTATIaI C 
C a C a a A C a a C CA C c a .TICIC C a r CA C a a T a a T C a a A C A C C A I I C IC IC a C a a A A C C C C T 
C. 
	a T a I C T C C C a a T C I A T I a I C 
C A C a A A C a a C C A C C a TICIC C a I C A C a a I C A I C a a A A A C C A I T C T A T C- A C a a a a c A C C I C C A T a T C T C C C A A T C T a T I A T C 
CA CA A AC a a C CA C CA TICIC CAT Ca CA a IC AT CC A AC AC CAT T C T 	IC AC A A 	a Ca CC T C CA TAT CT C C 
C
 A AT C T 	I TAT C 
cac a A A C a a C CA CC A 11A1C C A T 	AC A AIC AT CA A A 	a C CAT I C TA T 	AC A A 	ac a CC T CC ala TC T C C C a a T 	TAT TAT C 
;. Utif z. 	 41 2 
CC Ca aa TAG (TAlC C TIAI TA IC CAA CCAATT CIA C C A a c CIA CA CCa CC TA TAC CAATIAA IAaIC CAIAT CIC CC IC 
6CCaCaIaCCTA1cCTIaTTaTCCaaCCaAI1 CIACCAaCCTACCCCACCIATACCAAIIAaTaaTCCATATCTCCCIc 
CC CAAAIC C CTaT C C ITAT ITC Ca A 
C 
 C A AlT C 	A C C A A C CIA CACCA CC TATAC Ca A T T A A TaA T C C A TAT C1CC C T  
CC CA A 	TAC CIAT C CTTAI Talc CA AC CAaII aTa CCaA C CIA CA 
C C A 
CC TA TAC(AATIAATaa T 	CaTAICICCCTC 
CCCaAaIaCCTATCCIIATIATCCAaCCAaII 7 CTACCAACCIAGA CCCCTATCCCaATIAATAAICCATaTCTCC(TC 
241 CCACAIATTAICCaAACCCACCICIACIIACCCCACAIGCCCAAATTCCTCACCCCCaATACCTCCCAAAIACCCACCCAI.(.,.OA. 
2411cacala IraTaca AACCCAC CTC TACT TACC C Ca CATC CC CAAaTTCC T  A CC CCCAAIA CCTCCCAAATAC C C A CC CA 37/2A.4.3 
211 C C A C A I A I I A T C C £ A A C C C C C C T A T a C T I A C C C C A C A T C C C C A A A T T C C I C C C C C C C A A T A C C T C C C A A A T A C C C A C C C A 37/24.14.1 
241 CC AC A IA TT A TCCA A A 
 
 C CACCT CIA CTTAG CCCACATCCC C A A A TICC TCACC CC CCATA C CTGCCAAATACC Ca CC Ca 37/27.12.4 
241 C C A C A T  I IA 
 
  CA A A C C C A C C T C IA a I r a C C C C A C A IC C C CA A A T I C C IC A C C C C C a A TA C C T C C C A A A T a C C C A C C Ca 37/24.23.3 
AN 344 354 	 ]is 	 3I ill 314 4•S 
321 C C C A C T I T C C I a C C T C C C C C A A A C C I C C a I C C A T C A T T I a T I C C C A I C C C C C C A A A C a a a a I I C A C C A I A A A A I A A I C A T A.(.r.na. 
321 C C C A C I C TA C TA C C T C C C C CA A A C C T C C A IC C A T C A T T T A I I AC CA IC C C C C C A A A C A A A A TIC a C CA TA A A A TA C IC A 1 37/24.4.5 
321 C C C A C T C I C C I A C C I C C C C C A A C C C 1 C C A T C C A I C A I I I a I I C C C A I C C C C C C A A A C a a A A T I C A C C A T A A A A I A A T C A I ,7/2.i..i 
321 C C C A C T C I C C IA C C I C C C C CA A A C C T C CC T C C A I C A IT TA I I C C C A T C C C C C CA A A C A A A A T IC A C CA TA A A A IA A T CA 1 37/27.12.4 
321 C C C A C I C T C C TA C C I CA C C C A a a C CI C CA T C Ca I CA II IA T I C C CA T C C C C C C A A A C A A A A TI Ca a CA TA A A A T A A I C A I 37/2*25.3 
441 C C CIA C CAT C A AlA C CAT T  C IA CT C TIC A AC CIA CA CC A C C IIC C ICC C A C TA A A C C A A C C C TCC A CA CT C TA CI C A C IC A.(..na. 
411 C C C I A C C a I C A A IA C C A T I C C T  C I C IT C A A C C TA C A C C A C C T C C I C C C A C T CA A C C A A C C CT C CA C A CI C IC CI C A C I C 7/Z4.1.5 
441 C C C T A C C C T C A A TA C Ca I I C C IA C I C I T.C.LL CC TA C A C CA C C I C C T C C C A C I CA A C C A A C C C T C C A C A C I C TA C I C A C IC 17/2A.1I.l. 
441 C C C I A C C A I C A A T A C C A I I C C I A C I C I I C A A C C I A C & C C A C C I C C T C C C a C I C A A C C A A C C C T C C A C A C T C I A C I C A C I C 37/27.12.4 
441 C C C TA C CAT C AA IA C Ca TIC CTA CI CIT CA AC CIA C A C C AC C IC C TA C C AC IC A AC C A AC C C IC CA CA CT C TAG IC ACT C 37/24.25.3 
461C  C AC C CIII TIC A GA CT C CAT CA IC A C CA C CCC C C C IC A CA C A A C C A C ACT C C C A CII ACT C C A C C ICC C C C ATA C A A A Refer me 
441 C A C A A CC I I ITT CC C ACT C Ca ICC IC A CC A C Ca C C C CIA A ca Ca a C C C A T C C CA CIT ACT C CA C C IA C C C Ca TA CA A A l7/24.4.5 
411 Ca CA A C C TI T ITCA CA CT C CAT CAT C A C C A CC AC C C CTCA CA Ca AC CA C CAT CC Ca a I IA CT C CA C C TA C C CA IA A A A A 37/24.14.1 
4S  C AC A AC CT T T ITC A C ACT C C a IC AT CA C C A CC AC C C CT C AC A Ca a C C AC ACT C CCC CIT ACT C C AC C TA C C C CA TA A A A A 37/27.12.4 
411 C A C C A C C T I T I T C A C A C T C C A I C A T C A C C A C C A C C C C I C A C A CA A C CA C A C T C C CA C I IA C T C C A C C I A C C C C A I A A A A C 37/24.23.3 
5. 	 5i# 	 "4 	 9. 	 'I 	 434 
541 C A C C A A C C A A C T A I C A A A C A A CA C A C C C C C C C C C I I C C I C A A A C C A A A I T  C I C C I I C C C A C T C I C C I C C 	 Referem 
541 CA C C AC CCC A TAT C A' A CC A A CA C A A CCC AG CA C TIC C IC AC AC CCC A TIC CIA CT IC A CA CT C IC CT CC 37/24.4.5 
541 C AC C AC CC AC A TAT C A A CCC A CCC A, A C C C A CCC C 11CC ICC CCC CACA T TACT ACT ICC CCCI CT CCI CC 	 37/24.14.1 
Sal Ca C C AC C C CA A T A I C AC AC CA CCC CA C C C A C AC C IT CCI CCC A C C CA A TI A CIA CIT CCC a C T CT C CI CC 37/27.12.4 
541 C A C C A A C C A A C T A I C A A A C A A C C C C A C C C A C C A C I I C C I C A A A C C C A A I T A C T A C I T C A C A C I C T C C I C C 	 37/23.25.3 
Figure 6.8 — RTPCR product sequences 
K casein RTPCR products (Figure 6.7) were cloned and sequenced and the sequences aligned to 
the published sequence of the human KcaSein cDNA ("Reference"). The alignment software 
was MegAlign (Lasergene). The alignment is perfect except for three apparent amplification 
errors (bo). - 
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Oposition 97 in Figure 6.8. Only one RTPCR product was cloned from this animal so it is 
impossible to definitively ascribe this to PCR-introduced error, but it seems highly likely. GIA 
substitutions are the most common misincorporations introduced by Taq polymerase. The 
97/27.12.4 product contains an R at position 194 in Figure 6.8. Out of three clones sequenced, 
two contained the expected G at this position and one contained an A. Thus this is a 
misincorporation. Similarly, 97/26.10.1 shows a Y at position 443 in Figure 6.8. Out of three 
clones sequenced, one contained a C at this position and the other two contained the expected T. 
Again, this is therefore a misincorporation. The human K casein RTPCR products were also 
sequenced and were found to be genuine products (not shown). 
Target RNA Predicted 
product 
Primers 
Human a casein 558 bp HACPI: ATGAGGCTFCTCATTCTCACCTG 
HACP2: TCACCACTGTAGCATGACGTTAT 
Human K casein 623 bp HKCP1: GTGCAATAATGAAGAGT!ITCTT 
HKCP2: CCAGGAGAGTGTGAAGTAGTAAT 
Human/Mouse 701 bp BSSL1: 
BSSL TCTFCGGGGAGTCTGCTGGAGGTGCCAGC 
BSSL2: CCGAGAGGGATGGGAAAACAGGTAG 
Table 6.4: RTPCR primers 
The upper (forwards) primer is numbered 1 in each case. BSSL: bile salt-stimulated lipase. 
BSSL1 and BSSL2 anneal to both human and mouse BSSL transcripts. They were used as a 
positive RTPCR control, indicating that the RTPCR was successful. No primer pair anneal 
within the same exon. 
Thus, the cloned RTPCR products from all four lines matched the published sequence for the 
human K casein cDNA (Figure 6.8), indicating that they are all genuine amplified transcripts and 
therefore that human Kcasein RNA is present in the lactating mammary glands of these mice. 
The sample which failed to give a band was from 97/27.46.4. This mouse apparently has one 
copy of the human 0 casein gene but has no right YAC arm (Figure 6.5). Since the human 
K casein gene lies near the right arm of HP8, it is conceivable that this animal lacks an intact 
copy of the gene. To test this, a Southern blot was probed for each of the three human casein 
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genes, using hcas8 and the cDNAs of human a and K casein. 
6.7.3 Southern analysis of GI mice 
HP8-transgenic mouse tail biopsy genomic DNA was digested with EcoRI and analysed for the 
presence of the three human casein genes by Southern blot. H3cas8 was used to detect the 
human 3 casein gene. The human a and K casein genes were detected with the cDNA probes 
hacasi and hiccasi (Table 6.1; Figure 6.2). 
All five transgenic mouse samples hybridised to the human 3 casein probe (Figure 6.9), 
confirming the presence of the gene. However, there was some variation in the apparent size of 
the detected EcoRI fragment. This variation has not been observed before (c.f. Figure 6.5), and 
so might be an artefact of this gel. The relative intensities of the 3 casein bands in this blot are 
in agreement with those in Figure 6.5 and serve to confirm the copy number estimates of these 
lines. 
The same filter was stripped and reprobed with the human a casein cDNA probe hacasi, 
corresponding to the published sequence (Genbank accession X78416) from translation start to 
polyadenylation site (a kind gift from M. Dalrymple). All five samples hybridised to a casein, 
and similar mobility differences to those observed with the 3 casein probe were seen, indicating 
that this phenomenon probably is due to variation within the gel or samples rather than 
differences in the transgenes themselves. The major band detected by hacasi was of 
approximately 7 kb, and this was also detected in human genomic DNA on the same filter 
(Figure 6.10). In addition, the two high-copy samples, 97/26.4.5 and 97/28.25.3, also gave 
bands at 4.2 and 5 kb approximately. The structure of the human a casein gene has not yet been 
reported, but these extra bands presumably represent internal EcoRI sites within the gene which 
are spanned by the cDNA probe. The absence of these bands from the other HP8 mouse lanes 
and the human DNA lane is probably due to the lower abundance of the target sequence in these 
lanes such that minor signals are undetectable. 
The filter was stripped again and hybridised to the hkcasl probe corresponding to the human 
K casein cDNA from translation start to polyadenylation (Figure 6.2). Four of the five samples 
hybridised to the K casein probe and gave a band of 7.8 kb as expected (Figure 6.11). However, 
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Figure 6.9: Scoring HPS G  mice for the human 3 casein gene 
EcoRl restriction digestion was performed on genomic DNA from live lines of HP8 mice (lanes 1-5) 
and one wild-type mouse (lane 7), and on a sample of human placental DNA (lane 9). The restriction 
digests were separated on a 1% agarose gel, Southern blotted and hybridised to a human 13 casein intronic 
probe (h13cas8). All of the l-1P8 samples hybridised to the probe. The variation in the band sizes appears 
to be an artifact. 
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Figure 6.10: Scoring HP8 mice for the human a casein gene 
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Figure 6.10: Scoring HP8 mice for the human a casein gene 
The filter from Figure 6.x was stripped and rehybridised to a human a casein cDNA probe. All of the 
HP8 samples hybridised to the probe. giving a band of approximately 6.5 kb. Two additional bands are 
visible in lanes I and 5, which probably represent internal EcoRt sites which are spanned by the a 
casein cDNA probe. 
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Figure 6.11: Scoring HP8 mice for the human K casein gene 
The filter from Figure 6.x was stripped and rehybridised to a human K casein cDNA probe. The expected 
band is 7.8 kb. 97/27.46.4, which failed to express detectable human K casein RNA, gave an aberrant 
EcoRl restriction fragment (lane 4). In lane 2(97/26.10.1) both expected and aberrant bands are visible. 
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in the sample from 97/27.46.4, which did not give detectable human K casein expression, the 
K casein probe detected a band of approximately 10 kb. The simplest explanation for this is that 
the human K casein coding region has become perturbed in this animal, and that the 10 kb band 
spans from the internal EcoRI site at position 1870 within the gene (Genbank accession U51899; 
Figure 6.2) to the next EcoRl site within the transgenic locus. This could be within the YAC or 
within flanking mouse DNA. In addition to the expected 7.8 kb band, 97/26.4.5 gave a very 
faint band of approximately 7 kb. This may reflect a deleted copy of human K casein in this 
animal. Similarly, the Kcasein probe hybridised to an additional band from 97/26.10.1, at 
approximately 6.5 kb. This also presumably indicates the presence of a deleted copy of the gene 
in the 97/26.10 line, which is approximately 2-copy. 
6.8 Discussion 
In this chapter a YAC carrying the human casein gene locus was introduced into transgenic mice 
by pronuclear microinjection. Subsequent analysis of these mice indicated that there was no 
significant expression of the human casein genes. The northern blot data for human P casein 
expression convincingly demonstrate that any expression of the transgenic P casein is 
approximately three orders of magnitude below that of P casein in the human lactating mammary 
gland. Similarly, expression of human a and K casein in the HP8 mice appears to be less than 
1% of that in the human. However, since the sensitivity of the northern blots was less for a and 
K casein than for P casein, the expression of a and K casein was also investigated by RTPCR. 
No expression of human a casein was detected, but in four of five animals some Kcasein 
expression was detected. RTPCR can detect extremely rare transcripts, and indeed the positive 
human RNA controls suggested that the K casein RTPCR was more sensitive than the a casein 
RTPCR. Further work would attempt to quantify this expression and to evaluate more, fully the 
sensitivity of the RTPCR. At present, it can be concluded from the northern blot data that 
human a and K casein RNA abundance is at least 100 fold lower in the HP8 mice than in 
humans. There is some Kcasein expression in four of the five transgenic lines, but 
quantification is impossible without further work. 
Thus expression from the YAC transgenes is negligible in these animals. There appear to be at 
least two possible explanations for this. The YAC might be perturbed in all transgenic mice to 
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the extent that no intact casein gene loci remain. Alternatively, sequences which are essential 
for human casein gene expression might be absent from the HP8 YAC. 
The generation of transgenic mice from YACs is a relatively new technique, having first been 
reported in 1993. At the time of this work, initial reports of YAC transgenes suggested that the 
YAC could be stably maintained and that the functional yeast sequences had no detrimental 
effect on stability in mitosis or meiosis. Furthermore, expression of previously intractable genes 
was possible from YAC transgenes, demonstrating the power of the method of introducing a 
gene embedded within its normal chromatin environment on a large construct. However, a 
growing body of literature suggests that integrated YAC copies are rarely intact. The work 
reported here would seem to offer some support for this view. Five transgenic lines were 
examined with three gene-specific probes and a probe specific for each arm. Only high-copy 
animals possessed all markers. In addition, the ends of the YAC copies were not joined in a 
simple tandem array. Indeed, the data obtained by probing for junction copies within the YAC 
arrays are very confused. The data are most clear in low or single-copy animals and here none 
appear to carry all three markers, indicating that the YACs are perturbed. However, there are 
currently very few data regarding the extent of this perturbation. Transgene arrays in general 
rarely demonstrate perfect tandem repeats (e.g. Clark et al. 1992, various unpublished work at 
PPL Therapeutics); in particular the ends of the transgene copies are frequently deleted to a 
small extent. Therefore, it might not be significant in terms of the overall structure of the YAC 
copies that the transgene-transgene junctions are not as expected (Figure 6.5). Evidence that the 
YAC copies might be intact is similarly inadequate, however. The low-level expression of the 
c casein gene indicates that at this gene is present, although important control sequences appear 
not to be. Further evidence that the YAC is intact in these animals comes from the Southern 
blots probed with the human casein gene probes (Figures 6.9, 6.10 and 6.11), but the fragments 
detected are small and internal to the three genes. Nevertheless, this is evidence that at least 
some internal YAC structure remains in these animals, although in some cases aberrant bands 
are also apparent (Figure 6.11). More detailed Southern blots, especially incorporating PFGE to 
resolve large fragments, would reveal more concerning the structure of the transgene array in 
these animals. 
There are several means by which the HP8 transgenes may have become rearranged. YAC DNA 
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is extremely sensitive to shear, and though polyamines successfully protect large DNA in vitro, 
some shear must still occur. Data referring to the fate of large DNA upon passage through a 
microinjection needle is absent from the literature. In addition, the small volume of DNA 
solution injected into an egg would mean that attached polyamines would very rapidly be diluted 
out. Simple traffic through the cell might then cause shear of the DNA. Several hundred kb of 
naked DNA would represent a large, unusually fragile macromolecule even within the cell, and 
uptake into the nucleus for example might be expected to involve significant shear forces. 
Alternatively, enzymatic action might cause perturbations in YAC sequences. YAC DNA, by its 
very size, can usually be expected to carry multiple repeat sequences such as Alu sequences. 
Recombination between these sequences would fragment the YAC within the cell. Since YACs 
are so much larger than previously introduced transgenes, the risk of inter- and intramolecular 
recombination within the YAC copies must be correspondingly greater. Finally, although the 
mechanism by which exogenous DNA is integrated into the genome of the zygote is not 
understood, it is conceivable that the integration of very large pieces of DNA into a single locus 
might carry with it an increased risk of breakage and repair at that locus. 
In this project there is a further possibility, however. Although in general few problems were 
experienced in preliminary YAC preparations, the batches of YAC DNA which were used to 
generate the mouse lines examined here were not tested by PFGE, due to time constraints and 
the amount of material available. Thus the possibility cannot be ruled out that the YAC was 
fragmented before it was microinjected. Microinjection characteristics of this DNA did not 
differ markedly from those of other YAC preparations in terms of needle blockage and viscosity 
of material (Y. Gibson, personal communication). Nevertheless, it is impossible to state with 
certainty that this YAC DNA was injected in an intact state. 
Thus there are several means by which the HP8 YAC transgenes might become rearranged 
relative to the YAC clone, and this might account for the negligible levels of transgene 
expression in the mice. However, another possible explanation for the expression data reported 
here is that the YAC is essentially intact in the transgenic mice, but does not contain sequences 
which are essential for human casein expression. Although there is evidence of some 
rearrangement of the YAC in the transgenic mice, the evidence is inconclusive and where it 
directly relates to the human casein genes themselves, the majority of the fragments detected are 
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intact (Figures 6.9, 6.10 and 6.11). It is therefore possible that the YAC copies are substantially 
intact but lack vital human sequences. It is also possible that the overall structure of the locus is 
important for human casein expression, such that even large fragments might not express if 
rearranged relative to each other. However, although there are no published reports of human 
casein transgenes, the casein genes of other species are able to direct detectable expression in 
small constructs, albeit at varying levels. As discussed in chapter 7, casein promoters have been 
used to drive expression of both cognate and heterologous transgenes, though expression has 
generally been highly position-dependent and lower than that of the endogenous casein genes. 
This has led to the assumption that there are elements involved in controlling casein gene 
expression which have not been included in the truncated constructs employed to date. 
Rijnkels and colleagues analysed the expression of the bovine casein genes in transgenic mice 
(Rijnkels et al. 1995, 1997d) using cosmids. The 0 casein construct contained 16 kb of 5' and 8 
kb of 3' flank, the a02 construct contained 8kb of 5' and 1.5 kb of 3' flank, while the ic gene was 
flanked by 5 kb of 5' and 19 kb of 3' genomic DNA. Two a, 1 constructs were used, with 10 kb 
of 3' flanking DNA and either 5.4 or 14.2 kb of 5' flank. Expression of the larger a, 1 construct 
was assayed at up to 160% of the endogenous bovine gene at the mRNA level, although the 
smaller construct expressed at less than 2% of endogenous bovine mRNA. P casein gene 
expression was detected at between 0.5 and 40% of endogenous bovine levels at the RNA level, 
while the a,2 and K constructs failed to give detectable levels of expression. 
Comparing this work with the results reported in this thesis, if the assumption is made that the 
human caseins are similar in structure and control to the bovine genes then it is surprising that no 
significant expression was detected in the HP8 mice. The possibility that the HP8 mice harbour 
no human a or P casein gene fragments as large as the bovine cosmids used by Rijnkels et al. 
(1997d) seems unlikely, especially given that the expected restriction fragments were detected 
by the internal gene probes (Figures 6.9 to 6.11). Moreover, the detection of low level human 
K casein expression clearly indicates that intact Kcasein genes are present in these animals. 
Indeed, the fact that the bovine K casein cosmid employed by Rijnkels and co-workers failed to 
express might indicate that quite large gene fragments are present in the HP8 mice, though 
differences between the human and bovine genes might also account for this result. 
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Thus the failure of the HP8 mice to demonstrate any significant human casein gene expression 
remains unexplained. The possibility that the YAC transgenes are perturbed to the extent that no 
sizeable casein gene fragments remain seems small, and yet there is negligible transgene 
expression. In the light of the existing data regarding casein transgenes from other species, this 
is difficult to account for. However, in the absence of published data concerning the human 
casein locus, the possibility that the human locus is inherently refractory to expression in other 
systems cannot be excluded. In support of this, Rijnkels and co-workers (M. Rijnkels, personal 
communication) have attempted to express the human caseins in HC1 1 cells (Ball et al. 1988), 
using the same YAC clone, HP8, as that used here to make transgenic mice. Although the 
experiment was preliminary, no human casein expression was detected in HCI 1 cells. This is 
despite the finding (Rijnkels et al. 1995) that HCI 1 cells express casein constructs which are not 
expressed by transgenic mice, indicating that HC 11 cells might represent a more permissive 
casein expression system. If this result is repeatable,, it indicates either that human casein 
expression is not readily achievable in other systems, or, more likely, that HP8 lacks important 
sequences. Whether this is because HP8 does not contain an unperturbed genomic region or 
because HP8 does not span sufficient human DNA could be tested by the use of other YAC 
clones. 
Further work with these mice would involve quantitative RTPCR and a more detailed analysis 
of the structure of the transgenic arrays. Although technically difficult, this could yield useful 
data and might offer an explanation for the expression data. Peterson et al (1995) were able to 
capitalise on spontaneously-deleted YAC transgenes to study the P globin locus in transgenic 
mice. They isolated a set of transgenic animals in which the YAC had fortuitously become 
deleted such that it mimicked disease genotypes and studied globin expression in these animals. 
It is possible that detailed analysis of the HP8 mice might yield some information about which 
regions of the transgenic casein locus are intact and which are not. If YAC perturbation is 
responsible for the lack of transgene expression, such data might be very informative in terms of 
studying human casein gene expression. 
If YAC perturbation is the reason for the lack of expression in the HP8 mice, a natural 
progression might be to make more transgenic animals in order to obtain a line with intact YAC 
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copies. Two lines of animals generated here remain to be analysed; time constraints prevented 
detailed analysis of all lines. However, if none of the seven HP8 lines proves to harbour an 
intact YAC copy, then in terms of analysing casein gene expression this study will be fruitless. 
Since the generation of transgenic animals represents a significant investment of time and 
resources, some consideration of alternatives is merited here. Transfer of the YAC into cultured 
mammary cells is one option. HC  1 cells express the endogenous murine Ocasein gene 
following induction with prolactin and dexamethasone, and are easily transfected (Ball et al. 
1988). Therefore HCl I cells are an attractive alternative to transgenic animals. At the outset 
the decision was made to pursue transgenic animals as a model system because the full range of 
developmental controls of casein gene expression are not accurately mimicked by cultured cells. 
This view is still valid but must now be weighed against the difficulty of obtaining cells or 
animals bearing intact YAC transgenes. In this context cell culture begins to look more 
attractive as multiple transfected lines are more easily and quickly established and screened. 
However, the selection which is necessary to isolate transfectants remains a problem as this 
might prejudice expression data by skewing the transfected population towards those which have 
integrated the YAC into open chromatin. The marker system of choice is neo (Southern and 
Berg, 1982). Very low levels of the neo gene product are required to provide resistance against 
the aminoglycoside G418 and thus even basal expression of the transgene should be sufficient 
for selection. This, coupled to the relative difficulty of obtaining enough transgenic animals to 
ensure a line with an intact YAC, argues in favour of cultured cells as testbeds for YAC 
expression. However, the control of mammary gland gene expression is highly complex and 
relies heavily on intercellular interactions in vivo, which are necessarily absent from the HC  1 
cell line. Neither do HC1 1 cells express all of the milk genes at appropriate levels in response to 
hormonal induction, further underlining the difference between HC1 1 cells and the mammary 
gland in terms of gene expression. More recently another mammary epithelial cell line has been 
derived, Kim-2 (Gordon et al. 1999), but the case here is much the same. Thus any study of the 
control of milk gene expression in these cells would be subject to significant inaccuracy as an 
indication of the likely behaviour of such genes in vivo. Nevertheless, the speed with which 
large numbers of transfected cell lines may be generated and characterised argues in favour of 
cultured mammary cells as a "first-pass" system for YAC transgene analysis. 
155 
Chapter 6- Human YAC transgenic mice 
Cell-mediated transgenesis is another option. YACs may be transferred into ES cells and thus 
give rise to transgenic mice (Jakobovits et al. 1993). As discussed in the introduction to this 
chapter, the DNA may be transfected into the ES cells or introduced by spheroblast fusion. 
Since the incorporation of additional DNA may prejudice this study, spheroblast fusion is not an 
attractive option. Transfection of purified YAC DNA would be preferable. Compared to 
microinjection, this method does not increase the chance of integrating an intact YAC. 
However, characterisation of the transgene array in transfectants prior to implantation would 
facilitate isolation of lines carrying intact YAC transgenes. 
In the event that the YAC was found to be substantially intact in the HP8 transgenic mice, the 
alternative explanation, that HP8 does not contain all of the sequences necessary for human 
casein transgene expression, would be explored. Generation of transgenic mice or cell lines 
harbouring other YAC clones spanning the human casein locus would be a first. step in this 
process. Detailed analysis of HP8 itself might also be informative, since current data indicate 
that it represents a genuine genomic region (M. Dalrymple and A. Tomlinson, unpublished; 
Rijnkels et al. 1997d). If a minor rearrangement of HP8 relative to the human genome has 
resulted in the low expression seen here, any data regarding the nature of the change would be 
highly informative. 
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7. Chapter 7— Discussion 
7.1 Casein gene expression 
In this project an attempt was made to study the expression of the mammalian casein genes in 
the context of the intact locus on a YAC. The mammalian milk protein genes have long 
attracted attention as a model system for studying the developmental control of gene expression. 
The transition from virgin to lactating mammary gland is accompanied by considerable tissue 
remodelling and changes in gene expression in response to multiple endocrine signals. In 
particular, the milk proteins are largely undetectable in the virgin gland but are stimulated by 
two to three orders of magnitude over the course of pregnancy and lactation (Rosen 1987) before 
disappearing below the threshold of detection again at involution, which is accompanied by 
another round of tissue remodelling. Thus the mammary gland provides an opportunity to study 
profound developmental changes in gene expression in postnatal animals. 
The caseins are the major milk proteins, making up approximately 80% of the protein in bovine 
milk. In mice 0 casein mRNA makes up approximately 50% of the mRNA in the lactating 
mammary gland (Mercier and Vilotte, 1993). This represents a considerable potential for gene 
expression. Since the mammalian mammary gland is a popular target for the expression of 
proteins in transgenic animals, there is considerable interest in the milk protein genes as vehicles 
for directing high levels of expression of heterologous proteins to the lactating mammary gland. 
As the most active transcription unit in the mouse lactating mammary gland, the 0 casein gene 
has been studied extensively. 
In mice 0 casein mRNA is undetectable in the virgin mammary gland, reaching the threshold of 
detection by mid-pregnancy and increasing to a maximum at mid-lactation (Rijnkels et al. 
1997a). The levels of casein protein have previously been shown to follow those of mRNA, and 
the changes in steady-state mRNA levels to result from changes in transcription rates, 
demonstrating that the primary control of casein gene expression is vested at the level of 
transcription (reviewed by Mercier and Vilotte, 1993), although there is also some evidence of 
post-transcriptional control (Eisenstein etal. 1988; Altiok and Groner, 1993, 1994). 
Transcription of the calcium-sensitive casein genes is regulated by a synergistic combination of 
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peptide hormones, growth factors and the basement membrane (Topper and Freeman, 1980; 
Taketani and Oka, 1983; Bissel and Hall, 1987; Streuli et al. 1991; Roskelly et al. 1994; 
reviewed by Mercier and Vilotte, 1993). Work with milk protein gene promoters in transgenic 
and tissue culture systems has elucidated some of the molecular mechanisms of this regulation. 
A large number of deletion studies involving chimaeric constructs have resulted in a broad 
consensus concerning the structure of the calcium sensitive casein gene promoters. The MGF 
consensus binding site was identified for the so-called mammary gland factor (MGF; Schmitt-
Ney et al. 1991; Watson et al. 1991; Wakao et al. 1992) which was later included in the 
cytokine-regulated transcription factor family and renamed stat5 (Gouilleux et al. 1994; Wakao 
et al. 1994). This binding site is essential for the induction of transcription in response to 
prolactin (Wakao et al. 1994), but this function also requires a second, more distal element 
(Pierre et al. 1994). 
A highly conserved region in milk gene promoters is the "milk box" (Laird et al. 1988) which is 
located at —140 to —110 of the mouse Ocasein gene. This region is necessary for hormonal 
induction of milk gene expression by an apparent relief of repression (Schmitt-Ney et al. 1991). 
By a combination of tissue culture and gel-retardation assays, it was determined that the 
ubiquitous transcription factor YYI (Shi et al. 1991) is involved in this repression, and that in 
response to lactogenic hormones YYT is released, leading to the formation of a activating 
transcription factor complex at the milk box, which has been termed the lactation associated 
complex (LAC; Raught et al. 1994). 
The glucocorticoid response of the fasein promoter appears to involve synthesis of a the 
CIEBP protein and binding of CIEBP to an overlapping MGF/CIEBP consensus binding site 
within the milk box (Raught et al. 1995). This region has been named the composite response 
element or CoRE and is conserved in casein promoters of all species (Raught et al. 1995) 
although the exact structure (overlap) of the composite elements varies between casein genes. 
Thus the proximal promoter of the calcium-sensitive casein genes is highly conserved and 
contains CoRE regions which allow synergistic interaction of hormone signals to control the 
transcription of the genes during pregnancy and lactation. However, over the course of these 
studies, and in attempts to use casein promoters to drive heterologous protein production in 
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transgenic animals (see chapter 1), it has been noted that in general expression from all casein 
promoters has been low compared to the endogenous genes. Tissue and developmental-
specificity of casein gene expression is conferred by the proximal (-1.5 kb) promoter, but high-
level position-independent expression has not been achieved. This has led to the assumption that 
there are elements involved in controlling casein gene expression which have not been included 
in the truncated constructs employed to date. It has been shown that introns within the 3 casein 
gene enhance transcription (see chapter 1). Studies at PPL Therapeutics involving a BLG 
expression vector including intron 1 of the bovine 0 casein gene have shown a considerable 
increase in the expression and the frequency of high expression of linked transgenes 
(unpublished results). However, expression levels are still below those of the endogenous genes 
and position-dependent. 
In an attempt to study the expression of casein genes in a more natural context than that 
employed in experiments involving chimaeric constructs and cultured cells, entire casein genes 
have been introduced into the germline of other species. Rijnkels and colleagues analysed the 
expression of the bovine casein genes in transgenic mice (Rijnkels et al. 1995, 1997d; see 
Section 6.8), and obtained significant expression (up to 160% of endogenous bovine at the 
mRNA level) from two of the four genes using relatively large constructs (30-40 kb) in cosmid 
vectors. However, expression was again highly variable and not related to copy number, 
although higher than previously reported for chimaeric casein gene constructs. Nevertheless, the 
expression remains position-dependent even in the presence of large genomic constructs. 
In summary, casein promoters have been used with some success to direct cognate and 
heterologous gene expression to the transgenic mammary gland and in cultured cells. Correct 
developmental regulation of casein gene expression has usually been achieved, and seems to 
follow that of the source rather than host species. However, in transgenic animals expression is 
always position dependent, even with large genomic constructs. The simplest explanation for 
this is that there are functional elements at the endogenous casein gene locus that have not been 
included in individual gene constructs. 
Since the regulatory elements responsible for high-level expression of the casein genes have so 
far eluded discovery via plasmid and cosmid constructs, a YAC-based strategy was indicated. 
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YAC inserts are commonly 400-2000 kb in size, and YACs of up to 800 kb have been 
introduced into transgenic mice. Therefore the decision was taken in this project to generate 
transgenic mice carrying an entire casein locus on a YAC. This approach has been fruitful in 
the discovery and study of long-range control elements in other loci (Schedi et al. 1993a; 
Montoliu et al. 1995; Peterson et al. 1997). To maximise the probability of introducing 
functional elements on the YAC, a mouse YAC was sought. It was envisaged that this would 
present problems in detecting expression from the transgenic YAC, since the transgenic and 
endogenous casein transcripts and proteins would be indistinguishable. The most subtle change 
to a YAC would have been to introduce a small mutation such that RNA could be detected 
against a murine background. However, a practical goal in this project was to enhance 
expression of heterologous constructs in the transgenic mammary gland. cDNAs are often 
introduced into transgenic animals owing to their ease of isolation and small size, or to the 
occasionally prohibitive size of the corresponding gene. However, eDNA expression is 
generally very low in transgenic mice, and is moreover subject to severe position effects and 
PEV. In the mammary gland some rescue of this expression is possible if the cDNA construct 
incorporates introns from another gene or is co-injected with the ovine BLG gene (Brinster et al. 
1988; Clark et al. 1992), but in general cDNA expression is still very poor compared to that of 
genomic constructs. It was hoped that the active 0 casein locus would potentiate expression of 
an inserted cDNA or minigene construct, and for this reason the protein CIBLG minigene 
construct pCorp3 was chosen as a reporter to be used to modify the mouse casein YAC. In a 
parallel experiment pCorp3 was targeted to the endogenous 0 casein locus via ES cells (A. Kind, 
unpublished) which was anticipated as a control for the YAC experiment. 
7.2 Mapping and manipulation of the murine casein YACs 
The ICRF YAC library (Larin et al. 199 1) was screened with two genomic mouse 0 casein 
probes, and after screening of 15 0 casein YAC clones four were identified which also 
hybridised to cDNA probes for murine a, y Land Kcasein. Two of these, MP14 (380 kb) and 
MP12 (430 kb), were restriction mapped. This was important to assess the integrity of the 
YACs in these two clones as well as to characterise them before further work. YAC clones are 
often chimaeric or otherwise rearranged relative to the genome; comparison of a YAC clone to 
genomic DNA is therefore a common first step in characterising the YAC. However, a more 
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rapid method was devised based on the YAC restriction mapping protocol of Hamvas et al. 
(1994). It was reasoned that if two independent YAC clones overlap extensively, and within the 
region of overlap are collinear, the likelihood that either is rearranged must be very small. This 
approach was taken with MP12 and MP14 in Chapter 4. The two YACs were restriction 
mapped by partial restriction digest and hybridisation to YAC end probes. The YACs overlap in 
a central region of approximately 360 kb, and within this region are collinear. The possibility of 
gross rearrangements within either YAC was thus discounted. 
The casein genes were positioned on the map of these two YACs by a combination of partial and 
complete restriction digest. Where possible the same Southern blot was reprobed in an attempt 
to avoid gel-to-gel variation, which in PFGE can be considerable. However, the accumulation of 
noise on the filters reduced the quality of the data somewhat, although the map could still be 
generated with confidence. Further work would address the quality of these data by repeating 
some of the blots. 
The bovine casein locus had been mapped at the start of this project (Ferretti et al. 1990; 
Threadgill and Womack, 1990). Since the mapping work described here (this thesis; Tomlinson 
et al. 1996) further reports of the human (Rijnkels et al. 1997b) mouse (George et al. 1997; 
Rijnkels et al. 1997a) and bovine (Rijnkels et al. 1997d) have been published. A comparison of 
these maps is made in chapter 6. In general the structure of the locus appears conserved across 
the taxa. However, in humans there are three casein genes, while cattle have four and mice have 
five. This is not indicative of a high level of conservation of the structure of the locus. 
Nevertheless, the basic spatial organisation of the genes is maintained, and no species has been 
found to harbour more than one K—like casein gene. It has been suggested that the casein genes 
are under locus control (Alexander et al. 1988). This is based on the conserved structure of the 
locus but also on the linkage of K casein. Kcasein is structurally unrelated to the calcium-
sensitive caseins of the a and P types. It appears that K casein is related to y fibrinogen, to which 
it is genetically linked in pigs. In other taxa the linkage with yfibrinogen is much reduced, 
while the linkage to the caseins is conserved. Thus K casein appears to share a common ancestor 
with y  fibrinogen, but to have been recruited to the casein family. The physical proximity of the 
K gene to the other casein genes lends credence to the notion of a casein LCR. 
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Once the munne casein YACs had been characterised and found to represent unrearranged 
regions of the mouse genome, MP14 was chosen for further work. As discussed in chapter 5, 
pCorp3 was chosen as a reporter gene to be inserted into MP14 in order to follow expression 
from the YAC in transgenic animals. This necessitated a succession of yeast manipulations. 
Unfortunately, these manipulations did not proceed smoothly. The MP14 YAC repeatedly 
rearranged when manipulated. In particular, targeting of the pCorp3 construct to the right arm of 
MP14 resulted in fragmentation of the YAC such that no full-length clones were recovered. 
This may have been due to a repeat element within pCorp3 recombining within the YAC. A 
second attempt to insert pCorp3 into the YAC was aborted due to lack of time. This second 
attempt was based on a two-step gene targeting strategy, which was conceptually flawed, 
resulting in delays to the project. In retrospect a pop in-pop out (PIPO) strategy would be far 
more efficient. This highlights what must be considered a recurrent lesson from this project, 
which is that work with YACs is technically demanding and requires a background of yeast 
expertise. At the start of this project YACs were chosen as the large cloning system of choice, 
and it was felt that their ease of manipulation, particularly by homologous recombination, was a 
great advantage. This is certainly true, but the corollary is that YAC clones tend to recombine 
spontaneously and in unexpected ways, necessitating vigilance and care in their maintenance and 
manipulation. The acquisition of the knowledge and skills required for effective work with 
YACs took longer than anticipated. Despite this, MP14 was modified to carry HIS3 instead of 
URA3 on the right arm of the YAC following transfer into a his3 host strain by classical mating 
and random sporulation. The URA3 counterselectable marker was then removed from the right 
arm of the YAC (replaced by H!S3) and reintroduced 3' to the polyadenylation site of the 
casein gene in MP14. It was at this point that the second targeting step, replacement of URA3 
with pCorp3, foundered. Had this targeting been achieved, MP14 would have been 
microinjected to generate transgenic mice, and also transfected into a murine mammary 
epithelial cell line, to study expression of the reporter construct from within the YAC. 
7.3 Human casein YAC transgenic mice 
Since the work with the murine casein YACs did not allow generation of transgenic animals 
within the period of this project, an alternative was sought. The human casein YAC HP8 was 
kindly provided by M. Dalrymple. This clone had been obtained from the ICRF human YAC 
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library (clone number ICRFy9O1CO518) and had been shown to represent an unrearranged 
portion of the human genome (Rijnkels et al. 1997b; M. Dalrymple and A. Tomlinson, 
unpublished). This YAC was therefore gel-purified and microinjected into fertilised mouse 
oocytes. By screening with either a TRPJ or f casein probe 9 transgenic founders were 
obtained, of which 7 transmitted the YAC markers in the gennline. Five lines were analysed for 
human casein expression by northern blot. No expression was observed within the limits of the 
assay, which admittedly was only sensitive to about 1% of endogenous mouse casein expression. 
a and iccasein expression was then investigated by RTPCR, which is more sensitive. No 
a casein RNA was detected. In contrast, K casein gene RNA was detected in 4 out of the 5 
transgenic lines. A Southern blot revealed the K casein gene in the non-expressing line to be 
rearranged. 
The structure of the transgene array in the mouse lines was not studied in detail. A preliminary 
Southern blot (Figure 6.5) suggests the structure of the YAC junctions within the multi-copy 
arrays to be complex and not as expected. However, this experiment was not primarily intended 
to study the transgene junctions and the gel conditions were inappropriate for resolution of the 
relevant bands. Additionally, rearrangement and deletion at the ends of transgenes is common, 
and does not necessarily indicate perturbation elsewhere within the array. Nevertheless it is 
possible that the YAC was rearranged in these lines. YAC transgene fragmentation can result 
from a number of possible mechanisms which in this case must include fragmentation during 
preparation (see chapter 6). Due to pressures of time and availability of purified material, the 
YAC DNA which was used to generate the mice analysed in this thesis was not tested for 
integrity. In general, little fragmentation has been observed to occur during YAC preparation, 
and during injection this material exhibited characteristics of high molecular weight DNA. 
Nevertheless the integrity of this YAC preparation prior to injection was not defined, an 
omission which may have prejudiced the outcome of the experiment. It could also explain the 
rather low transgenic frequency observed, which could reflect the presence of other lines 
carrying different YAC portions from those assayed for. 
No significant expression of the human casein genes was observed in these mice. Although 
K casein mRNA was detected by RTPCR the northern blot suggests that this is some two orders 
of magnitude less abundant than the endogenous murine K casein mRNA. One explanation for 
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this would be fragmentation of the YAC. However, significant levels of casein gene expression 
have been obtained by others with small constructs, and the K genes at least are intact in four out 
of five of the HP8 mouse lines. There is only one report of a human casein transgenes, and this 
describes the expression of human t3casein in transgenic potato plants under the control of a 
mannopine synthase promoter (Chong et al. 1997). However, the expression of the caseins of 
other species has been studied in cell culture and transgenic animals (Sections 6.8 and 7.1). In 
general, although expression has been low compared to the endogenous genes it has been 
detectable, and should have been within the limits of detection of the northern blots described in 
Figure 6.6, especially in the case of 0 casein. Thus casein gene expression has been seen from 
constructs of a few tens of kilobases. That disruption of the HP8 YAC DNA could have 
produced no calcium-sensitive casein gene fragments in excess of this seems unlikely. Other 
possible explanations for the expression data might include small changes in the YAC relative to 
genomic human DNA that are not detected by PFGE but disrupt gene expression. Alternatively 
the YAC might not contain sequences which are crucial to expression of the human caseins. 
Although from work with other casein genes this would be unexpected it is conceivable, and no 
human casein transgenes have been reported in animal systems. As described in Section 6.8, 
Rijnkels and co-workers have introduced HP8 into HC  1 cells and could detect no expression, 
but this experiment was preliminary and has not been repeated. 
7.4 Further work 
The mouse lines generated in this project do not express significant levels of human casein 
mRNA. In light of this further work with these lines would be confined to analysing the 
transgene arrays and quantifying the low levels of human casein mRNA which were observed. 
The RTPCR performed here was not quantitative. A quantitative or semi-quantitative RTPCR 
would yield more informative data concerning the level of human K casein mRNA in these mice. 
Truly quantitative RTPCR is difficult to achieve without access to specialised equipment, but 
semi-quantitative RTPCR merely requires careful optimisation and control. Although the levels 
of human iccasein RNA detected here were certainly below 1% of that of the endogenous 
murine mRNA, they may still be significant and amenable to quantification relative to copy 
number. In addition, the expression level of the 0 and a casein genes will be reinvestigated by 
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RTPCR, with some quantification as to the sensitivity of the assay. 
Further restriction analysis of the HP8 transgenic array is also warranted. Initially the junctions 
of the YAC copies would be examined in more detail to clarify the results presented in Chapter 
6. PFGE and Southern blotting could yield further information about the structure of the array 
as a whole. However, interpretation of such data is problematic. It should also be feasible in 
principle to observe the transgene array directly by extended fibre FISH, which is able to resolve 
to 10 kb or more. In combination with standard FISH of interphase nuclei this might be 
expected to yield detailed information about the structure of the YAC copies in these animals. 
However, the considerable cost and effort involved in this type of work would render it 
inappropriate for study of these mice. A more reasonable approach might be to simply generate 
additional lines of mice from intact purified HP8 YAC DNA. In addition, the introduction of 
rare-cleavage restriction enzyme sites into the ends of the YAC (Peterson et al. 1995) would 
allow testing for intact YAC copies by PFGE and Southern blotting. This procedure seems to 
facilitate YAC transgenic experiments to the point where its inclusion in future work would be a 
certainty. 
Given the problems associated with YAC transgenes, it might also be prudent to examine 
alternative systems in which to characterise the expression of the caseins on a YAC. In general, 
work with cultured cells provides an alternative or complement to work with transgenic animals. 
However, as discussed in chapter 1 and above, the. behaviour of cultured cells does not 
accurately mimic that of the source tissue, particularly in cases where intercellular interactions 
are important factors in vivo; in vitro these interactions are necessarily disrupted. HC  1 cell& 
were derived from less readily-cultured mammary cell lines by selection for cells which could 
grow without interaction with extracellular substrata or other cell types (Ball et al. 1988). 
Further to this, the observation by Rijnkels et al. (1995) that bovine a, 2 and Kcasein cosmid 
constructs were expressed in HCI 1 cells but not in transgenic animals suggests that some levels 
of casein gene control are not active in cultured mammary cells. 
These results and prior observations of the discrepancies between cultured cells and transgenic 
animals in the behaviour of specific constructs (notably cDNAs) have recently been added to by 
suggestions that developmentally-regulated chromatin structures are not faithfully reproduced in 
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differentiated cell lines. Skarpidi et al. (1998) report the transfection of a yglobin gene linked to 
the 3 globin miniconstruct (the so-called micro LCR, 1iLCR) into MEL cells. This construct had 
previously been expressed position-independently in transgenic mice (Stamatoyannopoulis et al. 
1993, 1997). Although pools containing large numbers of clones exhibited average gene 
expression patterns similar to those of transgenic mice, they saw no correlation between copy 
number and globin gene expression when small pools or individual clones were examined. 
Peterson et al. (1993a) introduced a 248 kb Pglobin YAC into MEL cells. To overcome 
technical difficulties experienced when attempting to directly transfer the YAC into MEL cells, 
it was first transferred into non-committed L cells (Gnirke et al. 1993) and then these cells were 
fused with MEL cells (Peterson et al. 1993a). Once in MEL cells the globin genes were 
faithfully expressed independent of the position of integration, and showed a developmental 
switch from the foetal genes expressed in the L cells to adult genes in the MEL/L hybrids. In 
contrast, a subsequent experiment which successfully transfected a 155 kb Pglobin YAC into 
MEL cells directly resulted in widely varying globin gene expression levels per YAC copy and a 
random pattern of activation of the genes over time (Vassilopoulos et al. 1999). However, when 
the 155 kb YAC was transfected into L cells as before and then introduced into MEL cells by 
cell fusion, expression was once again position independent and properly regulated over time. 
This result is striking in that it casts serious doubt over the validity of differentiated cells lines to 
study developmentally-controlled gene expression per Se. It may be that the globin locus is 
unique in this requirement for an undifferentiated chromatin environment in order to develop 
normally. However, the globin locus is perhaps the most intensively studied in terms of gene 
expression, and it is conceivable that new insights gained here will be applicable at other loci. 
At the very least, this result and that of Skarpidi et al. (1998) underscore the caution with which 
results gained in vitro must be interpreted. 
One considerable advantage of tissue culture is that it allows the relatively rapid generation of 
numerous lines harbouring a YAC, which may then be screened for an intact YAC copy. One 
way to combine this advantage with the undoubted superiority of transgenic animals as a model 
system would be to introduce a YAC into mice by cell-mediated transgenesis. In mice this is 
readily achievable via lipofection of ES cells (Choi et al. 1993; Lamb et al. 1993; Pearson and 
Choi, 1993; Strauss et al. 1993; Lee et al. 1996). If the YAC was modified to carry rare 
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restriction sites at each end (above), screening of transfected clones by restriction digest would 
allow mice to be generated only from those clones harbouring intact YAC copies. 
The mapping data reported in this thesis are largely in agreement with those reported elsewhere 
(Rijnkels et al. 1997a; George et al. 1997). However, there are some discrepancies. Further 
work would be required to resolve these. In particular, probing partial restriction digests of 
MP14 and MP12 with the RA probe would be desirable to ask if any of the discrepancies 
between the maps are due to the small region of the RAI probe used here that hybridises to the 
left arm of the YAC. Additional digests would also aim to more accurately define the limits of 
the e gene and confirm the orientation of the genes reported elsewhere. 
With more time, the targeting of MP14 would be attempted again, but with a PIPO construct. A 
PIPO construct has already been made, but it did not prove possible to use it within the time 
allowed. The construct targets the reporter eGFPJ (Clontech) to the mouse P casein locus using 
URA3 as the selectable marker. The insertion of eGFPJ into the (3 casein locus would facilitate 
the rapid study of gene expression from the YAC in the HC 11 mammary epithelial cell line. 
However, given the limits of cell culture described above, a PIPO vector targeting pCorp3 or 
another suitable reporter would also be constructed, so that the original goal of introducing the 
murine casein gene locus into mice might be fulfilled. The use of pCorp3 was based on a 
parallel experiment targeting pCorp3 to the endogenous murine casein locus. This experiment 
successfully replaced the murine f3casein gene coding region with the pCorp3 construct. 
However, expression of the transgene was poor, leading to the detection of 1 7.igIml of human 
protein C in the milk of these animals (A. Kind, unpublished results). Although this represents a 
two-fold improvement in per-copy expression level over the best seen in transgene rescue 
experiments (Table 5. 1),. it is considerably lower than the best total protein level achieved by 
rescue, which was approximately 57 .tg/ml. Thus the high rate of transcription of the (3 casein 
gene is not necessarily acquired by a heterologous replacement in the (3 casein locus. 
Unfortunately the second targeting experiment which aimed to insert pCorp3 downstream of the 
(3 casein gene was unsuccessful. The attraction of replacing the (3 casein gene with pCorp3 in 
MPI4 is diminished by these results. The insertion of pCorp3 downstream of the (3 casein gene 
might still yield interesting data, but a more definitive test of the YACs ability to behave as an 
intact locus would be to modify it as little as possible, so that any difference between the YAC 
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expression pattern and that of the endogenous murine locus could not be attributed to the 
structural changes made to the YAC. Point mutations allowing discrimination of the 
endogenous and transgenic mRNAs would be the most attractive prospect. 
7.5 Summary 
Two YACs harbouring all five murine casein genes were isolated from the ICRF genomic mouse 
YAC library. These two clones were mapped by restriction digest and Southern blot, generating 
the first reported physical map of the mouse casein locus. The locus covers 260 kb and contains 
the murine casein genes in the order a—f3—y—E—K. The P casein gene is transcribed towards the 
a gene. The map generated here broadly agrees with maps generated elsewhere (Rijnkels et al. 
1997a; George et al. 1997) and shows the gross structure of the casein locus to be conserved 
across mammals. 
The collinear maps of the two mouse casein YACs preclude the possibility of gross 
rearrangement within either. One, MP14, was manipulated to attempt to place a protein C 
reporter construct within the P casein locus. The YAC was transferred to a his3 strain by mating 
with yPH500 (Sikorski and Hieter, 1989) and random sporulation. The URA3 gene was 
removed from the right arm of the YAC and reintroduced 3' to the P casein gene as the first step 
in a two-step gene replacement strategy. However, the second step was unsuccessful, and was 
realised to be flawed. The selection against URA3 in the second step would be expected to yield 
large numbers of spontaneous revertants such that those clones arising as a result of the desired 
replacement event would be difficult to isolate. Within the time allowed it did not prove 
possible to make any further progress with this strategy. A better strategy would have been to 
use the more efficient pop in-pop out (PIPO) method. 
An attempt was also made to directly insert the protein C reporter into the right arm vector 
sequence of MP14. However, the transformation of the yeast cells with the targeting construct 
resulted in gross deletions within the YAC, probably due to recombination of the targeting 
construct with the YAC DNA at several internal sites which may be repeat sequences. 
The human casein YAC HP8 had been previously characterised and shown to contain an 
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unrearranged region of the human genome including 400 kb of the human casein locus, 
containing the three human casein genes a, P and K, in a similar organisation to the murine and 
bovine genes. This YAC was gel-purified and used to generate transgenic mice by pronuclear 
microinjection. Of five transgenic lines analysed, none expressed detectable human a or 
casein mRNA. Four out of five lines expressed human K casein mRNA which was detectable 
by RTPCR. The non-expressing line appeared to harbour a rearranged copy of the K casein 
gene. Southern analysis suggested that the YAC transgene arrays might be rearranged, but was 
inconclusive. The expression of K casein suggested that some significant YAC fragments are 
intact in the HP8 transgenic mice. 
Further work would include more detailed analysis of the murine casein locus by Southern blot 
of conventional and pulsed field gels to resolve certain discrepancies between the three 
published maps of the locus. The manipulations of the mouse YAC would be repeated but by 
the PIPO method, and possibly to make a more subtle change to the locus, since the 
incorporation of the protein C reporter construct into the endogenous mouse P casein gene by 
gene targeting resulted in low expression levels (A. Kind, unpublished). 
The transgenic mice will be more thoroughly characterised to attempt to gain information about 
the structure of the transgene array and ask if the lack of appreciable gene expression can be 
attributed to the fragmentation of the transgene in all lines. To continue the investigation of this 
locus in transgenic mice, more animal lines would be generated using a modified version of HP8 
bearing rare restriction enzyme sites on each end, such that screening for animals with intact 
YAC copies would be simplified. The feasibility of cell-mediated transgenesis would be 
investigated, as screening of ES cells prior to their transfer into blastocysts would allow intact 
YAC transgenes to be identified before the generation of mice. 
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The caseins are the major mammalian milk proteins (reviewed by 
Mercier and Vilotte 1993), constituting a dietary supply of amino 
acids and calcium to the infant. In the presence of calcium, the 
so-called calcium-sensitive caseins of the a and 13 types form 
loose, non-crystalline aggregates termed micelles, which are sta-
bilized by calcium-insensitive K casein. In the gut the site-specific 
cleavage of K casein by rennin causes the milk to clot and remain 
in the stomach, facilitating digestion. The caseins are encoded by 
a small gene family, which in cows and sheep Consists of four 
members. a,, 13, a 2 , and K, and in mice and rats five, a, 13, y, e, 
and K (Yu-Lee and Rosen 1983; Jones etal. 1985: Thompson etal. 
1985). The casein genes all map to a single chromosome in ro-
dents, sheep, cows, humans, and pigs (reviewed by Mercier and 
Villotte, 1993) and are very tightly linked genetically. All four 
bovine casein genes have been mapped to a single 250-kb locus 
(Ferretti et al. 1990: Threadgill and Womack 1990). This close 
linkage might be expected in the case of the evolutionarily closely 
related calcium-sensitive caseins, but there is no evidence that K 
casein is evolutionarily related to the other caseins. Both in se-
quence homology and protein function it appears to be related to y 
fibrinogen (Jolles et al. 1974; Thompson etal. 1985; Alexander et 
al. 1988), which performs a cleavage-induced clotting function in 
blood similar to the clotting function of K casein in the stomach. 
Therefore, the proximity of the bovine K casein gene to the other 
casein genes is noteworthy. 
Two yeast artificial chromosome (YAC) clones bearing the 
five murine caseins were obtained by screening the Imperial 
Cancer Research Fund mouse genomic YAC library, primarily 
with two genomic probes for murine f3 casein as described (Cox 
et al. 1993) and secondarily by screening 13 casein-positive clones 
with cDNA probes for murine a, 'y, €, and K casein, by colony 
hybridization and pulsed field gel electrophoresis (PFGE). The 
two clones are ICRFy9O2GO78I, renamed MP12. and 
ICRFy9O2CI 1116, renamed MP 14. MP 14 is approximately 380 
kb in size, and MP12 is approximately 435 kb in size, as deter-
mined by PFGE and Southern blotting (data not shown). 
A restriction map of the two YACs was generated by partial 
digestion with PmeI. Sail, Xhol and Clal, and probing a single 
filter with probes specific to the left and right arms of pYAC4 (LA 
and RA: Fig. 1). The restriction fragments detected by LA and RA 
are listed in Table I. When the MPI2 and MPI4 P,nel band 
patterns are represented as maps, the two maps can be aligned so 
that the 121-kb MPI4 band is lined up with the 105-kb MPI2 
band. The alignment is almost perfect over the region of overlap, 
varying by less than 5 kb. By this analysis, the 26-kb MP I4 band 
should fall some 10 kb from the left telomere of MP 12 and there-
fore give a band in the MP12 lanes, but, given that there are 6 kb 
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Fig. 1. Southern blot analysis of MPI4 and MPI2. Yeast genomic DNA 
was prepared in 0.8t° InCert agarose and digested with restriction enzymes 
essentially according to Hamvas et al. (1994), with the exception that 20 
units of each enzyme were used in a volume of 200 p.1,  reactions were 
carried out for 30 min for partial digests and overnight for complete di-
ge.sts, and reactions were stopped by placing on ice. PFGE was carried out 
in a CHEF DRII apparatus (Bio-Rad) with 1% Rapid Agarose (Life Tech-
nologies) cast and run in 0.5x TBE buffer. Running conditions were 200 V, 
14°C. with switching ramped linearly from 5.0 s to 30.0 s. Gels were 
stained, photographed, blotted, probed. and stripped according to standard 
procedures. 1200 mJ/cm 2 UV (254 nm) light were used to nick the DNA 
before blotting. The probes for the left (LA: panel A) and right (RA: panel 
B) arms of the YACs were the two fragments generated by digesting 
pBR322 with Pvull and EcoRl. 13  casein probes were generated by poly-
merase chain reaction (PCR) from genomic murine DNA, with the follow-
ing primers (upper, then lower): 5' (M13C5'): GACTTGACAGCCAT-
GAAGGTCT and CGACGTTTATGGAGTCTCCTTC: 3 (M f3C3'), 
GGAGACACTCCTFAAGAACACT and CAGATTCTCCTAAAGGTC-
CAAT. Other casein probes were generated from murine lactating 
mammary gland RNA by reverse transcriptase PCR (RTPCR) with the 
following primers: a casein, GCAGTTCGCAGTCAAACTCAGC and 
CACTGACCTGGGAGGTAAGAGG: -y  casein, AGCAATACAT-
CTCCAGTGAGGA and TGACAGAAGTGAAGACGAGGGT: K casein. 
CAGATTCAAACTGCCGTGGTGA and GTCTAGAAAGAG-
CAGAAGGGAA. 
of vector sequence at this end, it is possible, within the accuracy of 
the blot below 48.5 kb, that MP 12 does not contain this PmeI site. 
Because of the gel conditions and the markers used in this gel 
(X concatemers), the accuracy of the blot is compromised below 
48.5 kb. 
The Sail, XhoI and ClaI patterns were treated the same way, to 
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Table 1. Restriction fragments detected by LA and RA probes. 
Probe 	YAC 	Pntel 	 Sail 	 XhaI5 	 CIa! 
LA 	MP14 26, 121, 179. 206. 279. 350. 59. 85, 251. 293, 350, 381 28. 114 23. 92, 124. 137, 154. 167, 
381 210, 382 
MP12 105. 164. 193. 265. 336, 381, 41, 70, 236, 276, 343. 437 3, 102, 124, 159. 206. 286, 78, 109. 122. 139, 152, 195. 
437 327 437 
RA 	MP14 22, 98. 164, 196, 251. 365c, 20, 88, 126. 293. 322, 381 3 3, 23, 161, 172, 206, 221. 240, 
381 253, 289, 355. 382 
MP12 77, 116, 179, 249, 281, 343, 8, 65. 74. 90. 109. 168, 206, 23, 119. 156, 233, 283, 323w. 23. 100. 114, 242, 255, 295, 
437 377. 402g, 437 351. 437 307, 320, 340, 370,r.  437 
Fragments denoted as less than 50 kb are below the limit of resolution of the gel. 
XhoI digest of MPI4 was excessive, leading to incomplete partial band pattern. 
Bands that are faint in Fig. I but clearly discernible on the original autoradiograph 
generate a four-enzyme map of the locus from the LA autoradio-
graph. The same was done for the RA band patterns, and then the 
two maps were aligned about a central site: the PmeI site 206 kb 
from the left arm of MP 14 was chosen arbitrarily and aligned with 
the PmeI site 249 kb from the right arm of MPI2. The agreement 
between the two maps is almost perfect with an error of about 5-10 
kb. but with the following ambiguities: the Xhol site at 220 kb was 
positioned at 230 kb by the RA map, but at 215 kb by the LA map 
(this was the only site that diverged to this extent between the two 
maps): the pattern of MPI4 bands cut with Xhol was incomplete in 
this gel owing to over-digestion, but the MP 12 XhoI digest allowed 
the map to be generated. with good agreement between the LA and 
RA band patterns: RA detected a C/at doublet in MPI4 and MP12, 
at 200 kb and 210 kb in Fig. 2. but only a single diffuse band could 
be discerned in the LA pattern. The RA autoradiograph is clearer 
than the LA autoradiograph, so this doublet is considered to be 
genuine. The collinearity of MP12 and MPI4 precludes the pos-
sibility that either YAC is rearranged or chimeric. 
The same filter was then probed with the probes for the other 
caseins, in order to map their locations within the YACs. Another 
blot was generated (not shown) from complete single and double 
digests to confirm the partial digest results. 
a and P casein probes map to the same 65-kb C/al fragment in 
partial digests. In complete digests, a casein maps to a 25-kb Sail 
fragment, while MC5' maps to a 165-kb Sall fragment. Mj3C3' 
detects both of these fragments. Taken together, these data indicate 
that a casein lies between the Sail sites at 60 and 85 kb in Fig. 2 
and that f3 casein spans the Salt site at 85 kb and is transcribed 
from right to left in the YAC. 
casein was positioned primarily on the basis of partial Patel 
digests. but these data alone were inconclusive. Confirmation was 
provided by the detection by the -y  probe of identical Pmel and 
PmelJSalI complete digestion fragments of 65 kb; the minimal 
fragment detected by 'y is a 15-kb C!aI-PmeI fragment which 
maps between the sites at 165 and 180 kb in Fig. 2. 
The partial mapping data were inconclusive with respect to € 
casein, but did allow assignment in the middle of the map. Com-
plete PmeI, ClaI, PmeI/ClaI. PmeL/SalI and PmeL/Xhol digests 
position € on a 10-kb C/al fragment between the sites at 200 and 
210 kb in Fig. 2, spanning the PmeI site at 205 kb. 
On the basis of partial Pmel data and complete Xhol, Pmell 
Xhol, and Sail restriction fragments, K casein maps to a 34-kb 
fragment between the C/al sites at 300 and 335 in Fig. 2. 
The bovine genomic casein region has been restriction mapped 
(Ferretti et al. 1990; Threadgill and Womack 1990; Fig. 2). The 
spatial arrangement of the genes is largely conserved between the 
two species (bovine a, 1 . 0 , a 7 . and K caseins are homologous to 
murine a, P, €. and K caseins respectively cattle have no known 
'y casein). The murine calcium-sensitive caseins are present as two 
pairs, separated by approximately 75 kb of intergenic DNA. The K 
casein gene, although some 90-155 kb from the other genes, is 
nevertheless remarkably close considering its evolutionary unre-
latedness. The ratio of K to the calcium-sensitive caseins in milk is 
believed to play a significant role in determining micelle size, milk 
volume, and milk quality (Lin etal. 1989). As has been suggested 
(Alexander etal. 1988: Mercier and Vilotte 1993), the presence of 
the K casein gene close to the other casein genes may indicate that 
coordination of casein gene expression is effected at the transcrip-
tion level, and thus may be indicative of the existence of casein 
locus control. 
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Fig. 2. Restriction nap of the murine casein locus. Scale in kb is shown below the map. C. Cia!; P. Pmel; S. Sail; X. XhaI: 14L and 14R. left and right 
ends of MPI4: 12L and 12R. left and right ends of MPI2. Casein genes are represented by Greek letters: shaded boxes delimit the minimal restriction 
fragment that each gene has been mapped to. Below the murine map are represented the two published maps of the bovine casein locus, to scale and aligned 
at aia 1 . A from Threadgill and Womack 1990; B from Ferretti ci al. 1990. 
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